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ABSTRACT
Climate change is impacting human, wildlife, and ecosystem health in the Arctic. 
Currently, we lack sufficient information to fully appreciate the ramifications of these 
changes and are thus ill equipped for predicting, mitigating or adapting to the outcome of 
such impacts. Warming in the Arctic has generated a need for baseline information on 
biodiversity and ecosystem health such that change over time may be assessed. Sentinel 
species can be used to monitor and therefore, intervene to prevent adverse health 
outcomes before they manifest at the population level. This dissertation examines the use 
of polar bears (Ursus maritimus) and arctic foxes (Alopex lagopus) as sentinels for 
climate change in the Arctic. To this end we: develop hematological biomarkers in polar 
bears which can be used to model change over time in health; demonstrate relationships 
between this biomarker and infectious agent exposure (e.g serology); and establish 
prevalence and risk factors for infectious agents that can serve as indicators of change in 
disease occurrence at the Arctic marine-terrestrial interface. We found that den emergent 
female polar bears with dependent young were the most immunologically vulnerable 
cohort and suggest therefore, that they be targeted in future monitoring efforts. We also 
detected evidence suggesting serologic exposure of polar bears to morbillivirus and 
Toxoplasma gondii may be associated with immunological status and age (morbillivirus 
only). Furthermore, we used molecular epidemiologic techniques to identify the strain of 
the highly lethal morbillivirus in arctic fox as “arctic” canine distemper virus and the 
species of Echinococcus in arctic fox on the Alaska North Slope as Echinococcus
multilocularis. The results of this study illustrate the utility of the “One Health” approach 
in addressing the impacts of climate change. Understanding Arctic ecosystem health will 
require the collaborative efforts of experts in diverse fields as well as input from local, 
traditional ecological knowledge over the proper spatial and temporal scales.
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1INTRODUCTION
The Fourth Assessment Report of the Intergovernmental Panel on Climate Change 
(IPCC, 2007) determined warming of the climate system to be unequivocal. Projections 
for the 21st century demonstrate that global warming will accelerate with predictions of 
the average increase in global temperature ranging from 1.8° C to 4°C. In addition to a 
rise in temperature, IPCC models also predict an increase in precipitation, especially 
during the winter months. Large-scale changes in ocean currents and pH are anticipated 
with warming of the climate system and increases in CO2, with large scale food web 
consequences predicted. In the past 100 years, average Arctic temperatures have 
increased at almost twice the global rate (IPCC, 2007). Over the last thirty years, seasonal 
minimal sea ice extent has decreased by 45,000 km2/year (Parkinson and Cavalieri,
2008). Coastal and marine ecosystems, in particular, are anticipated to be impacted by 
increasing temperatures, changes in precipitation patterns, sea-level rise, altered salinity, 
ocean acidification, and more frequent and intense weather events (Portier et al., 2010). 
These changes are expected to have both direct and indirect impacts on ocean and coastal 
ecosystems by affecting community structure, biodiversity, and the growth, survival, 
persistence, distribution, transmission, and severity of infectious agents, vectors and 
reservoirs (Niemi et al., 2004).
Concerns for Climate Change Impacts on Human Health
Climate change was reported as the most significant global health threat of the 21st
century (Lancet and University College London Institute for Global Health Commission; 
Costello et al., 2009). The Commission statement stressed the necessity of an integrated 
multidisciplinary approach for understanding and potentially reducing the adverse health 
effects upon humans resulting from climate change-based responses. Furthermore, they 
emphasized that climate change will have the greatest impact on those who are already 
the poorest in the world, and increase existing inequities and health disparities (Costello 
et al., 2009). Poverty increases vulnerability to the health effects of climate change, due 
largely to inadequate access to health care alone. It also increases a population’s risk of 
displacement by extreme weather events or environmental degradation. This is due to the 
fact that these groups are not well equipped to recover easily, and as a result, may suffer 
much higher disease risks. Those who work outdoors and people living in coastal and 
riverine zones have also been identified as “at risk” to groups to climate-induced 
environmental changes resulting from flooding and extreme weather events (Portier et al., 
2010). Climate is directly linked to health through changing patterns of disease and 
mortality, extreme weather events, and security of food, water, and shelter. Resident 
indigenous populations of the Arctic are especially vulnerable to climate change due to 
their close relationship with and dependence on the land, sea, and natural resources for 
their well being (Parkinson and Berner, 2009), socioeconomic status, and limited access 
to healthcare infrastructure in some remote regions. In order to develop effective 
adaptation strategies to mitigate risks posed, we must understand the local needs of 
individual populations. Climate change adaptation strategies should include measures to 
provide early warning in order to reduce exposure and susceptibility to climate change
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associated health hazards (Portier et al., 2010). Two of the health concerns for peoples of 
the Arctic with climate change focused upon in these studies are those relating to food 
security (e.g. nutrition and increasing physical hazards associated with subsistence) and 
changing patterns of disease exposure.
Climate Change Impact on Arctic Marine Food Web Dynamics
Over the last few decades, the extent of annual sea-ice has decreased by 5-10% and 
average thickness by 10-15%. Sea-ice is also forming later and breaking up earlier than in 
previous decades (Post et al., 2009). Sea-ice is critical for current polar marine 
ecosystems. For example, it provides a habitat for photosynthetic algae and nursery 
ground for invertebrates and fish during times when the water column cannot support 
phytoplankton growth. When the ice melts, organisms are released into the surface water, 
cultivating large ice-edge blooms important to the overall productivity of the seas 
(Michel et al., 2002). Ice algae are an essential part of the marine food web, contributing 
an average of 57% to the total arctic marine primary production (Gosselin et al., 1997). 
Sea-ice dynamics affect various marine populations and the overall food web in polar 
waters (the cryopelagic food web), which has provided the foundation for the sustenance 
for generations of Inuit peoples. In more practical terms, the sea ice is a needed platform 
for hunting and moving around the Arctic for many species, including humans.
Declines in arctic marine biodiversity expected with climate change may affect 
availability of traditional foods thus presenting an issue for food security. There is
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evidence that changes in biodiversity in the marine food web are already occurring. For 
example, phytoplankton have been declining globally over the 20th century, and long 
term population decreases were negatively correlated with rising sea surface temperatures 
and changing oceanographic conditions (Siegel and Franz, 2010). Phytoplankton forms 
the basis of the marine food chain and sustains diverse assemblages of species ranging 
from tiny zooplankton to large marine mammals, seabirds, and fish. Most of the 
phytoplankton declines occurred in polar and tropical regions in the open oceans where 
most of the phytoplankton production occurs. Furthermore, an analysis of global 
biodiversity patterns for over 11,000 marine species, ranging from zooplankton to sharks 
and whales, found striking similarities among the distribution patterns, with temperature 
strongly linked to biodiversity (Tittensor et al., 2010). These results imply that future 
changes in ocean temperature may greatly affect the distribution of biota in the marine 
environment, and thus alter pathways for environmental agents of disease, such as 
infectious and toxic agents.
Climate Change and Security o f  Traditional Foods in the Arctic 
The availability and cost of store-bought foods are prohibitive in small, isolated 
communities with high poverty rates that are based on combinations of cash and 
subsistence economies. Shipping costs for goods (such as groceries) to these isolated 
communities has increased with the rise of fuel and postage costs. As a result of high 
food costs and socioeconomic factors, subsistence foods provide food security for 
families in northern communities. Declines in Arctic biodiversity may affect availability
4
of traditional foods. Subsistence foods provide between 24% and 98% of energy, protein, 
omega-3 fatty acids, iron, and vitamins A and B 12 in the diet o f Alaska Natives 
(Verbrugge and Middaugh, 2004). The replacement of subsistence foods that are low in 
fat and high in omega-3s, with a market-based Western diet has increased the risk of 
cardiovascular disease and diabetes in Alaska Natives (Verbrugge and Middaugh, 2004). 
Decreased access to traditional foods due to climate change may exacerbate this problem. 
Climate change is already impacting northern communities. For example, the weakening 
and retreat of sea-ice has made access difficult and hazardous for subsistence hunters in 
some regions. Hunting has already become more dangerous and less successful, with 
greater occurrence of injuries and death by drowning (A. Parkinson, 2010 pers. comm.). 
Declines in biodiversity coupled with unpredictability of sea-ice will adversely affect the 
ability of northern peoples to sustain traditional ways of life and also the well-being of 
other apex predators of the ecosystem such as polar bears and arctic foxes.
Climate Change Impact on Biodiversity and Infectious Disease in the Arctic 
Predicted effects of climate change on biodiversity include: changes in distribution, 
geographical range, and abundance of species (including invasive species). These 
changes will impact genetic diversity as well as behavior of migratory species, and in 
severe cases result in local extirpations (e.g., rats on sea bird colonized islands, 
competition between red fox and arctic fox). Alteration in migration routes of prey and 
subsistence species not only impacts nutrition, but also has significant implications for 
disease exposure. For example, as species change ranges carrying potential pathogens
with them, new exposures may occur in naive hosts (e.g., unaffected carrier introduces 
pathogen to a region where highly vulnerable hosts are impacted). In some regions new 
diseases may be established and alteration in host feeding ecology may exacerbate these 
effects. In addition, climate change may increase the transmission cycle of vectors (e.g., 
magnitude related to abundance of vectors, duration of effective disease transmission, 
timing with hosts and parasites) as well as the range and prevalence of vectors and 
reservoir species. Alteration in parasite ecology in the Arctic, associated with warming 
trends, has already been observed. For example, Kutz, et al. (2005) documented a 
shortened life cycle of the nematode parasite (Umingmakstrongylus pallikuukensis) of 
muskoxen, and a resulting increase in parasite burdens within the hosts. This increase has 
been suggested as a contributing factor to increased mortality of muskoxen in Norway 
(Ytrehus et al., 2008). In addition, the increased occurrence of the filarioid nematode 
Setaria tundra in Finnish reindeer (Rangifer tarandus) has recently been linked to higher 
temperatures (Laaksonen et al., 2010).
Climate plays a large role in governing population dynamics of arvicoline rodents. These 
species are not only an important prey base for some Arctic predators, but also hosts for 
some zoonotic diseases. Throughout 2006-2007 there was a sudden, large outbreak of a 
form of hemorrhagic fever called nephropathia epidemica, caused by the Puumala 
hantavirus in northern Sweden. The affected region had experienced a record-breaking 
warm winter. The lack of snow cover likely resulted in a greater contact between the 
bank vole (Myodes glareolus) reservoirs and humans, as voles concentrated inside or
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nearby human dwellings (Evander and Ahlm, 2009). There is concern that climate will 
alter the ecology of Echinococcus spp., an important parasitic zoonosis in the Arctic, 
leading to increased infection pressure to humans. Alterations in fox and rodent 
population dynamics may also impact the ecology of Arctic rabies, a well-known lethal 
zoonosis.
Climate change will affect the microbial population of the macro-environment (soil, air 
and water), as well as host and vector populations. The melting of permafrost, for 
example, can compromise the integrity of sewage lagoons, allowing the discharge of 
waste into rivers, oceans and into contact with human and wildlife hosts. An increase in 
flooding events may result in outbreaks of waterborne infection, such as Giardia spp. or 
Cryptosporidium spp.
Climate alteration is also expected to impact the long-range transport and fate of 
contaminants in the Arctic. Persistent organic pollutants (POPs) volatilize from lower 
latitudes and are transported to the Arctic where they are then deposited via precipitation 
and through other mechanisms (Lohmann et al., 2007). Locally, melting of glaciers may 
directly increase contaminant levels entering the food chain as contaminants deposited 
during their years of historical use are liberated (Blais et al., 2001). Permafrost has acted 
as a sink for POPs, and as it melts the contaminants are released (Suk et al., 2004). 
Reduced marine ice cover will increase ocean-atmosphere gas exchange and therefore, 
deposition of contaminants like polychlorinated biphenyls (PCBs) and toxaphene, which
are still entering the Arctic Ocean via the atmosphere (AMAP, 2003). Indirect effects 
may occur as predators shift prey species. For example, increasing contaminant loads 
have been documented in some polar bear sub-populations, possibly as a result of dietary 
shifts due to declining sea-ice (McKinney et al., 2009). Stressors including decreasing 
access to optimal prey species, heat stress, exposure to increasing levels of contaminants 
and increasing burdens of infectious agents may act in synergism to decrease fitness of 
arctic apex predators who reside at the top of the arctic marine food web.
Climate Change and Ecosystem Health: The “One Health” Approach
Anticipated changes in the Arctic have generated concern for the health of both human 
and wildlife populations. The health of ecosystems is reflected in the health of animals 
inhabiting those ecosystems; and the animals affect the health of the system as well. 
Viewing the health of animals and humans as intertwined (“One Health”) can allow the 
development of indicators that are suitable for both. The term ‘health’ has historically 
been used to describe the vitality of individuals and, more recently, of populations 
(humans, domesticated animals and wildlife). The extension of the use of the term to 
describe regional ecosystems is a response to accumulating evidence that human- 
dominated ecosystems have become highly dysfunctional (Vitousek et al., 1997). The 
concept of ecosystem health integrates the health humans with that of animals and 
ecosystems. Here we use the term ecosystem health to indicate an ecosystem’s resilience, 
biodiversity, and ability to provide services to humans (Rapport et al., 1998). Rapport et 
al. (1998) define indicators of ecosystem health as: vigor measured in terms of ‘activity,
metabolism or primary productivity’; organization which can be assessed as the diversity 
and number of interactions between system components; and resilience (counteractive 
capacity) measured in terms of a system’s capacity to maintain structure and function in 
the presence of stress.
There is a need for greater data sharing and collaboration between animal and human 
health professionals regarding animal and human populations. In the United States, links 
between human and animal disease surveillance are still limited by the separation of 
human and animal disease monitoring efforts. With the exception of disease-specific 
programs for rabies and potential bioterrorism agents, there are few mandates for direct 
communication between animal and human health officials. A survey of United States 
Veterinarians in agriculture departments in 43 states found that only 19% of states require 
reporting of zoonotic diseases to public health departments (Rabinowitz et al., 2009). The 
increased use of molecular techniques to understand the evolution of pathogens crossing 
between animal and human populations and between species has been identified as a 
useful means to address knowledge gaps in linking animal and human health (Rabinowitz 
et al., 2009). The increasing sophistication o f informatics tools and surveillance using 
molecular epidemiologic approaches can greatly enhance our ability to monitor 
ecological health. Enhanced animal surveillance and detection of emerging (and re- 
emerging) zoonoses are needed to assess ongoing challenges posed to ecosystem health.
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Using Sentinels to Assess Arctic Ecosystem Health
The precise consequences of changes in climate in the Arctic cannot be predicted 
adequately based on our current understanding of these systems, and certainly not via an 
assessment of the status of a single species (e.g., humans). This deficiency of information 
is due to a number of challenges including but not limited to: the lack of knowledge of 
the natural history of many organisms in the Arctic; logistical challenges associated with 
collecting data in the Arctic environment, and inadequate surveillance and diagnostics. In 
the sea-ice ecosystem, the study of individual ecological components is unfeasible and 
inefficient. The dearth of information concerning impacts of ongoing changes in the 
Arctic and the difficulty of gathering information in these remote ice-covered areas 
underscores the need to identify and monitor sentinel species.
A sentinel species is defined as one that can provide insight into the health of an 
ecosystem, based on user-defined (e.g., researchers, conservationists or policymakers) 
objectives (e.g., disease, parasites, toxics, climate change, habitat destruction), coupled 
with the utility and vulnerability of this species to the stress (Aguirre, 2009). Because 
animals typically have shorter, more physiologically compressed life-spans than humans, 
the latency periods for the development of some diseases are shorter. Animal studies are 
also free from some confounders (lifestyle and occupational risk factors) that complicate 
interpretation of human studies (Backer et al., 2001).
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Use of animals as sentinels for human health threats dates at least as far as the era when
coal miners brought canaries into mines to provide warning of toxic gases. Sentinel herds 
of livestock are utilized to indicate exposure to brucellosis and other transmissible 
diseases (Rabinowitz et al., 2009). In the 1962 publication the Silent Spring, Rachel 
Carson wrote “our fate is connected with the animals”. Carson recognized that humans 
and animals share local environments, air, water, and food chains and that the molecular, 
biochemical, and cellular processes, which respond to toxic agents are common among 
most vertebrate species. This work launched the modem environmental movement. 
Ecosystem approaches to health, or EcoHealth emerged in the 1990s, and include the 
“One Health” initiative and Conservation Medicine. These movements emphasize the 
links between human, animal and ecosystem health and support the collaboration of 
practitioners and researchers in ecology, wildlife biology and management, fisheries, 
toxicology, human medicine and veterinary medicine. Studies utilizing the ecosystem 
health approach differ from traditional, single discipline studies in that they require the 
expertise of professionals from diverse disciplines to work together. This is clearly 
reflected in the diverse backgrounds of the Graduate Committee that guided the following 
body of research for this PhD student.
Species with limited distributions or with specialized adaptations that depend on sea-ice 
will be impacted by climate change in the Arctic. Polar bears, for example, require sea- 
ice for prey access and other aspects of their life history (Stirling and Lunn, 1997; 
Amstrup, 2003). Observed declines in sea-ice availability associated with reduced body 
condition have been linked to declines in reproduction, survival, and population size in
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some subpopulations. Continued habitat reduction is likely to increase nutritional stress 
among polar bears. Observed (Comiso, 2006) and projected (Holland et al., 2006) sea-ice 
declines led to the conclusion the future welfare of polar bears may be diminished 
(Amstrup et al., 2008) and to their listing as a threatened species in the US (U.S. Fish and 
Wildlife Service, 2008).
As apex predators in the Arctic, polar bears integrate the status of lower trophic levels.
For example, changes in biodiversity among lower trophic levels are reflected in the 
health of consumers at the top of the Arctic marine food web (e.g. “bottom-up” effects). 
Thus, polar bears provide a means to assess the health of a largely invisible and 
inaccessible marine sub-sea-ice ecosystem. Species that are high on the food web are also 
most comparable to humans conducting subsistence activities in the Arctic. Futhermore, 
they are the most sensitive to bioaccumulative and biomagnifying stressors. Humans are 
also apex predators in the Arctic marine food web, thus polar bears can serve as proxies 
for assessing impacts of changes in the arctic ecosystem upon subsistence users. Because 
human arctic residents and polar bears both feed at the apex of the ecosystem (consuming 
many of the same species), polar bears can serve as indicators of human health in the 
Arctic, regarding access to and “quality” of subsistence foods (e.g. low in contamiants, 
free of disease.
A major challenge of using apex predators as sentinels is that such species are often rare 
and difficult to study. Efforts to assess polar bear health, for example, are quite costly and
1 2
logistically challenging. Furthermore, only minimally invasive sampling techniques may 
be used, limiting the amount of information obtained regarding reproductive status, 
general condition, health and disease. The arctic fox has a similar feeding ecology as the 
polar bear and can therefore be used as a “surrogate sentinel” due to its abundance, and 
because collecting tissues does not impair populations, especially when coordinated with 
ongoing trapping and nuisance program efforts. In additon, they are well known to thrive 
around human habitation thus contact with this species and their associated pathogens, is 
very likely. This makes them particularly useful as a sentinel for changes in disease 
ecology because they share some pathogens with polar bears and humans [e.g. rabies 
(with both humans and polar bears), Echinococcus (with humans only), morbillivirus 
(with polar bears only)].
While there are a number of human health concerns related to climate change, this thesis 
focuses on the use of sentinels to indicate changes in food security and patterns of 
infectious disease exposure in the Arctic (Figure 1). Figure 2 illustrates the complex 
interrelatedness of these factors. Change in patterns of infectious disease and in food 
security impact the health of both humans and apex predators. For example, hazards 
associated with hunting on sea-ice effect food security directly (e.g. via lowered hunting 
success, risk of injury) and indirectly as change in sea ice dynamics impact the 
availability of specific prey species. Increases in contaminant levels in subsistence foods 
and/or shift in subsistence/prey species, which may occur with warming in the Arctic 
might result in adverse health outcomes in apex predators. Change in the ecology of
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zoonotic disease impacts both the health of humans and of wildlife directly, via morbidity 
and mortality and indirectly by influencing the availiability of subsistence/prey species. 
Change in ecology of non-zoonotic disease impacts the health of some apex predators 
directly and also affects food security of apex predators and humans both.
Using Biomarkers to Evaluate Ecosystem Health
The development of diagnostic tools and epidemiology is needed to establish a tool set 
for evaluating ecosystem health. In many countries, human health data are archived in 
publicly funded centralized databases and can be retrieved for epidemiologic studies. In 
contrast, births, deaths, and health status of free ranging animals are largely unobserved 
and therefore, unrecorded. If recorded, data quality varies and is generally inaccessible. 
Few animals are found and thoroughly necropsied to ascertain cause of death and/or 
assess variations in these events over time and space (trends assessment). The process of 
disease is a continuum from the onset of exposure to the stressor (s) through precursor, 
compensatory states (e.g. impairment), and clinical illness (or dysfunction), which may 
result in irreversible impacts or death (Fox, 2001). Change in physiological resilience or 
tolerance can be subtle and elusive. Often, there is a “tipping point” (defense mechanism 
is depleted or no longer effective) at which a major insult results from a stressor that is 
typically not harmful alone. For example, some epizootics occur only in the presence of 
other stressors (e. g immunosuppression which may result from one or multiple 
stressors). This “tipping point” perspective is not well appreciated or evaluated. However, 
morbidity and mortality lead to population level consequences (i.e. alterations in
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abundance and distribution, age and sex ratios, genetic diversity) and potential 
extinctions of local populations are then noted. Monitoring for the impairment of 
physiologic (molecular, biochemical, cellular) and behavioral responses can provide early 
warning before impacts occur at the population level and thus allow for effective 
management intervention. Biomarkers, which can assess the integrated impact of 
stressors, are of great utility for such monitoring, but underutilized.
Biomarkers have been traditionally defined as cellular, biochemical or molecular 
alterations that are measurable in biological media such as tissues, cells, or fluids (Hulka 
et al., 1990). This definition was later expanded to include biological characteristics that 
can be objectively measured and evaluated as indicators of normal biological or 
pathogenic processes (Naylor, 2003). With the growth and advancement of molecular 
biology and laboratory technology, the use of technically advanced biomarkers has 
greatly expanded and now moved well beyond human medicine.
The identification and quantification of individual stressors (e.g. chemicals, pathogens, 
etc.) and associated risk assessment is time consuming and costly. Furthermore, 
evaluating individual stressors cannot indicate the synergistic impact of combined 
stressors. Additionally, some biomarkers can reflect the entire spectrum of disease, from 
early manifestations to terminal stages. Biomarker data can be combined with 
demographic measures (population size, survival and recruitment rates, age structure, sex 
ratios) to develop predictive modeling capacity, identify at risk cohorts, and to facilitate
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observation of the cumulative effects of multiple stressors (Fox, 2001). Today, the great 
utility of biomarkers as tools for ecological health assessment is well recognized. With 
the “One Health” initiative, the use of such tools has grown vast.
Thesis Objectives
In the following studies, we employ a “One Health” approach for establishing capacity to 
monitor changes in ecological health on the Alaska North Slope anticipated with climate 
change. Such questions require the collaborative efforts of veterinarians, chemists, 
microbiologists, health care providers, as well as land and organism based managers 
(resource management). Thus, diverse techniques, tools and analytical methodologies 
were employed, which reflects need for transdisciplinary efforts to address questions 
regarding ecosystem health. Here we: establish cohort specific baseline data as a tool for 
sentinel population health assessment using hematological indices; use these indices as a 
biomarker o f exposure to select indicators of infectious agents; examine prevalence 
patterns and risk factors to these same indicators using serology; and employ molecular 
epidemiologic techniques to investigate strains of canine distemper virus (CDV) and 
Taeniid parasites in sentinel arctic canids.
Chapter one develops capacity for modeling trends in polar bear health by providing a 
benchmark point for a biomarker (hematological indices). Assessing specific biomarkers 
in polar bears can provide otherwise unavailable insights for resource managers. Long 
term trends of this biomarker can be used to assess the health of polar bears, as well as
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whether there may be cause for concern for the health outcomes of humans. For humans, 
and domestic and laboratory animals, this biomarker is a well-characterized tool used 
regularly by health professionals and researchers. For polar bears, we established these 
measures for specific age and reproductive cohorts before venturing into a response 
measure. Chapter two examines associations of hematological parameters (biomarker 
from Chapter 1) in polar bears with titers to two “indicator” infectious agents present in 
North Slope predators. In doing so, we relate a response metric to exposure instead of 
simply reporting seroprevalence, thus advancing these efforts to provide more relevance 
to potential impacts.
In chapter three, the arctic fox was examined to investigate the strain of CDV circulating 
on the North Slope of Alaska, because we did not have access to infected tissue (only 
blood) in polar bears or other potential carnivore hosts in the area. In chapter four we 
confirm the identity of and provide benchmark prevalence data for Taneiid spp. currently 
on the Alaska North Slope. Taeniid tapeworms (Eucestoda: Cyclophyllidea: Taeniidae) 
are parasites of mammals, with carnivores as definitive and mostly herbivores as 
intermediate hosts (Lavikainen et al., 2008). Because of their medical and veterinary 
significance, with respect to morbidity and mortality in humans and production losses to 
domestic food animals worldwide, taeniids have been the focus of intensive 
epidemiological, ecological and taxonomic studies (Hoberg, 2002). This research has 
utility for medical epidemiologists because echinococcosis is of particular public health 
concern in the Arctic. We also demonstrate the advantages of using canid definitive hosts
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as sentinels for risk of human infection with these significant parasite zoonoses.
These studies establish a “tool set” for assessing change in ecosystem health anticipated 
with climate change on the Alaska North Slope with a focus on apex ursid and apex canid 
predators. Such devices have utility in informing both public and wildlife population 
health. The evaluation of biomarker responses in sentinel species can provide valuable 
insights into alteration in ecosystem health if the proper multidisciplinary context is 
maintained to assure the best analysis and interpretation of these data. These efforts 
require logistical and intellectual inputs from the field (community) to the laboratory. To 
this end, this thesis strives to coalesce the relevant biological variables in an ecological 
context in the analysis and interpretation of these data. Through these studies, we hope to 
illustrate the value of using the “One Health” approach to answer questions regarding the 
impact of climate change on ecosystem health in the Arctic.
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CHAPTER 1
Hematology of southern Beaufort Sea polar bears (2005-2007): Biomarker for an
arctic ecosystem health sentinel1
1.1 ABSTRACT
Declines in sea-ice habitats have resulted in declining stature, productivity and survival 
of polar bears in some regions. With continuing sea-ice declines, negative population 
effects are projected to expand throughout the polar bear’s range. Precise causes of 
diminished polar bear life history performance are unknown, however climate and sea-ice 
condition change are expected to negatively affect polar bear (Ursus maritimus) health 
and population dynamics. As apex predators in the Arctic, polar bears integrate the status 
of lower trophic levels and are therefore sentinels of ecosystem health. Arctic residents 
feed at the apex of the ecosystem, thus polar bears can serve as indicators of human 
health in the Arctic. Despite their value as indicators of ecosystem welfare, population- 
level health data for U.S. polar bears are lacking. We present hematological reference 
ranges for southern Beaufort Sea polar bears. Hematological parameters in southern 
Beaufort Sea polar bears varied by age, geographic location and reproductive status.
Total leukocytes, lymphocytes, monocytes, eosinophils and serum immunoglobulin G
1 Published as: Kirk CM, Amstrup S, Swor R, Holcomb D, O'Hara TM. 2010. 
Hematology of Southern Beaufort Sea polar bears (2005-2007): biomarker for an arctic 
ecosystem health sentinel. EcoHealth. doi:10.1007/S10393-010-0322.
were significantly greater in males than females. These measures were greater in non- 
lactating females ages >5 than lactating adult females ages >5; suggesting females 
encumbered by young may be less resilient to new immune system challenges that may 
accompany ongoing climate change. Hematological values established here provide a 
necessary baseline for anticipated changes in health as arctic temperatures warm and sea- 
ice declines accelerate. Data suggest that females with dependent young may be most 
vulnerable to these changes and should therefore be a targeted cohort for monitoring in 
this sentinel.
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1.2 INTRODUCTION
Observed (Comiso, 2006) and projected (Holland et al., 2006) sea-ice declines led to the 
conclusion the future welfare of polar bears may be diminished (Amstrup et al., 2008) and 
to their listing as a threatened species (U.S. Fish and Wildlife Service, 2008). Polar bears 
require sea-ice for prey access and other aspects of their life history (Stirling and Lunn, 
1997; Amstrup, 2003). Body condition and stature changes have been reported for southern 
reaches of polar bear range and in the more northerly polar basin (Stirling et al., 1999,
Rode et al., 2010). Observed declines in sea-ice availability associated with reduced body 
condition have been linked to declines in reproduction, survival, and population size of 
polar bears (Stirling et al., 1999; Obbard et al., 2006; Stirling and Parkinson, 2006; Regehr 
et al., 2009). Continued habitat reduction is likely to increase nutritional stress among polar 
bears (Derocher et al., 2004; Amstrup et al., 2008, 2009). Climate warming, the 
concomitant alterations in environmental pathways and anticipated changes in nutritional 
status are expected to increase exposure and susceptibility of polar bears to an increased 
variety of disease agents (MacDonald, 2003; Derocher et al., 2004; Burek et al., 2008).
Arctic climate historically limited biodiversity of infectious agents and limited life cycles 
of those present (Kutz et al., 2005). Hence, polar bears are likely immunologically naive 
to a significant portion of new disease agents they will encounter with climate change 
driven entry via abiotic and anthropogenically driven abiotic routes. This raises concern 
that increasing temperatures, human activities, humidity and frequency of extreme 
climatic events will cause direct physiological impacts and result in range changes of
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disease vectors and intermediate hosts. For example, ballast water from large vessels is a 
well-known means for introduction of pathogens to new environments (van Riper, 1991). 
Anticipated expansions in vessel traffic may introduce new organisms concurrent with 
altered migration patterns and prey availability (MacDonald, 2003). With range shift and 
diminishing sea-ice, polar bears may access alternate and potentially less suitable prey 
species such as the harbor seal (Phoca vitulina) and their concomitant pathogens 
(Derocher et al., 2004). In addition, polar bears may begin to eat more of the intestines 
and internal organs of seals as they become nutritionally stressed, thereby exposing them 
to an increased burden and variety of pathogens (Derocher et al., 2004). Increased inter- 
and intra-species interactions, as higher densities of polar bears spend more time 
aggregated onshore will lead not only increased pathogen transmission opportunities, but 
also greater human-wildlife conflict. For example, presence of landfills and hunter-killed 
whale carcasses has concentrated polar bears, arctic fox, and possibly, domestic canines 
in close proximity to humans (Bentzen et al., 2008).
The polar bear is a circumpolar top predator of the arctic marine ecosystem (Amstrup, 
2003) and thus presents an ideal sentinel for arctic marine ecosystem health (Bossart,
2006). Polar bears integrate lower trophic levels and thus reflect ecosystem health (Grosell 
and Walsh, 2006). They provide an opportunity to assess the health of a largely invisible 
and inaccessible marine sub-sea-ice ecosystem. Humans are also apex predators in the 
arctic food chain, thus polar bears can serve as proxies for assessing impacts of changes in 
the arctic ecosystem on subsistence users. The dearth of information concerning impacts of
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ongoing changes in the Arctic and the difficulty of gathering information in these remote 
ice-covered areas underscores the need to identify and monitor sentinel species. Polar bears 
can provide otherwise unavailable insights for resource managers (Bonde et al., 2004). 
Leukocytes are an essential part of the immune system that protect the organism from 
infectious agents. Hematology represents valuable tools for evaluating general health status 
and response to infectious agents of free ranging wildlife. These measures include increases 
and decreases in general and/or specific cell type populations as concentrations (cells/pl) or 
as proportions (%) of populations. As a biomarker for monitoring the health of sentinel 
species, they in turn serve as indicators of ecosystem health. Although such physiological 
indices can detect changes in animal health before they are apparent at the population level, 
knowledge of immune system status of polar bear populations is inchoate. Descriptions of 
hematological indices, the blood values that indicate immune system status, are limited and 
sample sizes are small or absent and do not provide adequate reference for future change. 
Because polar bears reflect the health of their ecosystem, knowledge of “normal 
hematological values” will be an essential part of monitoring and response to projected 
changes (Aguirre et al., 2002).
Here we provide a hematological baseline for the southern Beaufort Sea subpopulation of 
polar bears. This baseline provides a yardstick against which hematology studies of the 
future can be measured and will assist in the use of the polar bear as the “canary in the 
[Arctic] coal mine” (Tabor and Aguirre, 2004; Bonde et al., 2004). The following 
companion paper establishes seroprevalence, patterns for exposure risk and associations
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with hematological biomarkers for two indicator pathogens (morbillivirus and 
Toxoplasma gondii) chosen based on previous documentation of antibodies to these 
agents in this species as well as their potential to be altered by climate change in the 
Arctic ecosystem.
1.3 METHODS
1.3.1 Animal Capture
We captured polar bears by injection of Telazol® in darts fired from helicopters (Stirling 
et al., 1989). Studies occurred in the southern Beaufort Sea from late March through early 
May 2005, 2006 and 2007. Study area encompassed the region between Barrow (157°00’ 
W) and Demarcation Point (141°00’ W) and up to approximately 80 km off shore (Figure 
1.1). Capture missions were launched from logistics bases at Barrow, Prudhoe Bay, and 
Kaktovik with the exception of 2006 (Kaktovik). Daily routine of launching and 
returning assured some clustering of captures near each of these locations. Capture 
procedures were approved by the U.S. Geological Survey, Alaska Science Center, 
Institutional Animal Care and Use Committee.
Ages of captured polar bears were known for animals first captured with their mothers as 
dependent young. Ages of independent animals were determined by counting cementum 
annuli of an extracted vestigial premolar (Calvert and Ramsay, 1998). Each bear was 
marked with a unique tattoo and ear tag number upon first capture assuring individual
identification upon recapture. We classified age classes representing distinct life history 
stages (Amstrup, 2003): 1-2 years of age (dependents captured with mother); 3-4 years 
(weaned, pre-breeding age); 5-7 years (age of sexual maturation); and > 8 years of age 
(greater likelihood of reproductive success) (Amstrup, 2003). First year animals (cubs) 
were not included in our study. We compared reproductive cohorts: females > 5 years 
with dependent young (lactating), solitary females > 5 years (non-lactating), and males >
5 years. Recognizing potential differences in exposure to human influences (discarded 
foods, stress from human encounters) we compared hematological parameters among the 
three logistics bases.
1.3.2 Blood Collection and Processing
We used evacuated tubes (Vacutainer, BD Biosciences; Franklin Lanes, NJ) for blood 
collection by venipuncture of the femoral vein or artery. Sera derived from blood without 
anticoagulant were separated by centrifugation at 1,500 x g for 5 minutes (TRIAC, Clay 
Adams Co., Parisippany, NJ, USA) and frozen at -20°C. Samples were designated as 
lipemic if a “fat plug” formed between the clot and serum. Sera were stored at -70°C 
upon return from the field. We prepared slides for leukocyte differentials, and determined 
total hematocrit, plasma protein and leukocyte counts using blood collected into EDTA 
treated tubes. These measures were determined on the day of capture to avoid time 
dependent post-sampling changes.
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1.3.3 Hematology
We determined leukocyte type counts as percentages to provide a differential profile for 
each polar bear and calculated absolute counts. The differential profile reveals the 
relative abundance of each cell type, while the absolute concentration expresses how 
many cells of each type are present per volume (pi) of blood. Differential blood cell 
counts were performed using blood smears stained with Wright’ s-Giemsa by identifying 
and classifying 100 leukocytes into the specific morphologic types (neutrophils, 
lymphocytes, monocytes, eosinophils, and basophils). Three independent readers 
conducted differential counts and statistical bias was assessed by plotting values obtained 
by readers against one another using the most experienced reader’s value as the 
independent variable. Counts were statistically unbiased among readers and therefore, 
count values obtained for all readers were averaged for each individual animal. Total 
leukocyte counts were determined microscopically using the Unopette® system (BD 
Biosciences; Franklin Lanes, NJ, USA) and hemocytometer according to manufacturer’s 
instructions. Absolute counts for specific cell types were calculated as the product of 
mean percentage as determined in the differential count (e.g. % neutrophils) and total 
leukocyte count for each individual. We determined hematocrit for EDTA treated whole 
blood using a high-speed micro-centrifuge for 3 minutes at 12,600 x g (TRIAC; Clay 
Adams Co., Parisippany, NJ, USA) and measuring the resulting packed cells as a percent 
of blood volume using Critocaps® chart-type microhematocrit tube reader (McCormick 
Scientific; St. Louis, MO, USA) taken in duplicate for each animal and averaged. We 
compared our data to hematological reference ranges reported in the International Species
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Information System (ISIS, www.isis.org; 200 samples collected from 90 individual polar 
bears) and the CRC Handbook of Marine Mammal Medicine where Cattet and Caulkett 
(2001) contributed hematological ranges (no means) for between 15 and 181 free-ranging 
Churchill, Manitoba (Canada) polar bears. Hematocrit values were compared to those for 
Svalbard (Tryland et al., 2002) and Manitoba (Lee et al., 1977) polar bears; and to 
previously unpublished hematocrit values measured for Beaufort Sea polar bears between 
1982 and 1988.
Immunoglobulin G (IgG) from polar bears was isolated by adsorption of serum IgG on a 
Protein G Sepharose 4 Fast Flow column (Sigma-Aldrich) and subsequent desorption 
using a reducing pH gradient starting with 0.01M PBS, pH 7.4 and then an increasing 
proportion of 0.1M citric acid, pH 2.7 was added (Bemhoft et al., 2000). Purified IgG 
was quantified using Pierce BCA protein assay kit and sent to Cocalico Biologicals,
Inc.™ (Reamstown, PA, USA) for generation of goat and rabbit-anti polar bear IgG. 
Specificity of antiserum generated was assessed via immunoelectrophoresis. Serum IgG 
concentration was measured using a single radial immunodiffusion assay as described 
previously (Mancini et al., 1964). A dilution series (1,000 mg/ml, 800 mg/ml, 600 mg/ml, 
400 mg/ml, and 200 mg/ml) of polar bear IgG was run on each plate to serve as a 
standard curve. An aliquot of pooled polar bear serum was also run on each plate to serve 
as a positive control and each serum sample was run in duplicate on independent plates. 
The diameters of the precipitation zones were evaluated using a “measuring viewer”
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(Behring Institut, Germany), and IgG concentrations (mg/ml) calculated from the 
standard curve on each corresponding plate.
1.3.4 Statistical Analyses
Summary statistics were calculated and normality assessed using boxplots and the 
Shapiro-Wilk goodness of fit test (JMP 7; SAS Institute, Cary, NC, USA). We used the 
Grubb’s test to determine the significance of outliers. Suspected outliers with lack of 
significant deviation were included in the calculation of means, 95% confidence interval, 
median, standard deviation, and range. Some individuals were excluded on the basis of 
missing values. Nine bears (<5% of those captured) were recaptured and re-sampled 
during the study. Correlation analysis demonstrated independence of sample 
measurements over time. Reference ranges were calculated with and without these 
replicate measures, the maximum difference in any calculated range was less than 2%. 
Therefore, reference ranges reported here include all samples. Log transformations were 
employed where data were not normally distributed. We compared means among age and 
reproductive cohorts and across years and locations using analysis of variance and post- 
hoc Tukey-Kramer test for normally distributed variables and the Kruskal-Wallis test for 
non-normal data. Homogeneity of variance among groups was assessed using O’Brien’s, 
Levene’s and the Brown-Forsythe test(s). We used the Welch test to compare groups 
where variance was unequal. We also used the post-hoc Dunnett-Tukey-Kramer pairwise 
multiple comparisons test to determine which groups were significantly different (R 
Development Core Team, 2006). Student’s t-tests were used for intersex comparisons
(JMP 7; SAS Institute, Cary, NC, USA). Interaction between variables (age, sex, location 
and year) and each hematologic parameter (e.g. hematocrit) were explored via regression 
utilizing a backwards stepwise approach and Akaike’s Information Criteria for model 
selection where age is a continuous variable, sex is male or female, year is 2005, 2006, 
2007 and location is Barrow, Prudhoe or Kaktovik (R Development Core Team, 2006). 
Linear relationships between age (continuous variable) and all parameters were assessed 
using simple bivariate plots.
Many statistically significant differences among sex and age classes were small, thus we 
emphasize that statistical significance among reference values may not imply biological 
significance. This is partly explained by the fact that the null hypothesis (samples being 
compared are identical) is probably seldom true (Heath, 1995), and when conducting a 
large number of statistical tests, some will appear significant by chance alone. Therefore, 
to avoid over-interpretation, we quantified differences among reference values as a 
percentage. We calculated percentage differences subtracting the first parameter from the 
second, dividing the difference by the first parameter and multiplying by 100. To be 
consistent with regard to possible direction of differences, parameters were designated as 
“first” or “second” based upon sex and age status. There are no established rules dictating 
how large a difference is required to achieve biological importance. We selected 
biological significance of differences smaller than 20% as questionable and that 
differences >20% are noteworthy.
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We analyzed hematological data from 98 female and 91 male polar bears captured in the 
southern Beaufort Sea of Alaska (2005, 2006, 2007). We observed no overt clinical signs 
of disease upon gross examination. Reference values for all polar bears across sample 
years and cohorts are presented (Table 1.1a). Mean values for total leukocytes, 
neutrophils, lymphocytes, monocytes, leukocyte differential counts, and hematocrit 
measured in the springs of 2005 (n=63), 2006 (n=68), and 2007 (n=59) are within one 
standard deviation of values reported for captive polar bears (ISIS Database) (Table 
1.1b). Eosinophil and basophil counts were less than those reported by ISIS and free- 
ranging Churchill, Manitoba polar bears (Catett and Caulkett, 2001) (Table l.la-c). IgG 
measured for southern Beaufort Sea polar bears fell within one standard deviation of that 
reported for Svalbard, Norway polar bears (Bemhoft et al., 2000).
Several parameters varied significantly between sexes. Total leukocyte, neutrophil, 
monocyte, and eosinophil counts and IgG were significantly greater in males than 
females (all age classes and reproductive cohorts are combined, Table 1.2 a-c). We also 
noted significant differences between lactating and non-lactating females (Table 1.3). 
Total leukocytes; lymphocytes, monocytes, eosinophils (absolute count and by % of 100 
cells); and IgG were significantly greater in non-lactating females ages >5 than lactating 
adult females ages >5. When males aged >5 were compared to each female reproductive 
cohort, total leukocytes, absolute counts for lymphocytes; neutrophils, monocytes, 
eosinophils and IgG were significantly greater than that of lactating females. Percent
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1.4 RESULTS
lymphocytes for males aged >5, however, were lower than that of lactating females. No 
biologically significant differences were evident between males ages >5 and non- 
lactating females ages >5. We also noted differences among age cohorts (Tables 1.4a-d 
and Table 1.4e). Neutrophil counts were significantly greater in bears > 8 than ages 5-7. 
Lymphocyte counts were significantly greater in polar bears aged 1-2, 3-4 and 5-7 than 
bears aged > 8 years. Percent neutrophils were greater in individuals > 8 than age cohorts 
3-4 and 5-7. Bears aged 3-4 displayed significantly greater percentage eosinophils than 
ages 1-2. We observed significantly greater percent lymphocytes in polar bears aged 1-2, 
3-4 and 5-7 than > 8 years. Total IgG was significantly greater in ages > 8 than all 
younger bears. Regression analyses revealed that log, neutrophils, and IgG increased with 
age while log (lymphocytes) and lymphocytes decreased with age. R2 values were less 
than 20%. Hematology parameters did not differ significantly across years. Mean 
monocyte counts varied among locations (Welch test p >0.0279). Dunnett-Tukey-Kramer 
pairwise multiple comparison test (adjusted for unequal variances and sample sizes) 
revealed that only Kaktovik and Prudhoe samples were significantly different (Figure 
1.2).
1.5 DISCUSSION
We report hematology values for free ranging polar bears with sample size sufficient to 
establish “normal” ranges for specific sex, age, and reproductive cohorts. Establishing 
normal baseline ranges for these parameters is necessary to monitor trends in polar bear 
health and for assessing impacts of toxicants, infectious agents, nutrients, etc. The ability
41
to better understand and monitor polar bear health will allow researchers and managers to 
use the polar bears’ sentinel status as a window into arctic marine ecosystem health.
Leukocyte data have been available for captive polar bears (ISIS) but sample sizes were 
potentially compromised by repeated measures and variation in animal care regimens 
among captive institutions. The utility of these data from captive bears for assessing free 
ranging bears may be limited. Insufficient data have previously been available from wild 
bears to establish useful baselines or to compare with values from captive animals. For 
example, studies in Manitoba, Canada and Svalbard, Norway (N=33, Lee et al., 1977; 
N=31 Tryland et al., 2002) reported biochemical values including hematocrit for wild 
polar bears. Sample sizes, however, were limited and leukocyte profiles were not 
available. Leukocyte data available from free-ranging Manitoba polar bears (Cattet and 
Caulkett, 2001) reported sample sizes ranging from 18 to 151 without details (e.g. mean 
values or measurements of variation) necessary for making comparisons among cohorts 
or geographic regions. This lack of detail in previously published data limits the ability of 
using polar bears as sentinel species for arctic ecosystem health.
Most equipment used (e.g. clinical analyzers) for assessing blood cell types is calibrated 
for domestic species presenting technical challenges in measuring blood cell types for 
wildlife. The majority of species have unique blood cell morphology and, therefore, using 
a clinical analyzer that is, for example, calibrated for canines, to determine polar bear 
leukocyte profiles, could result in erroneous measurements. Thus we used traditional
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microscopy wherein cell types were determined by multiple observers familiar with 
leukocyte morphology for a variety of species. Previously published values lack details 
on methodology, sample size and descriptive statistics; our dataset provides means, SD, 
and 95% Cl; parameters necessary for statistical comparisons among specific cohorts 
(age, sex, reproductive status) among polar bear populations and over time.
Many factors including nutrition, genetics and stress influence hematology values.
Despite differences between captive and free ranging polar bears (e.g. activity level, 
nutrition, environment) several hematological parameters were similar. Differences 
between our data and those observed for ISIS and Churchill, Manitoba (Cattet and 
Caulkett, 2001) polar bears in eosinophils and basophils may be due to differences in 
methodologies in animal capture, sample collection and measurement, environment and 
exposure and/or stochasticity, or a combination thereof. The absence of details regarding 
previously published values complicates assessment of variation.
Because hematological analyses for captive bears are primarily conducted using 
automated analyzers, differences in parameter values may reflect variation in equipment, 
reagents, and calibration across institutions and time. A description of methods used to 
count cell types for Manitoba bears (Cattet and Caulkett, 2001) was unavailable, but 
seasonality of sample collection, variation in environmental conditions and antigen 
exposure and other unknown factors could contribute to differences observed between
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sample populations. Cell types for which differences were observed are present in smaller 
numbers and therefore stochastic effects could play a role.
Variation we report may reflect ecological differences among sex and age classes of polar 
bears. We sampled polar bears in spring when females with cubs emerge from dens, 
when non-lactating females come into estrous, and when naive ringed seal (Phoca 
hispida) pups are most vulnerable to predation. At this time, female polar bears are 
focused on taking advantage of foraging opportunities. Den emergent females must 
restore body reserves lost during hibernation, gestation and lactation. Sexually mature 
males, however, often forego favorable feeding opportunities to focus on finding mates. 
Because males may be able to breed at 3 years of age (Rosing-Asvid et al., 2002; Cronin 
et al., 2009), the physiological effects of voluntary spring fasting may show up early in 
life. Hence, in addition to possible differences between the sexes, seasonal differences 
would be expected. Because our 2005-2007 samples were collected in spring only, we 
could not address seasonal differences. Comparing hematocrit values from our recent 
samples to values from samples collected in late winter, spring, and fall of 1982-1988 did 
confirm hematocrit values measured in the 1980s were higher in fall than in late winter or 
spring. Hematocrit provides an evaluation of red blood cell status and can indicate 
anemia (numerous causes, e.g. nutrition), blood loss, or dehydration. This corresponds 
with the fact that Beaufort Sea polar bears are in their best condition in fall and poorest in 
late winter and early spring (Dumer and Amstrup, 1996). Mean hematocrits for Beaufort 
Sea bears in the current study, (limited to spring captures) were similar to those
determined for spring captured bears in 1982-1988 (Tablesl.lc). The recent hematocrit 
measurements were also similar to those determined for free ranging fall captured 
Manitoba polar bears. The similarity between many of our values from spring captured 
polar bears in the Beaufort Sea and those captured during an extended fast when 
Manitoba bears are trapped on land during a protracted period of sea-ice absence (Lee et 
al., 1977; Table 1.1b), provides evidence that late-winter and early spring is a period of 
physiological limitation for polar bears in the Beaufort Sea.
Sex steroids may play a role in the sexual dimorphism of hematologic (immune) patterns. 
For example, human females typically have decreased cell-mediated immunity responses 
than males (Schuurs and Verheul, 1990). We detected numerous parameter differences 
between sexes in our study. However when data were subdivided by sex as well as 
reproductive status, it appeared that the majority of sex differences were attributed to 
lactation and/or care of dependent young. With the exceptions of neutrophils and 
lymphocytes measured by percentage, the same differences demonstrated between males 
aged >5 and lactating females aged >5 were present between non-lactating females and 
lactating females aged >5. Lymphocytes (%) were greater in non-lactating females than 
lactating females, but lower in males aged >5 than lactating females (Table 1.3). 
Decreased numbers can indicate an immunosuppressive condition. Neutrophils (most 
numerous circulating leukocyte) may increase in response to bacterial infection, 
inflammatory disease, and stress, whereas decreased neutrophil levels may result from 
severe and/or chronic infection.
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Lactation and dependent young impose both direct and indirect physiological burdens on 
female polar bears, which appear to affect hematologic measures and maintenance of 
homeostasis. Such burdens may include: nutritional stress due to lactation, sharing of 
food resources, and hypothalamic-pituitary axis mediated release of corticosteroids due to 
stress from care and protection of young. Thus, this cohort may be the most sensitive and 
vulnerable to stressors, making it the most useful and critical monitor for a stressed 
ecosystem (e.g. climate change, loss of sea-ice). Several hormones and factors associated 
with the need for fetal tolerance occur during pregnancy and parturition impacting 
immune function. During pregnancy cell-mediated immune responses are decreased, 
likely due to elevation in estradiol levels (Prieto and Rosenstein, 2006). At parturition, 
progesterone and estradiol levels decrease (Kaker et al., 1984) and plasma cortisol, which 
can impair polymorphonuclear neutrophils, increases by four-fold (Dosogne et al., 1999).
Neutrophils tend to decrease with age while lymphocytes increase (Thrall et al., 2004). 
Our data reflect this trend as the number of neutrophils was significantly greater in polar 
bears aged > 8 than ages 5-7 and lymphocytes were significantly greater in bears of each 
younger age cohort than bears aged > 8 years. For eosinophils, there was a percentage 
difference between the youngest two age cohorts of over 100%. Eosinophils may increase 
in response to allergic disorders, inflammation of the skin, and parasitic infection. Age 
related change in this cell type has not previously been recognized in mammals. Hence, 
larger sample sizes will be required to establish whether this finding is noteworthy or 
spurious.
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Circulating total immunoglobulin class G (IgG) comprises all of specific antibodies that 
have been produced in response to exposure to infectious agents and toxins throughout an 
organism’s lifetime. Hence, increasing levels of IgG with age is an expected result since 
the likelihood of antigenic exposure should increase over time and many immunological 
responses generate antibodies with long half-lives. Our analyses suggest the observed sex 
difference in IgG, like other hematological values, may be driven in part by lactation 
and/or care of dependent young, which emphasizes the need to assess this specific cohort. 
Bemhoft et al. (2000) also determined total IgG to be greater in males than female polar 
bears. They compared adult females to females with cubs of the year in order to 
determine whether fat loss due to denning may contribute to intersex difference, but 
found no change.
Monocyte counts were highest in polar bears sampled near Kaktovik however, 
significance was only achieved for disparity between Kaktovik and Prudhoe. Monocyte 
levels increase in response to a variety of infections and to inflammatory disorders 
(Murphy et al., 2005). Differences in monocyte numbers between sampling locations may 
be attributed to geographical or biological (e.g. antigen) variants of location sites, and/or 
may be associated with disparity in capture stress between locations. The Kaktovik area 
includes the presence of subsistence hunter-killed bowhead whale carcasses which draw 
polar bears close to human settlements and dump sites, thereby facilitating interaction 
with grizzly bears and conspecifics (Miller et al., 2006; Bentzen et al., 2008). 
Congregation of polar bears and grizzly bears, arctic and red foxes, and gull species at
47
carcass may increase risk of intra- and interspecies disease transmission (Miller et al., 
2006). Increased monocytes in polar bears captured near Kaktovik may reflect exposure 
to disease agents due to the occurrence of such anthropogenic food sources. Such 
supplemental feeding also occurs, although at a less predictable level, near Barrow. This 
might explain the lack of differences in monocyte counts between Barrow and Kaktovik 
bears.
Capture protocols and sequence of biological sample collection were consistent across 
logistic bases. Because Kaktovik was always sampled late in the spring, there may have 
been a temporal effect that caused variation in hematologic responses. Monocytosis is 
associated with chronic inflammation, bacteremias and sometimes with corticosteroid 
responses (Thrall et al., 2004). Stress or corticosteroid-induced leukograms are marked 
by mature neutrophilia, lymphopenia, and sometimes eosinopenia. Monocyte numbers 
are generally variable in stress leukograms; however, monocytosis often occurs in steroid 
or stress reactions in dogs and horses (Aiello and Mays, 1998). We were unable to 
adequately assess the possibility that the variation we observed might be attributed to a 
stress leukogram because a normal leukogram for polar bears has not previously been 
defined. However, when we examined leukograms by location, lymphopenia and 
eosinopenia in Kaktovik bears were not apparent.
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Increasing anthropogenic stressors faced by polar bears include: climate warming 
(altering sea-ice dynamics); proximity to growing industrial complexes, communities and 
domestic species; contaminants (long-range transport) and local sources such as the 
petroleum industry (MacDonald, 2003). Alteration in climate is likely to expose polar 
bears to an increased variety of pathogens (Derocher et al., 2004; Kutz et al., 2005). Here 
we provide a “benchmark” for hematological parameters for southern Beaufort Sea polar 
bears against which variation over time should be assessed. We propose these measures 
as part of the “tool box” that could be used to assess polar bear health. The polar bears’ 
strategic status as arctic sentinel means these “tools” provide a measure of the status of 
the whole arctic marine and coastal ecosystems.
Age related variation in hematologic parameters are consistent with those observed in 
other mammalian species. Lowered counts of some leukocyte types in female polar bears 
with dependent young suggest this cohort may be less resilient than other sex and age 
groups to new challenges that may accompany ongoing ecosystem changes. Lowered 
resilience of reproducing females may compound the already observed declines in 
reproductive performance of females related to declining sea-ice availability (Stirling et 
al., 1999; Regehr et al., 2009). This should be an important component of future polar 
bear health monitoring, research programs, and conservation monitoring that assesses 
arctic ecosystem health. The stage is now set to use these hematologic measures as 
biomarkers that may be used to assess polar bear responses to changing infectious agents,
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1.6 CONCLUSION
nutritional status, and toxicant exposure that may result from global warming. Because 
the polar bear is a legitimate sentinel and icon of the arctic, these biomarkers can provide 
meaningful measures of the status and health of the arctic and coastal marine ecosystems. 
The following companion paper compliments this effort by evaluating exposure of polar 
bears to specific indicator infectious agents.
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Figure 1.1 Map of northern Alaska and the southern Beaufort Sea, showing polar bear capture areas in spring 2005-2007 from 
Barrow, Prudhoe Bay and Kaktovik, Alaska. Note: polar bears were not captured out of Kaktovik in 2006.
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Table 1.1 (a) Hematology reference ranges for southern Beaufort Sea, Alaska polar bears for all cohorts and sample years 
combined; (b) hematology reference ranges for captive polar bears as cataloged in the International Species Database (ISIS) 
and for Western Churchill, Manitoba polar bears (Cattet and Caulkett, 2001); hematocrit values measured in springs 1982— 
1988 for southern Beaufort Sea polar bears (SBS) and for Manitoba polar bears (Lee et al., 1977).
(a)
southern Beaufort Sea Polar Bears 2005-2007
Parameter (unit) Mean Median ±SD 95% Cl N Range
Leukocytes (/pi) 8130 7500 3200 7670-8594 187 2375-22625
Neutrophils (/pi) 5340 4640 2800 4935-5750 184 807-20457
Lymphocytes (/pi) 1528 1265 1039 1377-1679 184 184-7766
Monocytes (/pi) 17345 1105 1598 1502-1967 184 195-7642
Eosinophils (/pi) 399 349 333 350-447 184 0-1666
Basophils (/pi) 9 0 26 5-13 184 0-255
IgG (mg/ml) 24 21.8 9.3 22.7-25.4 178 9.5-48.9
Hematocrit (%) 44.9 45.5 4.9 44.2-45.6 189 21.5-61.5
Neutrophils (% of 100 cells) 64 66 14.2 62-66.1 181 10.8-90.4
Lymphocytes (% of 100 cells) 19.9 17.1 12 18.2-21.7 181 3-68
Monocytes (% of 100 cells) 10.8 9.8 5.4 10.1-11.6 181 3-36
Eosinophils (% of 100 cells) 5 4.8 3.6 4.5-5.5 181 0.3-20.5
Basophils (% of 100 cells) 0.1 0 0.3 0.1-0.2 181 0-2.0
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33
33
33
33
33
33
33
33
33
33
33
33
ISIS Cattet and Caulkett SBS 1982-88 
(2001)__________________________
Lee et al. (1977)
Mean ± SD Range Sample # (N) Range N Mean ± SD Range N Mean ± SD Range
9515 3801 2500-3300 249 (94) 3300-10800 18-151 ND ND ND ND ND ND ND
6555 2461 1930-2060 224 (90) 1955-6405 18-151 ND ND ND ND ND ND ND
1628 820 296-5200 231 (90) 640-2095 18-151 ND ND ND ND ND ND ND
534 377 0-2814 220 (84) 370-1210 18-151 ND ND ND ND ND ND ND
758 670 0-4238 217(86) 130-420 18-151 ND ND ND ND ND ND ND
55 87 0-405 31 (20) 25-85 18-151 ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND ND
44 5 30-59.8 258 (96) 36-53 18-151 45 4 ND 43 44.5 3.2 37-50
ND ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND ND
ND ND ND ND ND ND ND ND ND ND ND ND ND
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Table 1.2 References ranges for southern Beaufort Sea, Alaska polar bears (2005-2007). By sex: (a) males (b) females (c) 
means for sexes compared.
(a)
Males
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 8872 7750 3085 7992-9365 80 3750-18625
Neutrophils (/pi) 5930 5199 2477 5268-6377 79 2200-15624
Lymphocytes (/pi) 1518 1313 925 1265-1679 79 315-5155
Monocytes (/pi) 991 865 514 878-1108 79 195-2850
Eosinophils (/pi) 479 413 364 407-570 79 26-1666
Basophils (/pi) 10 0 32 3-17 88 0-255
IgG (mg/ml) 27 25.5 9.9 24.4-28.9 75 10.3-48.9
Hematocrit (%) 47 47.0 4.4 46-48 81 31.5-61.5
Neutrophils (% of 100 cells) 65 66.0 11.1 63.1-68 79 29.5-86.5
Lymphocytes (% of 100 cells) 17.9 15.0 10.2 15.2-19.8 79 4.0-56.0
Monocytes (% of 100 cells) 11.1 10.6 4.3 10.3-12.2 79 3.8-25.0
Eosinophils (% of 100 cells) 5.5 5.3 3.5 4.8-6.4 79 0.3-20.5
Basophils (% of 100 cells) 0.1 0 0.3 0.1-0.2 79 0-2.0
(b)
Table 1.2 (Continued)
Females
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 7325 6750 2713 6754-7897 89 2375-15750
Neutrophils (/pi) 4690 4275 2213 4221-5158 88 807-12206
Lymphocytes (/pi) 1550 1207 1165 1303-1797 88 184-7766
Monocytes (/pi) 745 664 459 658-852 88 235-2670
Eosinophils (/pi) 333 255 297 258-384 88 0-1620
Basophils (/pi) 9 0 21 4-13 89 0-96
IgG (mg/ml) 21.1 20.1 7.6 19.4-22.7 86 9.5-48.4
Hematocrit (%) 43.4 44.4 4.2 42.5-44.2 91 33.3-51.8
Neutrophils (% of 100 cells) 62.9 66.3 15.7 60.1-66.6 90 10.8-89.0
Lymphocytes (% of 100 cells) 21.9 18.3 13 19-24.4 90 3.3-67.5
Monocytes (% of 100 cells) 10.6 9 6.1 9.3-12 90 4.3-36.4
Eosinophils (% of 100 cells) 4.5 3.3 3.3 3.5-4.9 90 0-17.3
Basophils (% of 100 cells) 0.1 0 0.3 0.1-0.2 90 0-1.5
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(c)
Table 1.2 (Continued)
Males Females
Parameter (unit) Mean t value; p-value % Difference
Leukocytes (/(d) 8872 7325 3.62; 0.0004 21.1
Neutrophils (/pi) 5931 4741 3.62; 0.0004 25.1
Lymphocytes (/pi) 1519 1550 0.19; 0.8504 NA
Monocytes (/pi) 991 745 3.74; 0.0002 33
Eosinophils (/pi) 479 333 3.26; 0.0014 43.9
Basophils (/pi) 10 9 0.38; 0.7042 NA
IgG (mg/ml) 27 21.1 4.12; <0.0001 28
Hematocrit (%) 46.6 44.4 4.68;<0.0001 5
Neutrophils (% of 100 cells) 65.1 62.9 1.07; 0.8567 NA
Lymphocytes (% of 100 cells) 17.9 21.9 2.30; 0.0226 18.4
Monocytes (% of 100 cells) 11.1 10.6 0.72; 0.47 NA
Eosinophils (% of 100 cells) 5.5 4.5 1.81; 0.0734 21
Basophils (% of 100 cells) 0.1 0.1 0.25; 0.8066 NA
Table 1.3 Means compared for reproductive females ages >5 and males ages >5 compared to each female reproductive cohort.
Reproductive fem ales ages >5 compared Males ages >5 compared to each female cohort
Lactating Non-
lactating
Males Lactating Non-lactating
Parameter (unit) Mean t value; p-value % Difference Mean F-ratio; p-value % Difference
Leukocytes (/pi) 6042 8094 3.50; 0.0008 25.4 9023 10.05; <0.0001 49.3 N A
Neutrophils (/pi) 4427 5007 0.34; 0.7313 NA 6216 5.08; 0.0078 40.4 NA
Lymphocytes (/pi) 883 1801 4.52; <0.0001 51 1381 9.21; 0.0002 56.3 NA
M onocytes (/pi) 1156 1869 2.38; 0.0202 38.2 2175 8.12; 0.0002 88.1 NA
Eosinophils (/pi) 176 410 4.04; 0.0002 57 489 22.25;<0.0001 177.2 NA
Basophils (/pi) 3 12 1.72; 0.046 N A 11 NA N A NA
IgG (mg/ml) 20.6 23.4 0.82; 0.4136 10.8 28.2 5.62; 0.0046 28.5 NA
Hematocrit (%) 41.9 44.6 2.97; 0.0041 6.8 47.2 19.28;<0.0001 12.7 5.7
Neutrophils (% o f  100 cells) 71.6 58.8 3.86; 0.0003 21.7 67 10.15; <0.0001 -6.8 13.5
Lymphocytes (% o f  100 cells) 16 23.9 2.82; 0.0066 33 16 6.16; 0.0028 -33.0 NA
M onocytes (% o f  100 cells) 9.4 11.9 1.93; 0.0595 21.5 11.3 3.53; 0.032 20.6 NA
Eosinophils (% o f  100 cells) 3 5.2 2.58; 0.0121 42.4 5.5 11.22, <0.0001 83.1 N A
Basophils (% o f  100 cells) 0.1 0.1 1.47; 0.1474 N A 0.1 NA N A N A
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Table 1.4 References ranges for southern Beaufort Sea, Alaska polar bears (2005-2007) by cohort for ages 1-2, 3-4, 5-7, > 8. 
(a) 1-2 years, (b) 3-4 years, (c) 5-7 years, (d) > 8 years, (e) age cohort comparisons. NA=not applicable.
(a)
1-2
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 7946 7250 3398 6476-9415 23 3125-15750
Neutrophils (/pi) 5129 4010 3128 3777-6482 23 807-12206
Lymphocytes (/pi) 1885 1737 1019 1445-2326 23 569-5063
Monocytes (/pi) 1324 800 1377 728-1920 23 253-5298
Eosinophils (/pi) 252 245 154 185-319 23 33-709
Basophils (/pi) 6 0 16 0-13 23 0-61
IgG (mg/ml) 17.7 14.8 8.17 14.2-21.2 23 9.5-48.4
Hematocrit (%) 43.2 42.5 4.4 41.3-45.1 23 33.3-51.8
Neutrophils (% of 100 cells) 61.4 66 16.8 51.2-68.7 23 10.8-79.6
Lymphocytes (% of 100 cells) 26.2 24.5 14.6 19.9-32.5 23 8-67.5
Monocytes (% of 100 cells) 8.9 8.3 3.1 7.6-10.2 23 4.5-16.2
Eosinophils (% of 100 cells) 3.4 3.0 1.8 2.6-4.2 23 0.3-7.0
Basophils (% of 100 cells) 0.2 0 0.4 0-.3 23 0-1.5
6 8
(b) Table 1.4 (Continued)
3-4
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 8104 7000 3185 6407-9801 15 4250-13500
Neutrophils (/pi) 4345 3666 1938 3313-5378 15 1913-8322
Lymphocytes (/pi) 2219 1902 1458 1442-2996 15 478-5155
Monocytes (/pi) 1062 796 674 703-1421 15 279-2454
Eosinophils (/pi) 592 534 495 328-856 15 39-1666
Basophils (/pi) 14 0 26 1-28 15 0-64
IgG (mg/ml) 19.7 19.5 5.4 16.7-22.7 15 10.3-30.6
Neutrophils (% of 100 cells) 54.4 57 14.7 46.6-62.3 15 29.5-76
Lymphocytes (% of 100 cells) 26.4 22.9 12.4 19.8-33.0 15 8.5-56.0
Monocytes (% of 100 cells) 12.2 9.6 8.4 7.7-16.6 15 5.0-36.4
Eosinophils (% of 100 cells) 6.8 5.3 5.2 4.1-6.8 15 0.8-20.5
Basophils (% of 100 cells) 0.2 0 0.4 0-0.4 15 0- 1.0
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(c) Table 1.4 (Continued)
5-7
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 7319 7000 2709 6453-8186 38 2375-16875
Neutrophils (/pi) 4438 3987 2248 3720-5157 38 898-12353
Lymphocytes (/pi) 1690 1430 963 1382-1998 38 315-4140
Monocytes (/pi) 1759 940 1687 1220-1759 38 195-6581
Eosinophils (/pi) 389 360 326 285-493 38 26-1473
Basophils (/pi) 9 0 23 2-16 38 0-96
IgG (mg/ml) 21.6 21.4 6.9 23.8-29.3 38 11.9-38.6
Hematocrit (%) 48 45.6 4.2 43.7-46.4 38 34.5-55.8
Neutrophils (% of 100 cells) 59.6 61.1 14.3 55.1-64.2 38 33-84
Lymphocytes (% of 100 cells) 24 21.9 12 20-27.8 38 6.0-59.7
Monocytes (% of 100 cells) 10.4 9.1 5.3 8.7-12.1 38 4.0-34.3
Eosinophils (% of 100 cells) 5.3 5.0 4.3 3.9-6.6 38 0.5-18.7
Basophils (% of 100 cells) 0.1 0 0.3 0-0.2 38 0- 1.1
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(d) Table 1.4 (Continued)
> 8
Parameter (unit) Mean Median ± SD 95% Cl N Range
Leukocytes (/pi) 8459 7750 3304 7803-9115 100 3375-22625
Neutrophils (/pi) 5886 5221 2841 5322-6449 100 1704-20457
Lymphocytes (/pi) 1265 1095 928 1081-1449 100 184-7766
Monocytes (/pi) 1861 1229 1607 1542-2180 100 235-7642
Eosinophils (/pi) 414 358 325 349-478 100 18-1614
Basophils (/pi) 10 0 30 3-16 100 0-255
IgG (mg/ml) 27.1 25.2 9.7 25.2-29 100 11.3-48.9
Hematocrit (%) 41.4 46 5 44.5-46.4 100 31.5-61.5
Neutrophils (% of 100 cells) 68.1 68 11.9 65.7-70.5 100 30.5-90.4
Lymphocytes (% of 100 cells) 15.6 13.0 9.4 13.7-17.4 100 3.3-57.0
Monocytes (% of 100 cells) 11.3 10.3 5.1 10.3-12.3 100 2.5-33.7
Eosinophils (% of 100 cells) 4.9 5.0 3.1 4.3-5.5 100 0.3-13.0
Basophils (% of 100 cells) 0.1 0 0.3 0.1-0.2 100 0-2.0
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(e) Table 1.4 (Continued)
1-2 3-4 5-7 >8
Parameter (unit) Mean Comparison F ratio; p-value % Difference
Leukocytes (/pi) 7946 8104 7319 8459 NA 1.51; 0.2121 NA
Neutrophils (/pi) 5129 4345 4438 5886 > 8 vs. 5-7 5.10; 0.0021 24.6
Lymphocytes (/pi) 1885 2219 1690 1265 > 8 vs. 1-2, 3-4, 5-7 7.02; 0.0002 32.9, 43,25.1
Monocytes (/pi) 1324 1062 1759 1861 NA 1.68; 0.1721 NA
Eosinophils (/pi) 252 592 389 414 NA 1.57; 0.1996 NA
Basophils (/pi) 6 14 9 10 NA 0.28; 0.8431 NA
IgG (mg/ml) 17.69 19.73 21.56 27.07 > 8  vs. 1-2, 3-4, 5-7 10.48; <0.0001 53.02, 37.20, 25.56
Hematocrit (%) 43.2 45.3 48 41.4 NA 1.67; 0.1772 NA
Neutrophils (% of 100 cells) 61.4 54.4 59.6 68.1 > 8 vs. 3-4, 5-7 7.57; <0.0001 25.2, 14.2
Lymphocytes (% of 100 cells) 26.2 26.4 24 15.6 > 8 vs. 1-2, 3-4, 5-7 11.26; <0.0001 40.5,41.0,35
Monocytes (% of 100 cells) 8.9 12.2 10.4 11.3 NA 1.65; 0.1795 NA
Eosinophils (% of 100 cells) 3.4 6.8 5.3 4.9 3-4 vs. 1-2 3.19; 0.0252 101.5
Basophils (% of 100 cells) 0.2 0.2 0.1 0.1 NA 0.28; 0.8371 NA
CHAPTER 2
Morbillivirus and Toxoplasma exposure and association with hematological 
parameters for southern Beaufort Sea polar bears: Potential response to infectious
agents in a sentinel species1
2.1 ABSTRACT
Arctic temperatures are increasing in response to greenhouse gas forcing and polar bears 
have already responded to changing conditions. Declines in body stature and vital rates 
have been linked to warming induced loss of sea-ice. As food webs change and human 
activities respond to a milder Arctic, exposure of polar bears and other arctic marine 
organisms to infectious agents may increase. Because of the polar bear’s status as arctic 
ecosystem sentinel, polar bear health could provide an index of changing pathogen 
occurrence throughout the Arctic, however, exposure and monitoring protocols have yet 
to be established. We examine prevalence of antibodies to Toxoplasma gondii, and four 
morbilliviruses [canine distemper (CDY), phocine distemper (PDV), dolphin 
morbillivirus (DMV), porpoise morbillivirus (PMV)] including risk factors for exposure. 
We also examine the relationships between antibody levels and hematologic values 
established in the previous companion paper. Antibodies to Toxoplasma gondii and 
morbilliviruses were found in both sample years. We found a significant inverse
1 Published as: Kirk CM, Amstrup S, Swor R, Holcomb D, O'Hara TM. 2010. 
Morbillivirus and Toxoplasma exposure and association with hematological parameters 
for southern Beaufort Sea polar bears: potential response to infectious agents in a sentinel 
species EcoHealth. doi: 10.1007/S10393-010-0323-0.
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relationship between CDV titer and total leukocytes, neutrophils, monocytes and 
eosinophils, and a significant positive relationship between eosinophils and Toxoplasma 
gondii antibodies. Morbilliviral prevalence varied significantly among age cohorts, with 
1-2 year olds least likely to be seropositive and bears aged 5-7 most likely. Data suggest 
the presence of CDV and Toxoplasma gondii antibodies is associated with polar bear 
hematologic values. We conclude that exposure to CDV-like antigen is not randomly 
distributed among age classes and suggest that differing behaviors among life history 
stages may drive probability of specific antibody presence.
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Climate change has significant implications for the ecology of infectious disease in the 
Arctic. Evidence suggests that plant and animal range changes are occurring on a large 
scale in response to climate change. In a review by Root et al. (2003) including 143 
studies of 1500 species, meta-analysis indicated 80% of species reviewed had shifted 
their ranges north. Shifts are likely to be greater in polar regions where change in 
temperature increase is greater. As species move into other regions they are likely to 
bring their pathogens with them (Bradley et al., 2005) thus compromising the health of 
the arctic ecosystem. Warmer temperatures and increased humidity may alter 
transmission patterns of existing infectious agents and introduce new diseases (e.g. 
alterations in vector ranges) previously unknown to the Arctic, and alter dynamics of 
existing disease reservoirs.
Species especially sensitive to such changes include ice-dependent top predators such as 
polar bears. As described in Kirk et al. (2010), due to intimate ties with sea-ice and 
adaptation to a relatively “disease free” environment, polar bears are likely to confront a 
variety of new challenges related to climate change. These challenges may enhance their 
susceptibility to new and increasing numbers of pathogens. As apex predators, polar 
bears can be used as sentinels of change in occurrence of infectious agents in the arctic 
food web and their potential transmission between the arctic marine, coastal and 
terrestrial environments.
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2.2 INTRODUCTION
Antibodies to morbillivirus and Toxoplasma gondii have been previously documented in 
polar bears throughout the Arctic (Cattet et al., 2004; Tryland et al., 2005; Gamer et al., 
2000; Zamke et al., 2004; Rah et al., 2005; Oksanen et al., 2009; Tryland, 2000; Jensen et 
al., 2010). Transmission dynamics of morbilliviruses and Toxoplasma in the Arctic may 
be affected as climate changes impact vectors and the health, behavior, movement, and 
population dynamics of reservoir populations of marine (e.g. pinniped) and terrestrial 
hosts (e.g. domestic and wild canids). These agents have been associated with pathogen 
spillover to/from domestic species and with pathogen pollution between terrestrial and 
marine environments. Such phenomenona are anticipated to increase with warming in the 
Arctic (MacDonald et al., 2005). Furthermore, these agents have significant implications 
for human and wildlife health.
Because morbilliviruses and T. gondii pass between terrestrial and aquatic environments, 
they pose an important concern for marine organisms facing a warming world. For 
example CDV from terrestrial species (probably transmitted to seals from domestic dogs) 
was implicated in outbreaks among Baikal seals and Caspian seals (Phoca caspica, 
Kennedy et al., 2000). Conversely, PDV was suggested as the cause of distemper among 
farmed mink near coastal Denmark (Blixenkrone-Moller et al., 1989). Initial hypotheses 
suggested that exposure of polar bears to morbillivirus resulted from PDV infected seal 
prey. Pathogen pollution from terrestrial sources has been implicated for the presence of 
T. gondii in the marine environment (Miller et al., 2002). Since polar bears reside at the 
marine-terrestrial interface and have been increasingly “land-bound” in a decreasing sea
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ice environment, they may serve as a link in the ecology of morbillivirus and T. gondii 
transmission in the Arctic ecosystem. With changes in sea-ice extent and in the 
chronology of melting and reformation, polar bears are likely to spend more time onshore 
in proximity to expanding human habitation and industrialization and in contact with 
species with which they formerly had limited or no interaction. Groups of animals 
[including polar and grizzly (Ursus arctos)] bears congregate at hunter killed whale 
carcasses on the outskirts of some villages (Bentzen et al., 2008). Terrestrial based food 
sources, including those of human origin are likely to become of greater importance with 
changes in sea-ice conditions. These food sources are potential reservoirs of infectious 
agents including morbillivirus and T. gondii.
A hallmark of morbillivirus is the ability to interfere with specialization and 
differentiation of lymphocytes (Heaney et al., 2002). Immune suppression associated 
with morbillivirus infection or exposure can influence the mortality rate of infected 
individuals by facilitating secondary infections or activating latent infections, which can 
be lethal to the host. Although not zoonotic, morbillivirus has potential to significantly 
impact populations of marine mammals important to subsistence hunters. These foods 
provide an important source of protein and fatty acids and for some users, are the main 
source of these nutrients. T. gondii, in contrast, is typically of little clinical significance in 
immunocompetent animals, yet severe disease can result from latent infection in the 
presence of other stressors, which could include morbilliviral infection (Dubey et al., 
1989). Clinical toxoplasmosis has been diagnosed during necropsy evaluations of seals,
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dolphins and beluga whales confirming the possibility of natural transmission in the 
marine environment (Tryland, 2000). T. gondii is zoonotic and is of documented public 
health significance. Humans and wildlife become infected with T. gondii by ingesting 
raw or insufficiently cooked meat containing bradyzoites, ingesting oocysts from cat 
feces directly or indirectly via soil or other items that have been in contact with oocysts, 
or through vertical transmission from a mother to her fetus (Gilbertson et al., 2005).
These transmission modes are likely to increase in a warming Arctic. As in wildlife, this 
parasite typically significantly impacts only the health of immunocompromised 
individuals, however, it is well documented that infants infected in utero may develop 
learning and visual disabilities later in life (Gilbertson et al., 2005).
Introduction of anthropogenic agents, alterations in pathogen transmission pathways and 
foraging behavior may expose polar bears to an increased variety of infections to which 
they lack immunity. Here, we establish seroprevalence patterns for exposure risk and 
associations with hematological biomarkers for morbillivirus and Toxoplasma gondii in 
southern Beaufort Sea polar bears. Changes in morbillivirus and T. gondii prevalence that 
may occur with climate change could pose an increased threat to the health of local 
people living along the coast, trappers and wildlife. By establishing seroprevalence 
patterns for two indicator infectious agents (morbillivirus and T. gondii) and by drawing 
associations between seroprevalence and hematological biomarkers described in our 
companion paper, we demonstrate how monitoring polar bear health could provide an 
index of changing pathogen occurrence throughout the Arctic.
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Methods for capture including location, blood sample processing, hematology and cohort 
designations are described in Kirk et al. (2010). Blood was collected from the femoral 
vein or artery (Vacutainer, BD Biosciences; Franklin Lanes, NJ) into evacuated blood 
collection tubes for whole blood and serum and PAXgene Blood RNA tubes (Qiagen, 
Valencia, California) for RNA isolation. Viral CULTURETTE™ Collection and 
Transport Systems (BD Biosciences; Franklin Lanes, NJ) were also used to swab nasal 
cavities for morbilliviral RNA detection. Although we evaluated hematological values in 
southern Beaufort Sea polar bears captured over a three-year period (2005-2007), we 
examined specific antibody indicators in 2005 and 2006 only.
2.3.1 Serology
Serum was screened for morbilliviral and T. gondii antibodies at the Oklahoma State 
University Animal Disease Diagnostic Laboratory (Stillwater, OK USA). Differential 
serum neutralization (SN) assay for four morbilliviruses (CDV, DMV, PDV, PMV) was 
performed, as described by Gamer et al. (2000). Results are expressed as the reciprocal of 
the highest dilution that completely neutralized 100% of the respective challenging vims 
(‘neutralized’), using a cut-off of 1:4. Latex agglutination assay was performed for T. 
gondii as described previously by Rodgers and Baldwin (1990). Results are expressed as 
the reciprocal of the highest dilution of serum resulting in a clear agglutination; titers 
>1:16 were considered positive.
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2.3 METHODS
2.3.2 Molecular Analyses
RNA was extracted from blood using the PAXgene Blood RNA kit (Qiagen, Valencia, 
California) and nasal swabs using TRI REAGENT® LS (Molecular Research Center, Inc., 
Cincinnati, OH); according to the manufacturers’ instructions. Sample integrity was 
assessed via amplification of a housekeeping gene, p-actin (Kraft et al., 1995). We used 
the universal primer set, which amplifies a well-conserved region of the polymerase 
cofactor, phophoprotein for all known morbilliviruses (Barrett et al., 1993). Reverse 
transcription reactions were performed using Superscript™ III One-Step RT-PCR System 
with Platinum® Taq, according to the manufacturer’s instructions (Invitrogen, Carlsbad, 
California).
2.3.3 Statistical Analyses
We calculated summary statistics for all parameters using JMP 7 statistical software 
(SAS Institute, Cary, NC, USA). We assessed normality in the distributions of outcome 
values with Shapiro-Wilk goodness of fit test. Log transformations were employed where 
data were not normally distributed. Statistical analyses were performed using log 
transformed titer data, while means and ranges were calculated using raw titer data 
(1/titer). We used Pearson’s correlations to evaluate bivariate relationships among 
hematologic endpoints for 2005 and 2006 independently, and years combined (JMP 7; 
SAS Institute, Cary, N.C., USA). For parameter pairs where correlations were significant 
(e.g. CDV titer and total leukocyte count), the difference between the mean of a given 
parameter for all CDV positive animals and CDV negative animals was determined. The
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resulting number was divided by the mean for that parameter for all CDV negative 
animals and this number was converted to a percentage yielding “percentage mean 
difference” (Kirk et al., 2010).
We compared mean CDV titers for seropositive bears in each age class using ANOVA 
and the post-hoc Tukey-Kramer test. Risk factor analyses were conducted for the 
presence of antibodies to morbillivirus and T. gondii using statistical package R with 
epitools and epicalc libraries (R Development Core Team, 2006). We used y2 analysis 
(function prop.test) to test for homogeneity in prevalence between sampling years, sex, 
and age class. Recognizing that potential exposure differed at each of our logistics bases 
(Barrow, Prudhoe Bay, Kaktovik), we also used %2 analysis to test whether prevalence 
was homogeneous across logistics bases. The Cochran-Mantel Haenszel %2 test evaluated 
year-to-year and between sex differences in prevalence stratified by age (function 
mantelhaen.test). Probability of exposure to CDV-like antigen or T. gondii was assessed 
by age cohort using odds ratios (OR) and 95% confidence intervals (function 
ci.binomial), comparing bears aged 3-4, 5-7 and >8 years of age to bears aged 1-2. 
Interaction between the variables; age, sex, and year upon risk for presence of CDV 
antibodies were explored via logistic regression [function glm (CDV.sero ~ age + sex + 
yearf, family=binomial)] utilizing a backwards stepwise approach and Akaike’s 
Information Criteria for model selection (functions step, update, logistic.display). The 
variable CDV.sero indicates whether the animal was seropositive or seronegative, age is a 
continuous variable, sex is male or female and year is 2005 or 2006. We did not search
for interactions affecting risk for presence of T. gondii antibodies because there was no 
significant difference in prevalence among cohorts. In 2006, we were able to recapture 6 
antibody positive individuals originally captured in 2005. This allowed us to assess 
possible changes in prevalence and titer calculations over time.
2.4 RESULTS
We analyzed samples from 136 polar bears: 20 1-2, 12 3-4, 14 5-7, and 84 bears >8 
years, ranging up to 24 years of age. Mean values for total leukocytes, neutrophils, 
lymphocytes and monocytes measured in the springs of 2005 (n=61) and 2006 (n=67) for 
all cohorts combined were within one standard deviation of values reported for captive 
polar bears (ISIS) (Figure 2.1). Seroprevalence of CDV in both 2005 and 2006 was 
relatively high (Table 2.1). Antibodies to PDV, DMV and PMV and T. gondii were also 
detected in both sample years (Table 2.1). Mean titers for seropositive polar bears were 
highest for CDV (titer range = 1:8-1:512), followed by PDV (titer range = 1:8-l :96)
DMV (titer range = 1:8-l :24) and lowest for PMV (titer range = 1:16-1:32) as indicated 
in Figure 2.2. Each animal seropositive for DMV, PDV, and/or PMV presented a higher 
titer to CDV (Figure 2.3). Of all polar bears seropositive for CDV, 48.5% were also 
positive for PDV. Any animal positive for DMV or PMV had antibodies to both CDV 
and PDV (Figure 2.4). Three polar bears were seropositive for all 4 viruses. Of polar 
bears seropositive in 2005, we recaptured 6 in 2006. All 6 animals remained seropositive 
and in 4 of these animals, titers decreased by one dilution factor. One animal experienced 
an increase in titer by one dilution factor from 1:48 to 1:64 and another’s titer remained
81
the same. The proportion of polar bears seropositive for T. gondii was not significantly 
different between age class or sex with positive titers ranging from 1:16-1:2048. Viral 
RNA was not detected in blood samples or nasal swabs.
2.4.1 Hematology and Serology Associations
We examined relationships between select infectious agent antibody titers and 
hematological parameters revealing significant decreases in neutrophil, eosinophil, 
monocyte, and total leukocyte counts with increasing CDV titer (Table 2.2).
Relationships were statistically significant in 2005 and for combined sample years; no 
significant associations were found when data were analyzed for 2006 alone. We also 
detected a significant positive relationship between eosinophil count and T. gondii titer in 
2005 but not in 2006 or when data were pooled across sample years. No difference was 
demonstrated in titers by age class or sex and no associations were found for lymphocytes 
or basophils and infectious agent titer.
2.4.2 Risk Factors for Morbillivirus and Toxoplasma gondii Exposure
Homogeneity tests indicated prevalence to CDV varied significantly (p = 0.001) among 
age cohort while prevalence to T. gondii did not. Polar bears 1-2 years of age were least 
likely to be seropositive for CDV antibodies and 5-7 year olds were most likely to be 
seropositive. Polar bears aged 3-4 were approximately equally likely to possess CDV 
antibodies as 1-2 year olds and bears >8 years of age were approximately five times as 
likely to be seropositive. Variation between years in CDV prevalence among age cohorts
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was significant (%2 -  16.244, df = 4, p = 0.003; Table 2.1c) using the Cochran-Mantel- 
Haenszel test. The percentage of bears seropositive for CDV at each individual age is 
shown in Figure 2.2. We did not observe a difference in CDV antibody prevalence 
between males and females in 2005, 2006 or for sample years combined. This absence of 
an obvious link between sex and seropositivity was evident in a logistic regression of sex, 
age and year. That analysis revealed that the likelihood of having antibodies varied 
according to interaction of year and sex (sex*year: OR = 5.30, p = 0.029) with bears 
approximately 5 times as likely to be seropositive if they were female in 2006 or male in 
2005. Such a “flip-flop” pattern would not be expected if seropositivity were strongly sex 
linked. There was no difference in the proportion of bears seropositive for CDV or T. 
gondii between logistic base locations for sexes combined or between sexes.
2.5 DISCUSSION
The high prevalence of antibodies we observed to four morbilliviruses was consistent 
across sample years and with previous studies conducted for Alaska polar bears (Gamer 
et al., 2000). Semm neutralization assay results indicate that the vims(es) to which 
northern Alaskan polar bears have been exposed is most antigenically related to CDV. 
Current findings are consistent with that of Gamer et al. (2000) who concluded 
morbillivirus exposure in Alaska polar bears was most likely of terrestrial origin because 
each individual positive for either PDV, DMV, or PMV presented a higher titer (more 
reactive) to CDV. However, using these serological assays, we cannot determine whether
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these bears are infected with or exposed to a single strain of morbillivirus, multiple 
morbilliviruses or perhaps carry a distinct strain enzootic to polar bears.
Polar bears seropositive for CDV-like viruses have been found across the Arctic. In 
portions of Canada and in Svalbard, prevalence has been documented at 24% and 8%, 
respectively (Cattet et al., 2004; Tryland et al., 2005). In Alaska and Russia (Bering, 
Chukchi, and East Siberian seas) CDV prevalence has ranged from 26-46% depending 
upon sample year (Follmann et al., 1996). Morbilliviral antibodies have also been 
detected in terrestrial Arctic-dwelling carnivores in Alaska including: grizzly bears 
(Chomel et al., 1998; Philippa et al., 2004), and wolves {Canis lupus) (Zamke et al., 
2004). Evidence of CDV in arctic fox (Alopex lagopus) has been mostly anecdotal, 
however they are hypothesized to have been the source of infection for distemper 
outbreaks among sled dogs in the Arctic (Bohm et al., 1989; Campbell et al., 2007). 
Antibodies to morbilliviruses have not been documented in Alaskan Arctic marine 
mammals other than polar bears, however they have been reported in various pinniped 
and cetacean species in the Canadian Arctic including ringed seals (Phoca hispida), the 
polar bear’s main prey (Duignan et al., 1997).
2.5.1 Hematology and Serology Associations
The high prevalence indicates a negligible mortality rate (large percentage of bears 
apparently recover) from infection or exposure (e.g. presence of antibody does not equate 
to infection) to morbillivirus in polar bears. However, changes observed in hematological
parameters are suggestive of a biologically significant response. The significant inverse 
relationship between these parameters indicates the virus may have an 
immunosuppressive effect or alternatively that immuno-suppressed individuals are more 
likely to be seropositive to the virus. We recognize reported r-values are low, however 
this is likely due to the contribution of additional variables not accounted for in the model 
and/or some nonlinearity in the observed relationship. That a significant inverse 
relationship was observed in 2005 but not 2006 may reflect natural fluctuation in the 
population in response to changes in infectious agent exposure and/or immunity.
While we observed significant hematological associations with CDV status in polar 
bears, we do not know if seropositive animals are adversely affected by and/or 
susceptible to morbilliviral infection. We did not observe overt clinical signs typically 
associated with the disease in domestic or wildlife species upon gross examination of 
bears captured in this study and we did not identify viral RNA in blood and nasal swab 
samples. In order for virus to be detected, bears needed to be sampled during active 
viremia. Possibly, antibody production results from exposure only, with no significant 
resulting viremia or a viremia of no consequence. Alternatively, the virus may be able to 
replicate within polar bears without adverse effects, yet serve as a reservoir for other 
sympatric carnivores. This phenomenon has been observed among some seal species 
(Duignan et al., 1997).
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The inverse relationship between morbillivirus antibody titer and leukocytes observed in 
this study is consistent with observations documented in other species. In domestic 
canines and some wildlife species, CDV infection is characterized by 
immunosuppression followed by secondary infection. Much in vitro and in vivo work has 
been done exploring the pathogenesis of CDV using gnotobiotic canines in controlled 
laboratory studies. For example, viral antigen in monocytes (Appel and Gillespie, 1972) 
and circulating B and T lymphocytes (Krakowa et al., 1975) occurs during the acute 
phase of CDV infection. In dogs recovering from the disease, the presence of virus in the 
bloodstream is transient, however alterations in the anatomy of lymphoid tissue result 
(Krakowa et al., 1980). A similar pattern of infection in polar bears could account for the 
high percentage of bears found antibody positive without virus being detected. In vitro 
studies using lymphocytes isolated from convalescent nonviremic dogs exhibit a 
decreased response to mitogens when challenged (Krakowa, 1982). Furthermore,
Krakowa et al. (1987) discovered that infection with CDV results in both virus-dependent 
and independent immunosuppression. For instance, when lymphocytes from viremic dogs 
were cultured together with lymphocytes isolated from uninfected dogs, lymphocytes 
from CDV infected dogs suppressed the phytomitogen responses of uninfected responder 
dogs. Perhaps more importantly, lymphocytes collected from convalescent, seropositive 
dogs that were no longer viremic suppressed responses of uninfected responder dogs. 
These findings have significant implications. They demonstrate that although animals 
that survive and clear infection may be protected from repeated infection, they may be
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immunologically compromised and therefore more susceptible to other opportunistic and 
non-opportunistic infections.
Over the past two decades, these closely related morbilliviruses have caused significant 
disease and mortality in several marine and terrestrial mammal species (e.g. Dietz et al., 
1989; Aguilar and Raga, 1993; Kennedy et al., 2000). In some mortality events attributed 
to morbilliviral infections among seals and dolphins, which like polar bears are top 
predators in their systems, infected animals were also exposed to high levels of persistent 
lipophilic environmental contaminants accumulated through the food chain (De Swart et 
al., 1996). This observation led to the hypothesis that contaminant related 
immunosuppression may have contributed to the clinical severity of the outbreaks. Polar 
bears bioaccumulate lipophilic compounds such as highly persistent organochlorines 
(OCs) (De Wit et al., 2002). Measurements of OCs in northern Alaska polar bears 
indicate a varied geographical distribution and relatively low concentrations (Bentzen et 
al., 2008). Despite low concentrations, the effects of contaminants on polar bears are of 
particular concern due to some unique physiological features potentially rendering them 
more vulnerable to the adverse effects of OCs. These include dramatic periods of fat 
accumulation followed by extended periods of fasting, delayed implantation, and unique 
mechanisms of biotransformation which can result in the accumulation of different mixes 
of parent compounds and metabolites as compared to other species (Fisk et al., 2005). 
Studies on Svalbard polar bears demonstrated negative correlations between PCBs (a
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type of OC) and antibody-mediated immunity (Bemhoft et al., 2000; Lie et al., 2004). 
Thus morbillivirus may not act independently on the immune system.
We also observed a positive relationship between eosinophil count and T. gondii antibody 
titer with a maximum titer occurring in one individual of 1:1024. Eosinophils are a type 
of leukocyte characteristically released in response to parasitic infections and allergens, 
observed results are therefore, indicative of an expected response. Toxoplasmosis has 
been demonstrated to cause a low and discontinuous eosinophilia (Ripert, 2000). The 
apparent relationship between eosinophils and T. gondii antibody titer is suggestive of 
ongoing exposure to T. gondii rather than a previously resolved infection or exposure. T. 
gondii is typically of little clinical significance in immunocompetent animals and humans 
unless contracted during pregnancy. Severe clinical disease could however develop from 
a latent infection as immunity declines with age or where concurrent infectious or 
toxicant immunosuppressive stressors occur (Dubey et al., 1989).
2.5.2 Risk Factors for Morbillivirus and Toxoplasma gondii Exposure
Results of risk factor analyses for morbillivirus indicate a significant increase in 
prevalence with age peaking or reaching a plateau at sexual maturity. CDV prevalence 
was lowest in 1-2 year olds and greatest in 5-7 year olds for both sexes at all sampling 
locations. Polar bears are mostly solitary, interacting predominantly during the mating 
season or as female-cub(s) groups; therefore the time at which a polar bear terminates its 
juvenile period and becomes sexually active is analogous to a “first contact” setting in
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which an immunologically naive host is exposed to an increased variety of infectious 
agents. Sexually mature polar bears range widely during the breeding season and higher 
prevalence among prime aged bears could reflect increased probability of interacting with 
sources of exposure by associating with numerous different bears through breeding and 
fighting between males and possible alterations in foraging patterns. However, whether 
this observed pattern for risk arises from cumulative exposure to CDV-like antigen over 
time or from age-related changes in susceptibility remains to be determined. For example, 
once exposed and antibodies are generated, the animal may be more immunologically 
responsive in subsequent exposures. A more comprehensive understanding of CDV 
epidemiology, including both roles and interactions of demographic, spatial, and 
temporal factors, is needed to assess the implications of morbilliviral exposure in 
southern Beaufort Sea polar bears.
Our analyses of risk factors for the presence of antibodies to T. gondii indicate that age, 
sex, and geographic area do not affect the likelihood of exposure to this pathogen for 
southern Beaufort Sea polar bears in Alaska. However, the total number of animals we 
sampled and found seropositive for both sample years combined was relatively low 
(13.2%), limiting the power of this assessment. Although incidence of clinical 
toxoplasmosis among marine mammals appears low, antibodies to the parasite have been 
detected in numerous species across the Arctic (Tryland, 2000). Seroprevalence for 
Alaskan polar bears was 6% (Rah et al., 2005) and in Svalbard and Greenland polar bears 
ranged from 3.6%-28.7% depending upon age, sex, and location (Oksanen et al., 2009).
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Antibodies to T. gondii occur in several species sharing habitat with polar bears in Alaska 
including: walrus (Obobenus rosmarus), bearded seals (Erignathus barbatus), spotted 
seals (Phoca largha) and ringed seals (Dubey et al., 2003); grizzly bears (Zamke et al., 
2000); wolves, and caribou (Rangifer tarandus) (Zamke et al., 1997) and in Canada: 
hooded (Cystophora cristatd) and grey seals (Halichoerus grypus) (Measures et al.,
2004). Antibodies have also been detected in wildlife species in other regions of the state 
including black bears (Ursus americanus), harbor seals {Phoca vitulina), stellar sea lions 
{Eumetopias jubatus) and in one sea otter in southcentral Alaska (Zamke et al., 2000; 
Gilbertson et al., 2005). Seropositive lynx {Lynx canadensis) have been found in interior 
Alaska and are the only wildlife species in the state known to pass T. gondii oocysts in 
feces (Zamke et al., 2001). Antibodies were not detected in a serosurvey of 645 arctic 
marine mammals [harp {Phoca groenlandica), hooded ringed seals, and minke whales 
{Balaenoptera acutorostrata)] from the coast of Norway and the Barents Sea (Oksanen et 
al., 1999), however prevalence for T. gondii in arctic fox on Svalbard was 43% (Prestrud 
et al., 2007).
Serosurveys of other arctic wildlife on the north coast of Alaska such as arctic fox, ice 
seals (polar bear prey) and walrus as well as domestic dogs {Canis familiaris) could assist 
in elucidating whether sources of morbillivirus and T. gondii exposure for polar bears in 
Alaska are of marine or terrestrial origin, as they represent potential reservoirs for these 
agents. If morbilliviral nucleic acid were isolated from polar bears, sequence data would 
provide valuable information regarding probable sources and transmission pathways.
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There are numerous potential routes for morbillivirus and T. gondii transmission, which 
may be impacted by warming in the Arctic and there is reason for concern that exposure 
may increase with such changes. This may occur for example, as potential reservoir 
species such lynx (T. gondii) and other carnivores (T. gondii and morbillivirus) move 
further north and as polar bears are increasingly forced to spend more time on land. A 
serosurvey of grizzly bears in Alaska demonstrated higher prevalence of T. gondii in 
northern Arctic regions than in other regions of Alaska (Zamke et al., 1997). Because this 
region is where grizzly bear habitat overlaps with that of polar bears, it is reasonable to 
conclude that contact between polar bears and grizzly bears may increase. Changes in 
camivory may occur as species access alternate food, sources driven by climate change. 
Cannibalism, which has been observed among polar bear (Amstrup et al., 2006), arctic 
fox and walrus, is a suspected means for the maintenance of T. gondii in a population 
(Prestrud et al., 2007). Scavenging on carcasses is also a known means for morbillivirus 
transmission and survival of the virus in the environment may improve in a warmer, 
wetter Arctic. The infectivity of T. gondii is enhanced by the aeration and humidity of 
soil conditions (Dubey, 2004). Increasing temperatures and humidity can thus result in 
increasing transmission of T. gondii with dissemination of fewer eggs from definitive 
hosts. Increasing sea levels and coastal erosion have the potential to increase pathogen 
pollution into the marine environment. Thawing of tundra combined with increased 
precipitation may mobilize pathogens from sewage lagoons and solid waste dumps 
containing human and pet waste in Arctic communities. With permafrost degradation, 
landfills can be washed directly into rivers or the ocean (MacDonald et al., 2005).
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Pathogen pollution from terrestrial to the marine environment is a common phenomenon 
in temperate areas. For example, coastal freshwater surface runoff was determined to be a 
risk factor for sea otter (Enhydra lutis) infection with T. gondii in California (Miller et al., 
2002). Studies in Svalbard revealed that the prevalence of T. gondii in polar bears has 
doubled in the past decade and now antibodies have been found in ringed seals for the 
first time. Jensen et al. (2010) hypothesize that survivorship of oocysts transported via the 
North Atlantic current from southern latitudes may have increased due to warming waters 
and the concomitant influx of marine invertebrate filter feeders that may serve as vectors 
for oocysts. Jensen et al. (2010) point out that the recent change in species diversity of 
migratory birds in the area, as well as increased human traffic, may also be responsible 
for observed increases. Alterations in avian migration routes with climate change, can 
similarly impact the ecology of T. gondii in northern Alaska.
2.6 CONCLUSION
Arctic marine ecosystem health is likely to be disrupted by a warming climate and the 
associated loss of essential sea ice habitats. Polar bears reside at the marine-terrestrial 
interface and may be increasingly exposed to infectious agents from multiple sources. A 
warming Arctic may alter microbial and parasite transmission pathways as well as 
susceptibility of polar bears to disease. Currently, limited data exist on the health status of 
U.S. polar bear populations. The current effects of morbillivirus on polar bear health are 
unclear. However, the combination of low-level effects of morbillivirus and T. gondii 
exposure with potential increases in nutritional stress due to losses of essential hunting
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habitats may have significant implications for polar bear health and population dynamics. 
Our findings underscore the importance of efforts to monitor southern Beaufort Sea polar 
bears on a physiological as well as population level, and provide a benchmark for 
hematological parameters as well as seroprevalence and risk factors for “indicator” 
pathogens. Associations we develop between serological evidence of exposure to 
infectious agents and hematological parameters described in our companion paper 
substantiate the value of using these sentinel species biomarkers to monitor Arctic 
ecosystem health. The hematology and serology data we present for Alaskan polar bears 
emphasize the potential importance of synergisms among various potential stressors 
(morbillivirus, organochlorines, climate change, increased human presence etc.) that may 
undermine the future resilience (immune system) of polar bears to changes in their 
habitats. The sentinel position of polar bears, and the influence of their essential sea-ice 
habitats on global climate suggest that monitoring these indicators in polar bears has 
ramifications throughout the Arctic marine ecosystem and beyond.
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Figure 2.1 Statistics for blood cell type counts for southern Beaufort Sea, Alaska polar bears for 2005, 2006, and for captive 
polar bears in the International Species Information System (ISIS) database for captive polar bears.
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Table 2.1 Antibody prevalence rates (number positive) for polar bears captured in 2005, 
2006, and both years (total) as determined using serum virus neutralization assay. By: (a) 
pathogen (b) gender and (c) age class including odds ratios.
(a)
Pathogen Total 2005 (63) 2006 (73)
CDV 50.0% 49.2% (31) 50.7% (37)
PDV 24.3% 20.6% (13) 27.4% (20)
DMV 4.4% 6.3% (4) 2.7% (2)
PMV 4.4% 1.6% (1) 6.8% (5)
Toxoplasma gondii 13.2% 12.7% (8) 13.7% (10)
canine distemper (CDV), phocine distemper (PDV), porpoise morbillivirus (PMV) and 
dolphin morbillivirus (DMV).
(b)
Sample year (N)
Cohort Total 2005 (63) 2006(67)
Sex class Prevalence Prevalence Prevalence
Females 50.7% 61.8% (21) 40.5% (15)
Males 47.5% 34.5% (10) 60.0% (18)
(c)
Sample year (N)
Cohort Total 2005 (62) 2006 (68)
Age class (years) Prevalence OR (95% CI)a Prevalence f) Prevalence 0
1-2 20.0% 1 14.3% (1) 23.1% (13)
3-4 25.0% 1.32 (0.16-9.90) 28.6% (2) 20.0% (5)
5-7 78.6% 13.2 (2.19-112.83) 100.0% (5) 66.7% (9)
>8 56.0% 5.01 (1.45-22.33) 53.5% (23) 58.5% (41)
ay2 = 15.96, df = 3, p = 0.001; for odd ratio calculations comparing all age classes to 1-2 
years.
p Cochran-Mantel-Haenszel y l = 16.244, df = 4, p = 0.003; for homogeneity in 
prevalence among age classes stratified by year.
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Table 2.2 Correlations between hematological and serological parameters for southern Beaufort Sea, Alaska polar bears.
Sample year (N)________________________________________
2005 (61)________________ 2006 (67) 2005 + 2006 (128)
Variable By Variable r P MD r P r P MD
CDV titer Total Leukocytes -0.36 0 -26.10% -0.22 0.08 -0.28 0 -22.60%
CDV titer Neutrophils -0.27 0.03 -28.20% -0.11 0.36 -0.19 0.03 -23.90%
CDV titer Eosinophils -0.31 0.01 -50.40% -0.11 0.41 -0.18 0.04 -29.90%
CDV titer Monocytes -0.27 0.03 -33.10% -0.16 0.22 -0.22 0.01 -27.80%
Variables were log transformed before correlations calculated, r = Pearson product-moment correlation coefficient, 
p = P-value where a< 0.05, and MD = % change in count means.
CHAPTER 3
Arctic Fox (Vulpes lagopus) Morbillivirus Ecology in Northern Alaska: 
Characterization of phosphoprotein gene fragment and comparison to serology of
polar bears (Ursus maritimus)1
3.1 ABSTRACT
Morbilliviruses pass between terrestrial and aquatic environments but their presence has 
not yet been confirmed in arctic foxes, which live at the terrestrial-marine interface and 
may therefore serve as an ecological link in morbillivirus transmission. Because 
increasing contaminant burdens and changing climate are likely to affect morbillivirus 
transmission dynamics in the Arctic, an understanding of the current ecology of these 
viruses is necessary to assess future variation. We examine potential morbillivirus 
transmission pathways among Arctic carnivores of northern Alaska using serology and 
molecular epidemiologic techniques. We characterize a fragment of the polymerase co­
factor phosphoprotein (P) gene of morbillivirus RNA isolated from arctic fox (Vulpes 
lagopus) and compare antibody cross reactivity profiles in serum neutralization assays for 
morbillivirus for arctic fox and polar bears (Ursus maritimus) captured in the Prudhoe 
Bay area over a three years period. Three of 11 arctic fox tested were positive for
1 Prepared for submission in the format of EcoHealth: Kirk CM, Beckmen K, Burek K 
Follmann E, O’Hara TM. 2010. Arctic Fox (Vulpes lagopus) Morbillivirus Ecology in 
Northern Alaska: Characterization of phosphoprotein gene fragment and comparison to 
serology of polar bears (Ursus maritimus).
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morbillivirus with identical sequences. Phylogenetic analysis using maximum likelihood 
clustered the arctic fox strain among “Arctic-like” isolates of canine distemper virus 
(CDV). Morbillivirus variants clustered by geographic rather than host origin as is 
typically observed for this virus. Antibodies reacting with phocine distemper virus (PDV) 
antibodies were detected in 90.1% (10/11), dolphin morbillivirus (DMV) in 72.7%
(8/11), CDV in 54.6% (6/11), and porpoise morbillivirus (PMV) in 36.4% (4/11) of foxes 
using serum neutralization assays. These results contrast with those found for polar bears 
where prevalences were 24.3%, 4.4%, 50%, and 4.4%, respectively. Although 
morbillivirus in arctic fox appears “canine” at the genetic (phosphoprotein) level, it 
cannot be distinguished from marine varieties using virus serum neutralization assays, 
especially for animals with recent exposure. Serology suggests morbillivirus circulating 
among polar bears is distinct from that which infected sympatric arctic foxes in 2007 or 
that polar bears have a different serologic response to the same virus.
112
Distemper is a complex disease affecting enteric, respiratory, lymphoid and neural 
systems (Appel, 1987). The causative agent is a single stranded negative sense RNA 
virus in the genus Morbillivirus that is transmitted primarily via aerosolization of 
mucosal exudate, for example through sneezing or scavenging (Alexander and Appel, 
1994; Cleaveland et al., 2000). Canine distemper virus (CDV) was historically known to 
infect only members of the families Canidae (dogs, wolves, foxes), Procyonidae 
(raccoon, coati mundi), and Mustelidae (ferret, mink, skunk). More recently it has been 
reported in all families of terrestrial carnivores and some marine mammals (Deem et al., 
2000).
Morbillivirus epizootics in wildlife can be associated with anthropogenic factors such as 
pathogen spillover, contaminant-related immunosuppression, habitat modification, or 
combinations thereof. However, the development of naive and thus vulnerable 
subpopulations lacking specific immunity to morbilliviruses also may be a mechanism 
for periodic epizootics as a critical number (density) of vulnerable hosts is reached. 
Interactions among age, stress, nutrition, population dynamics, and climate can affect 
wildlife health and therefore susceptibility to infection (Ross, 2002). In outbreaks among 
marine mammals contaminant-related immunosuppression and host range shifts due to 
warming waters and overfishing are hypothesized to have facilitated outbreaks in 
Northern Europe. This may have occurred as naive seal species (e.g. harbor seals) moved 
north, coming into contact with morbillivirus reservoir species of Arctic pinnipeds
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3.2 INTRODUCTION
(Hammond et al., 2002; Harkonen et al., 2002). As a result of such phenomena, the 
Arctic has been a suspected morbillivirus source of some large-scale marine mammal 
mortality events in the past (e.g., Duignan et al., 1997; Barrett et al., 1995).
In the last 20 years, four morbilliviruses have emerged as significant causes of morbidity 
and mortality in marine mammals: CDV, PDV, dolphin morbillivirus (DMV), and 
porpoise morbillivirus (PMV). Rima et al. (1995) suggested that DMV and PMV are 
different strains of the same species (CMV); however, van de Bildt et al. (2005) found 
that the viruses are more divergent than some distantly related measles viruses and thus 
not likely the same species. These four morbilliviruses are very similar genetically and 
antigenically and cross reactivity is known to occur in serological assays (Saliki et al.,
2002). Morbilliviruses apparently pass between terrestrial and aquatic environments. 
Canine distemper virus from terrestrial species was implicated for example in outbreaks 
among Baikal seals (Phoca siberica\ Mamaev et al., 1995) and Caspian seals (Phoca 
caspica), and was thought to be transmitted to seals from domestic dogs (Kuiken et al.,
2006). Conversely, PDV was suggested to be the cause of an outbreak of distemper 
among farmed mink (Mustela vison) near the coast in Denmark (Blixenkrone-Moller et 
al., 1989).
Arctic fox (Alopex lagopus) are found throughout the circumpolar arctic and like polar 
bears (Ursus maritimius) exploit both terrestrial and marine environments for food 
(Pamperin et al., 2008). The foraging ecology of these species makes them good sentinels
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for monitoring the introduction of infectious agents into the arctic food web and also the 
movement of infectious agents between the terrestrial and marine environments. Polar 
bears seropositive for CDV-like viruses have been found across the Arctic including 
Canada and Svalbard, where prevalence has been documented at 24% and 8%, 
respectively (Cattet et al., 2004; Tryland et al., 2005), and in Alaska and Russia at 26­
46% (Follmann et al., 1996). However, there are no published records of morbillivirus in 
arctic foxes. In 1994, an assessment of 99 Alaska arctic fox (Prudhoe Bay area) detected 
no evidence of morbillivirus in serum or neural tissue (Ballard et al., 2001). Early 
hypotheses regarding the exposure of polar bears to morbillivirus implicated the 
consumption of PDV-infected seal prey. Serological studies examining the reactivity of 
polar bears serum to all 4 morbilliviruses, however, demonstrated a greater reactivity to 
CDV antigen (virus) than to PDV, DMV or PMV (CDV, PDV, DMV, and PMV, Gamer 
et al., 2000; CDV and PDV, Cattet et al., 2004). Given the relatively high seroprevalence 
of polar bears to CDV-like antigen and the apparent lack of clinical manifestations, the 
vims may be able to replicate within polar bears without adverse effects. Thus they may 
serve as a reservoir for other sympatric carnivores, such as the arctic fox, pinnipeds, and 
domestic dog.
Canine distemper-like antibodies have also been detected in terrestrial arctic-dwelling 
carnivores in Alaska including brown bears (Chomel et al., 1998; Philippa et al., 2004), 
and wolves (Canis lupus) (Zamke et al., 2004). Serologic evidence of morbillivirus has 
not been documented in marine mammals of the Alaskan Arctic other than polar bears;
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however, antibodies to PDV have been reported in various pinniped and cetacean species 
in the Canadian Arctic including ringed seals (Pusa hispida), the polar bear’s principle 
prey (Duignan et al., 1997). There is evidence that morbillivirus is endemic in the North 
Atlantic and Barents Sea harp seal (Phoca groenlandica) populations where PDV 
seroprevalence ranging from 67% to 100% (N=183) have been reported (Tryland et al., 
2005). Recently, Goldstein et al. (2009) identified PDV via genetic analysis in Northern 
sea otters (Enhydra lutis) in Alaska, the first documentation of morbillivirus in any 
Pacific species. These authors hypothesize that sea ice reduction may have altered seal 
haul-out and migration patterns, resulting in contact between Atlantic, Arctic, and Pacific 
Ocean species. These findings have generated concern of infectious disease threats to 
several sympatric and declining Pacific marine mammals.
Climate change and anthropogenic influences (e.g. industry, proximity to growing 
communities and/or food sources) may be altering ecology of disease agents and host 
species in the Arctic. It is therefore essential to establish baselines of prevalence and 
current transmission dynamics of infectious agents so that change over time may be 
assessed. The impetus of this study was to elucidate morbillivirus transmission pathways 
among Alaskan arctic carnivores, using molecular epidemiologic techniques including 
sequence analysis and phylogeny as well as serology. To date, morbillivirus in arctic fox 
has not been described. We provide baseline information on morbillivirus seroprevalence 
in arctic fox. We also characterize a fragment of the polymerase co-factor phosphoprotein 
(P) gene of morbillivirus RNA isolated from arctic fox, performed phylogenetic analyses
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and compared cross reactivity profiles in serum neutralization assays for morbillivirus for 
arctic fox and polar bears. We focus on two species included in the conceptual model for 
morbillivirus transmission for this region (Figure 3.1). This model can be generalized for 
pathways of related infectious agents (similar transmission characteristics).
3.3 METHODS 
3.3.1 Arctic Fox Epizootics and Pathology Investigation
During January through May 2007, a rabies and morbillivirus mortality event occurred on 
the North Slope of Alaska among arctic and red fox ( Vulpes vulpes). Foxes were 
submitted to Alaska Department of Fish & Game (ADF&G) by oil industry personnel 
when found dead or when suspected to be infected with rabies on the basis of behavior 
including, aggression and lack of fear of humans. Personnel from ADF&G and 
University of Alaska Fairbanks (UAF) performed complete necropsies. Fox brains were 
submitted to the Alaska State Virology Laboratory (ASVL) for rabies testing. Tissues for 
histopathology were prepared at Veterinary Services, UAF. Immunohistochemistry was 
performed at Washington Animal Disease Diagnostic Laboratory (WADDL) and 
histologic evaluations for morbillivirus were performed at the Alaska Veterinary 
Pathology Services (AVPS, K. Burek).
3.3.2 Animal Capture and Sampling
We used Tomahawk Live Traps© baited with tuna in oil to capture arctic fox throughout 
the Prudhoe Bay area approximately between 148°60’ and 147°50’ longitude and from
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the coast to approximately 70°00 latitude between June 30th and July 11th, 2007 (Figure 
3.2). Eleven arctic fox (5 males, 6 females) were captured and transported to a holding 
facility. Animals were transferred to squeeze cages and injected (intramuscularly) with 
anesthetic agents by syringe [~ 6 mg/kg ketamine (Ketaset®; Fort Dodge, IA)/ 3 mg/kg 
xylazine (Boehringer Ingelheim Vetmedica Inc.; St. Joseph, MO)] in the hind leg. Blood 
was collected from the jugular vein (Vacutainer, BD Biosciences; Franklin Lanes, NJ) 
into evacuated blood collection tubes for whole blood and serum; and PAXgene Blood 
RNA tubes (Qiagen; Valencia, California) for RNA isolation. Sex, age class, physical 
condition, body mass and morphometries were recorded. Age class was designated as 
juvenile (< 1 year) or adult (> 1 year) based on tooth wear. Viral CULTURETTE™ 
Collection and Transport Systems (BD Biosciences; Franklin Lanes, NJ) were also used 
to swab nasal cavities for RNA extraction. Animals were given a passive integrated 
transponder (PIT) tag subcutaneously to enable identification of animals in future 
contacts. Animals were released at site of capture following observation and recovery. 
This project was approved by the UAF IACUC (Assurance 07-30). Polar bears were 
captured in the Springs of 2005 and 2006 (late March through early May) out of logistic 
bases in Barrow, Prudhoe Bay, and Kaktovik. Blood was collected from the femoral vein 
or artery (Vacutainer, BD Biosciences; Franklin Lanes, NJ) into evacuated blood 
collection tubes for whole blood and serum and PAXgene Blood RNA tubes (Qiagen, 
Valencia, California) for RNA isolation. Viral CULTURETTE™ Collection and 
Transport Systems (BD Biosciences; Franklin Lanes, NJ) were also used to swab nasal
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cavities for morbilliviral RNA detection. Sampling was conducted as described in Kirk et 
al. (2010).
3.3.3 Serology
Sera derived from blood collected without anticoagulant were separated by centrifugation 
at 1,500 x g for 5 minutes (TRIAC, Clay Adams Co., Parisippany, NJ, USA) and frozen 
at -20°C. Sera were stored at -70°C upon return from the field for later serological assays. 
Polar bear and arctic fox serum was assayed for morbilliviral antibody at the Oklahoma 
State University Animal Disease Diagnostic Laboratory (OADDL, Stillwater, OK USA) 
via differential serum neutralization (SN) assay for four morbilliviruses (CDV, DMV, 
PDV, PMV) as described by Gamer et al. (2000). Arctic fox serum samples were also 
assayed for morbilliviral antibodies at Athens Diagnostic Laboratory, College of 
Veterinary Medicine at the University of Georgia (UGA) via differential serum 
neutralization (SN) assay for three morbilliviruses (CDV, PDV, CMV). Polar bear serum 
was screened at only one laboratory since the intent of testing was surveillance as part of 
the health assessment study, while arctic fox were tested in response to a suspected 
morbillivirus-based mortality event.
Results from both laboratories are expressed as the reciprocal of the highest dilution that 
completely neutralized 100% of the respective challenging vims using a cut-off of 1:8 for 
determining presence of specific antibodies. Seroprevalence and 95% confidence 
intervals for mean prevalences were calculated for polar bears in 2005, 2006, and for
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arctic foxes in 2007 as described in Hughes-Hanks et al. (2005). Results for arctic fox 
serology were compared between laboratories. In order to compare morbilliviral exposure 
between arctic fox and polar bear, we compared cross reactivity profiles for the serum 
neutralization differential assay for data obtained from OADDL. Since the data were not 
normally distributed the non-parametric Wilcoxon signed-rank test was used to compare 
reciprocal mean titers for polar bears and arctic fox for each virus tested at OADDL.
3.3.4 Molecular Analyses
RNA was extracted from fox carcasses obtained from the North Slope from 
retropharyngeal lymph nodes, brain and/or lung depending upon sample quality and 
availability. Tissues were either preserved in RNA/afer® (Applied Biosystems; Foster 
City, California) or frozen and were processed using the FastPrep® Instrument with the 
FastRNA® Pro Green Kit according to the manufacturer’s instructions (MP Biomedicals; 
Solon, Ohio). RNA was extracted from blood using the PAXgene Blood RNA kit 
(Qiagen; Valencia, California) according to the manufacturer’s instructions. RNA was 
extracted from nasal swab samples using TRI REAGENT® LS [Manufacturer's protocol 
(1995), Molecular Research Center, Inc., Cincinnati, OH], Sample integrity was assessed 
via amplification of a housekeeping gene, P-actin (Kraft et al., 1995). For morbillivirus, 
we used the universal primer set, which amplifies a well-conserved region of the 
polymerase cofactor, phosphoprotein, for all known morbilliviruses (Barrett et al., 1993). 
Reverse transcription reactions were performed using Superscript™ III One-Step RT-PCR 
System with Platinum® Taq, according to the manufacturer’s instructions (Invitrogen,
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Carlsbad, California). Amplified products of expected molecular masses were purified 
using QIAquick Gel Extraction Kit (Qiagen, Valencia, California) and then cloned using 
TOPO TA Cloning® kit according to the manufacturer’s instructions (Invitrogen, 
Carlsbad, California). Sequencing was performed in duplicate in both the forward and 
reverse directions using vector specific primers at the Core Facility for Nucleic Acid 
Analysis Institute of Arctic Biology, UAF with use of the BigDye™ Terminator Kit 
(Applied Biosystems, Foster City, California) and an automated sequencer (ABI 3100 
Genetic Analyzer, Applied Biosystems) according to the manufacturer’s instructions. 
Primer sequences were removed prior to bioinformatics analyses. The complete sequence 
assemblies were created using Lasergene® v7.0 (DNASTAR, Inc., Madison, Wisconsin) 
using nucleotide data with quality higher than 20. Sequences resulting from a BLAST 
search of the National Center for Biotechnology Information (NCBI) database were 
imported and aligned with fox sequences using Clustal W in the Lasergene® v7.0 
software package. The reference CDV nucleotide sequences used for phylogenetic 
analyses were obtained from the NCBI database with assigned GenBank accession 
numbers given below. These sequences were chosen based on BLAST results (e.g. those 
with homology to the arctic fox strain) and geographic origin such that at least 2 isolates 
from each region of both canine and non-canine origin where available were represented 
in the analysis. Only one of the 2 Missouri dog isolates (18133) with high homology to 
arctic fox virus were included in the analysis as sequences were identical. Appropriate 
likelihood models were determined using the Akaike Information Criterion implemented 
in ModelTest 3.7, PAUP* 4.0bl0 (Posada and Crandall, 1998; Posada and Buckley,
121
2004). PHYML (Guindon and Gascuel, 2003) was used to construct a maximum 
likelihood (ML) tree for partial P gene sequences using the GTR model for nucleotide 
substitution with transition/transversion ratio, proportion of invariable sites, and gamma 
distribution empirically determined with 6 nucleotide substitution categories, 1000 
bootstrap replicates and the NNI+SPR tree topology search operation for Arctic Fox 
Alaska USA, 2007; Siberian Seal Russia, 1988 (AF259551); Alaska Sled Dog, 1996­
1997 (Maes et al., 2003); Missouri Dog case 18133 USA, 2004 (AY964107); Raccoon 
USA, 2003 (AY321298); Lynx Canada 2008 (FJ240229); Dog A75/17 USA, 1975 
(AF164967); Dog Hamamatsu Japan, 1992 -1994 (AB028915); Dog Jujo Japan 
(AB028916); Dog Yanaka Japan, 1992 -1994 (AB028914); Ferret Germany, 1989 
(AF259550); Dog 5804 Germany, 1990 (AY386315); Dog Germany, 1993 (AF259549); 
PDV-1 (X75960); DMV (AJ608288); CMV (AF333347); Dog Kazhakstan, 2007 
(EU888880); Caspian Seal Kazhakstan, 2007 (EU594261), CDV Rockbom vaccine 
(AF1814460); and CDV Onderstepoort vaccine (AF305419).
3.4 RESULTS
3.4.1 Serology
Interlaboratory differences between OADDL and UGA were found in cross reactivity 
profiles for individual arctic fox, however results were consistent in that the same single 
individual did not test positive for any virus in either differential panel. Based on UGA 
data, seroprevalences (Table 3.1a) and titer ranges for the three viruses were similar 
[CDV (titer range = 1:16-1:256), PDV (titer range = 1:16-1:128), CMV titer range =
1:16-1:128)]. Based on OADDL data however, 91% (N=l 1) of arctic fox demonstrated 
prevalence (Table 3.1a) to PDV (titer range = 1:8-1:128) with mean titers varied and 
ranges roughly equal [(CDV titer range = 1:8-1:128), (DMV titer range = 1:12-1:96), 
(PMV titer range = 1:16-1:128)] (Figure 3.3). The number of arctic fox seropositive for 
each virus tested via SN assay by both OADDL and UGA is provided in Table 3.1b.
Polar bear seroprevalence for CDV in both 2005 and 2006 was relatively high and 
antibodies to PDV, DMV and PMV were also detected (Table 3.1a). Mean titers for 
seropositive polar bears were highest for CDV (titer range = 1:8-1:512), followed by 
PDV (titer range = 1:8-1:96), DMV (titer range = 1:8-1:24) and lowest for PMV (titer 
range = 1:16-1:32) as indicated in Figure 3.3. All animals seropositive to DMV, PDV, 
and/or PMV had a higher titer to CDV. Of all polar bears seropositive for CDV, 48.5% 
were also seropositive for PDV. Any animal seropositive for DMV or PMV were also 
seropositive for both CDV and PDV. Reciprocal mean titers were significantly greater for 
polar bears sampled in 2005 than in 2006 and as compared to arctic fox (Figure 3.3). No 
other significant differences in mean titers were found.
3.4.2 Molecular Analyses
During the mortality event, 19 foxes (12 arctic and 7 red) were subject to complete 
necropsy and histopathological examinations. Of these 19 animals, 11 were tested for 
morbillivirus by RT-PCR and 27% (3/11) were positive. All 3 were arctic fox. Six of the 
19 animals evaluated in the mortality event were positive for CDV antigen via
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immunohistochemistry (IHC), including one red fox that was not tested via RT-PCR.
Four of these IHC positive animals were not tested via RT-PCR due to sample 
availability, one was negative via RT-PCR, and one was positive. For the animal where 
assay results for morbillivirus did not agree, different tissues were tested. Lung was 
tested via IHC whereas only the retropharyngeal lymph node was available for RT-PCR. 
Of foxes testing positive for CDV in either assay, two were adults (1 male and 1 female), 
three were juveniles (1 male and 2 females) and the age of two could not be determined 
due to damage to the carcass resulting from vehicular collision and scavenging. One of 
three foxes that tested morbillivirus positive via RT-PCR presented clinical signs and 
pathologic lesions consistent with canine distemper viral infection and also tested 
positive via IHC (K. Burek; data not presented). One co-infection of rabies and CDV in a 
red fox was diagnosed. Viral RNA was not amplified from nasal swabs of live-captured 
arctic fox or polar bears. The amplified P gene fragments were identical for the three 
positive arctic fox cases. Alignment with sequences available from GenBank revealed 
that the arctic fox isolate differed from a strain derived from two North American dogs 
(Missouri, June through October of 2004) by only 1 nucleotide transition (G to A)
(Figure 3.4). The arctic fox sequence also displayed very high homology with a sequence 
derived from a Siberian seal during a CDV outbreak in Lake Baikal, Russia (Mamaev et 
al., 1995) and with a sequence obtained from an Alaskan dog during a CDV outbreak 
among sled dogs in Kotzebue (Maes et al., 2003). The arctic fox isolate differed by only 
2 nucleotides (both transitions and transversions) from each of these sequences (Figure 
3.4). Phylogenetic analysis of the 389 bp P gene sequence using maximum likelihood
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clustered the arctic fox isolate among these sequences, however it did not form a clade 
with any sequences used in the analysis (Figure 3.5).
3.5 DISCUSSION
3.5.1 Serology Comparisons
Comparison of morbillivirus serological cross reactivity profiles shows a markedly 
different pattern for polar bear and arctic fox suggesting viruses to which they have been 
exposed are distinct and/or the antibody responses between these ursids and canids are 
dissimilar. Without viral sequences available from polar bears to compare, we cannot rule 
out differences due to variation in host immune response. Results for polar bears were 
consistent with those found by other researchers who concluded that the morbilliviral 
antigen to which Alaska polar bears had been exposed was most likely of terrestrial 
origin because the greatest number of animals demonstrated antibodies to CDV and each 
animal presenting a titer for any of the other 3 morbilliviruses tested (PDV, DMV, and 
PMV) presented a higher titer to CDV (Gamer et al., 2000; this study). Based on 
OADDL data, arctic fox in contrast demonstrated the greatest prevalence to PDV, and 
titer levels for seropositive animals were quite varied and did not show the consistent 
pattern we observe in polar bears. Arctic fox serology results from UGA were not 
identical to those from OADDL in titer level for each vims, however results were the 
same regarding which animals were seropositive for at least one of the viruses tested in 
each panel (Table 3.1b). Based on OADDL data, most animals (N=10) appeared to 
seroconvert to PDV+ while based on UGA data 9 animals seroconverted to PDV+ and
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CMV+ while 10 seroconverted to CDV+. The UGA and OADDL data together do not 
provide clear support for either marine or terrestrial origin. It is also possible that 
antibodies observed in arctic fox sampled after the epizootic did not result from exposure 
to the same virus, which caused mortality 3 months prior to sampling of live captured 
foxes. Foxes sampled in the summer could have seroconverted as a result of an infection 
occurring prior to the mortality event from which we obtained viral RNA. These data 
represent the first published serological profile for morbillivirus in arctic fox therefore 
there is no other data available for comparison. The results of this study underscore the 
limitations of using serology to elucidate transmission pathways of morbillivirus in 
wildlife and for specific identification of the antibody-inciting agent.
3.5.2 Phylogenetics
Of seven confirmed CDV cases examined during an outbreak among breeder dogs in 
Missouri there were two strains demonstrating high homology with the arctic fox strain 
examined in this study. These variants were determined by Pardo et al. (2005) to be 
genetically distinct from viruses previously detected within the continental United States 
and most closely related to a Siberian seal isolate. The infected dogs originated from a 
breeder within the state and had no history of recent travel, however, neither travel 
history for the bitch and stud (or other animals at the facility), nor breed information were 
provided in the manuscript. The authors suggested that the virus may have originated 
from non-canine species or may have been transmitted from dogs to other species. The 
arctic fox sequence demonstrated the second greatest percentage homology with a strain
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of CDV previously documented in Alaska among sled dogs and a high level of homology 
had previously been demonstrated between this Missouri dog isolate and the Alaska sled 
dog isolate (Pardo et al., 2005). A later study performed by McCarthy et al. (2007) to 
assess the role of selection and recombination in shaping viral genetic diversity and 
driving the emergence of CDV in non-dog hosts included the Missouri dog isolates in the 
“Arctic-like” cluster along with the Alaskan sled dog and Siberian seal. In phylogenetic 
analyses of CDV, isolates generally cluster by geographic region rather than host origin 
as is demonstrated here (Harder and Osterhaus, 1997). In the maximum likelihood 
analysis isolates from a dog and seal in Kazakhstan formed a clade, as did isolates from 
Japanese dogs and German dogs (Figure 3.5). The Siberian seal and Alaska sled dog, as 
well as 2 North American isolates [lynx (Lynx canadensis) and USA dog] also formed 
clades (Figure 3.5). Furthermore, the arctic fox isolate grouped in the “Arctic-like” 
cluster along with the Siberian seal, Alaska sled dog, and the Missouri dog case. The 
exception here is the German ferret isolate, which did not cluster among European strains 
but appears to be more closely related to the “Arctic-like” strains. This pattern whereby 
isolates cluster by geographic rather than host species or genus origin in phylogenetic 
analysis achieves greater resolution and statistical support (e.g. bootstrap values) when 
the haemagglutinin (H) and fusion (F) genes are examined because there tends to be more 
sequence divergence in these genes among morbilliviruses. The H and F proteins are 
required for virus attachment and entry and therefore these genes are under greater 
selection pressure, which is hypothesized to result in the greater sequence variability 
observed across morbilliviral species.
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The power of our phylogenetic assessment was somewhat limited due to the high 
conservation and therefore limited diversity of the P gene and because fewer sequences 
are available in the public databases as compared to other morbilliviral genes. We 
targeted this gene in RT-PCR precisely because it is highly conserved and therefore lent 
the greatest possibility of success in amplifying viral nucleic acid from our samples. For 
this initial study, we chose to target the only gene for which there exists a “universal 
primer set” capable of amplifying all morbilliviruses as the arctic fox morbillivirus was 
“novel” and results of serology did not indicate that canine specific primers would be 
useful. Examining the maximum likelihood tree, we can however clearly see that the 
arctic fox strain is more closely related to CDV than PDV, DMV, or CMV and appears to 
cluster among the “Arctic-like” isolates. Furthermore, the tree supports the hypothesis 
that the arctic fox isolate is distinct from vaccine strains and typical North American, 
European, Eurasian and Asian field strains based on sequences available in Genbank.
3.5.3 Other Distemper Epizootics in the Arctic
During the same time period that cases were reported in Alaska for arctic fox an outbreak 
of CDV occurred among sled dogs in the Canadian Arctic throughout Nunavut and the 
Northwest Territories (Campbell et al., 2007). Samples were confirmed positive via IHC; 
however viral sequences were not examined. Because the epizootic occurred in widely 
separated locations, arctic fox were suggested to be the source of infection. There were 
however, no reported cases of CDV in foxes in these regions during the epizootic. 
Although no cases of CDV were reported for Alaska dogs during this time, the number of
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dogs present in Alaska arctic communities has drastically decreased since the 
introduction of the snow machine as an alternative means for transportation (Rausch,
2003). In addition, many dogs living in Alaskan villages are now vaccinated through 
government sponsored immunization programs
(http://www.uscgalaska.eom/go/doc/780/310669/) and via private veterinarians.
Epizootics of CDV have occurred previously in the Arctic. In the winter of 1987-1988 an 
outbreak occurred over a broad geographic range in the Canadian Arctic concurrent with 
an outbreak among sled dogs in Greenland. Bohm et al. (1989) hypothesized that arctic 
fox were responsible for carrying the virus from Canada to Greenland similar to the 
facilitation of rabies epizootics, which occur as infected fox cross the sea ice. This 
suggestion was based on sea ice conditions at the time, the observation that settlements in 
which CDV cases occurred were geographically isolated from one another, and that 
previous studies demonstrated fox migration from Canada to Greenland. An epizootic of 
CDV occurred in Kotzebue, Alaska during the winter of 1996-1997 killing approximately 
200-300 dogs in the region. This strain was demonstrated to differ significantly from 
vaccine strains (Rockbom and Onderstepoort) with 19 nucleotide changes, 13 of which 
were shared with 7 other virulent field strains. This sequence determined to be most 
closely related to an isolate from a Siberian seal (99.4%) during the 1987-1988 epizootic 
in Lake Baikal. Although arctic fox do not live near Lake Baikal, there are other 
carnivores present in the region capable of long distance travel and potential 
dissemination of CDV (e.g. grizzly bears, wolves and red fox).
3.5.4 Concerns for Climate Change Impacts on Morbillivirus at the Marine- 
Terrestrial Interface
The arctic fox population in northern Alaska follows the cyclic abundance of lemmings 
and other rodents. Populations of arctic fox flourish when these prey are abundant and 
decline when prey populations decline, due to food availability. Arctic fox use sea ice 
more extensively for forage (e.g. seal carrion) in years when winter foods are limited, for 
example in low lemming years. Pamperin et al. (2008) followed collared individuals and 
suggested that diets for arctic fox were likely 100% marine while on the sea-ice given 
their consistent locations at distances that would preclude periodic trips to shore to feed 
on terrestrial resources. Rabies outbreaks in arctic fox populations occur in Alaska 
approximately every 3-5 years during the winter months (Ritter, 1981) when rodent 
availability is lowest and access to birds (and eggs) as alternative prey is lacking. Ritter 
(1981) hypothesized that traveling over long distances, congregation at food sources, and 
scavenging on infected carcasses in combination with nutritional stress may facilitate 
such outbreaks. The same forces may also drive epizootics of CDV, although whether the 
virus is endemic in arctic fox populations is unknown.
There is concern that diminishing sea ice may lead to increased presence of foxes and 
polar bears at human settlements (e.g. landfills and whale carcass remains) and industrial 
sites where anthropogenic food sources are present. This may facilitate greater interaction 
with domestic dogs and disease transmission. For density dependent disease, the presence 
of anthropogenic food sources such as baiting and waste stations that concentrate animals
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in a given area can greatly enhance transmission rates (Wobeser, 2006). Polar bears and 
arctic fox congregated at anthropogenic food sources are likely to have more intraspecific 
and interspecific interactions. Significant differences were found for risk of CDV 
seropositivity for polar bears by age class with bears ages 5-7 most likely to be 
seropositive (Kirk et al., 2010), however we could not perform the same assessment for 
arctic fox because we were only successful in capturing adult animals.
Climate change is also expected to impact the long-range transport and fate of 
contaminants in the Arctic through alteration in ocean and air currents. Persistent organic 
pollutants (POPs) volatilize from lower latitudes and are transported to the Arctic where 
they are then deposited via precipitation and through other mechanisms (Lohmann et al.,
2007). Locally, melting of glaciers may directly increase contaminant levels entering the 
food chain as contaminants deposited during their years of historical use are released 
(Blais et al., 2001). Permafrost has acted as a sink for POPs, and as it melts the 
contaminants are released (Suk et al., 2004). Reduced marine ice cover will increase 
ocean-atmosphere gas exchange and therefore deposition of contaminants like 
polychlorinated biphenyls (PCBs) and toxaphene, which are still entering the Arctic 
Ocean via the atmosphere (AMAP, 2003).
Indirect effects may occur as apex predators change prey species. For example, 
increasing contaminant loads have been documented in some polar bear sub-populations, 
possibly as a result of dietary shifts due to declining sea-ice (McKinney et al., 2009).
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Stressors including decreasing access to optimal prey species, heat stress, exposure to 
increasing levels of contaminants and increasing burdens of infectious agents may act in 
synergism to decrease immunological resilience, thereby increasing susceptibility to 
morbillivirus infection. Changes in morbillivirus prevalence that may occur with climate 
change could pose an increased threat to the health of local people living along the coast 
and to wildlife if populations of prey bases and subsistence species are adversely 
impacted by morbillivirus epizootics.
3.5.5 Considerations for Origins of the Epizootic
Based on these data, the source of morbillivirus for arctic fox appears terrestrial at the 
genetic level, but serology suggests it to be of equivocally marine or terrestrial origin.
The morbillivirus that infected arctic fox in 2007 may have entered the population from 
the marine environment (e.g. scavenging on infected seal carcasses), from interaction 
with terrestrial species (wildlife or domestic), or may be enzootic to this or neighboring 
populations of arctic fox, red fox or polar bears. It is of interest that a coinfection of 
rabies and distemper was diagnosed in one red fox (N=8) during the mortality event. 
Unfortunately, this animal was heavily scavenged and thus we did not have suitable 
tissue available for RT-PCR. Red foxes were not targeted in the capture studies and thus 
serological status was not assessed.
Using serology alone, we cannot determine whether polar bears are infected with or 
exposed to a single strain of morbillivirus, multiple morbilliviruses or perhaps carry a
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distinct strain enzootic to southern Beaufort Sea polar bears in and/or the Arctic. In order 
for virus to have been detected in live captured arctic fox and polar bears, animals needed 
to have been sampled during active infection. It is possible that antibody presence in 
polar bears results from exposure only, with no significant resulting viremia or a viremia 
of no consequence. Alternatively, the virus may be able to replicate within polar bears 
without adverse effects, yet they may serve as a reservoir for other sympatric carnivores. 
This phenomenon has been observed among some seal species (Duignan et al., 1997). It 
is also possible that antibodies found in live captured fox resulted from an exposure prior 
to the documented epizootic, which afforded their survival (e.g. these animals were 
immunoprotected).
Polar bears and arctic fox may be exposed to different morbilliviruses where their ranges 
do not overlap. For example, southern Beaufort Sea polar bears may travel over 50 km a 
day (Amstrup, 2003), while foxes generally maintain smaller, defined home ranges 
extending farther onshore. In addition, foxes presently spend more time in close 
proximity to humans and anthropogenic food sources as compared to polar bears. They 
are commonly observed near dump-sites, outside kitchen facilities at oil camps, and 
accept handouts from humans. Transmission of morbillivirus between the two species at 
shared food resources (e.g. whale and seal carcasses) may be prevented by viral 
dessication due to the harsh Arctic climate. Furthermore, the virus infecting arctic fox 
resulted in mortality whereas the morbillivirus to which polar bears have been exposed 
does not appear to be lethal at a detectable scale and the biological effects of exposure
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remain largely unknown. We do not know if polar bears actually become infected with 
the virus however hematology data collected for the southern Beaufort Sea polar bears 
(Kirk et al., 2010) demonstrate a significant negative association between specific white 
blood cell types and increasing titer to CDV.
3.6 CONCLUSION
Although morbillivirus in arctic fox appears canine (terrestrial) at the genetic 
(phosphoprotein) level, it cannot be distinguished from marine strains using serology. 
Viral RNA has not been successfully isolated from polar bears to date though serology 
suggests morbillivirus circulating among polar bears is distinct from that which infected 
sympatric arctic foxes in 2007. However, without viral RNA sequences from polar bears, 
seals, or other sympatric species of arctic fox, we are unable to determine which cross 
species transmissions of morbillivirus may be occurring in northern Alaska. The results 
of this study underscore the limitations of using serology alone to examine morbillivirus 
epidemiology. Phylogenetic analyses however do suggest that the strain is distinct from 
European, Asian, Eurasian, and North American field strains and most closely related to 
“arctic isolates” of CDV. Future studies should include not only obtaining morbilliviral 
nucleic acid from other carnivores across the Arctic, but also sequencing the less 
conserved H and fusion (F) genes to gain a better understanding of phylogeny of 
morbillivirus in the Arctic.
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GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTCCCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0
------------------------------------------------------------------------------------ CCTGCAGG 8
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0
------------------------------------------------------------------------------------ CCTGCAGG 8
GAAGAGATTAAGGGAATCGAAGATGCTGACAGCCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 50 
-AAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 4 9 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 50 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 50 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAGAGGTTAAGGGAATCGAAGATGCTGACAGTCTCGTGGTACCTGCAGG 5 0 
GAAAAGGTTAAGGGAATCGAAGATGCTGACAGTCTCATGGTACCAGCAGG 50
----------- GTTGAAGGAGTCAAGGATGCTGACCTGCTCGTGGTTCCAACAGG 4 4
CAAGCGGTTGAAGGAGTCAAGGATGCTGACCTGCTCGTGGTTCCAACAGG 5 0
O n d e s te rp o o rt_ V a c c in e
R o ckb o rn _V a cc in e
D og_K azhakstan  2007
C a s p ia n _S e a l_K a za kh s ta n  2007
S ib e r ia n _ S e a l_ R u s s ia  1988
_D o g_A laska  USA_1996-97
A r c t i c . Fox_A laska_U SA 2007
Dog_1813 3_USA 2 004
F e rre t_ G e rm a n y _ l989 
D og_G erm any_l9 9 3
Dog_5 8 0 4_Germany 1990
Lynx_Canada 2 008
Dog_A75-15_USA_1975
Dog_J u j o_Japan
Dog_Y a n a ka _1992-94
D og_H am am atsu_Japan_l9 92 -94
PDV-1
CMV
DMV
CACTGTCGGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CACTGTCGGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CACTGTCGGTAATCGAGGATTCGAGAGCGGAGAAGGAAGCCCTGATGATA 100 
CACTGTCGGTAATCGAGGATTCGAGAGCGGAGAAGGAAGCCCTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 5 8 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 5 8 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAGGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 9 9 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTCAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CGCTGTTAGTAATCGAGGATTCGAGAGAGGAGAAGGAAGCCTTGATGATA 100 
CCCTCCAAGTAATAGGGGATTCGAAGGAAGAGAGGGAAGCCTTGATGATA 100 
CAGTGATGATGATGCAGAATTCAGAGACGGAGATGAGAGCTCTCTCGAGA 94 
CAGTGATGATGATGCAGAATTCAGAGACGGAGATGAGAGCTCTCTCGAGA 100 
* * * * * * * * * *  * * * * *  * * *  * * * *
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GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 108 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 108 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 149 
GCACTGAGGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 150 
GCACTGAAGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 150 
GCACTGAGGATTCTGGCGAAGATTATTCCGAGGGAAATGCTTCATCTAAC 150 
GCATTGAAGATTCTAGCGAAGATTATTCCGAAGGAAATGCTTCATCTAAC 150 
GCGATGGTGAATCTGGCACTGTTGATACCAGAGGAAATTCTTCCTCTAAC 144 
GCGATGGTGAATCTGGCACTGTTGATACCAGAGGAAATTCTTCCTCTAAC 150
* *  * * *  * * * * * * * *  *  * * *
Figure 3.4 Nucleotide sequence alignment of a 389 bp P gene fragment of sequences 
included in phylogenetic analyses. Nucleotides identical to the consensus are shown in 
dot and missing nucleotides are designated by dashes. Sequences for the Alaska sled 
dog and Missouri dog case 18133 are 42 bp shorter than the Arctic Fox sequence and 
CMV is 6 bp shorter.
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TGGGGATATTCTTTCGGCCTTAAACCGGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCGGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGGGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGGGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 158 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 158 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
AGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 199 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCAGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCGGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCGGCTGATGTGAGCAT 200 
TGGGGATATTCTTTCGGCCTTAAACCAGACAGAGCGGCTGATGTGAGCAT 200 
TGGGGATATACTTTTGGCCTTAACCCAGACAGAGCAGCTGATGTGAGCAT 200 
AGGGGATCTGCTCCCAGGATTAAGGTCGAGAGATCTGCTGACGTTGAGAC 194 
AGGGGATCTGCTCCCAGGATTAAGGTCGAGAGATCGTCTGACGTTGAGAC 200 
* * ★ * ★ ★ * * *  ★ ★★★* * * * *  ★ ★★★*★★ *
GCTGATGGAAGAGGAATTAAGTGCTCTACTCAG-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTAAGTGCTCTACTCAG-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTAAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTAAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAG-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAG-------- GACAAGCAGAAAT 204
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAG-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAG-------- GACAAGCAGAAAT 204
GCTGATGGAAGAGGAATTGAGCGCTCTGCTCAG-------- GACAAGCAGAAGT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTAATGGAAGAGGAATTGAGTGCTTTGCTCAA-------- GACAAGCAGAAAT 245
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAG-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTGATGGAAGAGGAATTGAGTGCTCTGCTCAA-------- GACAAGCAGAAAT 246
GCTAATGGAGGAAGAGTTGACTACTCTGCTTGG-------- CACAGGCCACAAT 246
TATAAGCAGTGAAGAGCTACAAGGACTGATTAGATCTCAGAGTCAAAAAC 244 
TATAAGCAGTGAAGAGCTACAAGGACTGATTAGATCTCAGAGTCAAAAAC 250 
* * ★★ * *  * *  *  * * * *
GTAG-GGATTCAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACATAATC 295 
GTAG-GGATTCAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACATAATC 295 
GTAG-GGATTCAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACATAATC 295 
GTAG-GGATTCAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACATAATC 295 
GTAG-GGATTCAGAAAAGGGAGGGGAAAACTCTGCAGTTCCCACACAATC 295 
GTAG-GGATTCAGAAAAGGGAGGGGAAAACTCTGCAGTTCCCACACAATC 253 
GTAG-GGATTCAGAAAAGGGATGGGAAAACTCTGCAGTTCCCACACAATC 295 
GTAG-GGATTCAGAAAAGGGATGGGAAAACTCTGCAGTTCCCACACAATC 253 
GTAG-GGATTCAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACACAATC 295 
GTAG-GGATTCAGAAAAGGGATGGAAAGACTCTGCAGTTCCCACACAATC 295 
GTAG-GGATTCAGAAAAGGGATGGAAAGACTCTGCAGTTCCCACACAATC 295 
GTAG-GGATACAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACACAATC 294 
GTAG-GGATACAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACGCAATC 295 
GTGG-GGATTAAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACACAATC 295 
GTGG-GGATTAAGAAAAGGGATGGGAAGACTCTGCAGTTCCCACACAATC 295 
GTGG-GGATTAAGAAAAGGGATGGGATGACTCTGCAGTTCCCACACAATC 295 
GCCG-GGGGCCAAAAGAGGGACGGGAGAACTCTACAGTTTCCGAATAGTC 295
ATAATGGATTTGGAGTAG— AC------ AGATTCCTAAAGGTCCCAC-CAATT 288
ATAATGGATTTGGAGTAG— AC AGATTCCTAAAGGTCCCAC-CAATT 2 94
★ ★ * ++ *  * *  *
Figure 3.4 (Continued).
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CCGAAGGTAAGACAAG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAAG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAAG-GGTTCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAAG-GGTTCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGG-AGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGG-AGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 302 
CCGAAGGTAAGACAGG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 302 
CCGAAGGTAAGACAGG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGG-GGATCCGGAGTGTGGGTCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGG-GGATCCGGAGTGTGGGTCCATTAAAAAGGGCAC 344 
CAGAAGGTAAGACAGG-GGATCCGGAGTGTGGTTCCATTAAAAAGGGCAC 343 
CAGAAGGTAAGACAGG-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGA-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGTAAGACAGA-GGATCCGGAGTGTGGACCCATTAAAAAGGGCAC 344
CCGAAGGTAAGACAGA-GGATCCGGAGTGTGGATCCATTAAAAAGGGCAC 344 
CCGAAGGGAGTATAGG-GAACCAAGTATGCGAACCCATTAAAAAGGGCAC 344 
CCAACCTCCGTGCCGCTGGACCCCGCTTCCAAATCCATTAAAAAGGGCAC 338 
CCAACCTCAGTGCCGCTGGACCCCGCTCCCAAATCCATTAAAAAGGGCAC 344
AGAAGAGAGGTCAGTCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGAAGAGAGGTCAGTCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGAAGAGAGGTCAGTCTCACAGGGAATGGGGATAGTTGCTGGATC 389 
AGAAGAGAGGTCAGTCTCACAGGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 347 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAAGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 347 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGAGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGAGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 388 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAGGTCAGCCTCACATGGAATGGGGATAGTTGCTGGATC 389 
AGGAGAGAAGTTAGCCTCACATGGAATGATGACCGCTGCTGGATT 389 
AGGAGAGAGATCAGCCTTATCTGGGACGGTGACCGAGTTTTCATT 383 
AGGAGAGAGATCAGCCTTATCTGGGACGGAGACCGAGTTTTCATT 389 
* *  * * * * *  * * *  * *  *  * *  * * * *  * * * *
Figure 3.4 (Continued)
(a) Full Maximum Likelihood Tree
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(b) Subtree excluding P D V -1 , C M V , and DM V
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Table 3.1 (a) Morbillivirus seroprevalence (mean %, N, and 95% Cl) for southern Beaufort Sea polar bears (2005-2006) and 
Prudhoe Bay area arctic fox (2007), northern Alaska as determined by Oklahoma Animal Disease Diagnostic Laboratory 
(OADDL) and University of Georgia, Athens (UGA). (b) Matrix displaying the number of arctic fox seropositive by 
morbillivirus for both laboratories where OADDL: DMV + PMV = UGA: CMV.
(a)
Polar Bear Arctic Fox
OADDL OADDL UGA
Sample Year (N) Sample Year (N)
2005 (63) 95% Cl 2006(73) 95% Cl 2007 (11) 95% Cl 2007 (11) 95% Cl
CDV 49.2% (31) 36.4%-62.1% 50.7% (37) 38.7%-62.6% 63.6% (7)
oNG\001X®0s00oCO 90.9% (10) 58.7%-99.8%
PDV 20.6% (13) 11.5%-32.7% 27.4% (20) 17.6%-39.1% 90.9% (10) 58.7%-99.8% 81.8% (9) 48.2%-97.7%
DMV 6.3% (4) 1.8%-15.5% 2.7% (2) 0.3%-9.5% 72.7% (8) 39%-94% NT NT
PMV 1.6% (1) 0%-8.5% 6.8% (5) 2.3%-15.3% 36.4% (4) 10.9%-69.2% NT NT
CMV NT NT NT NT NT 81.8% (9) 48.2%-97.7%
(b)
OADDL UGA
# Arctic Fox CDV PDV DMV PMV # Arctic Fox CDV PDV CMV
3 + + + + 8 + + +
2 + + + -
1 - + + +
2 + + - - 1 + + -
I + - +
2 + + -
1 — 1 — —
CHAPTER 4 
Molecular Ecology of Echinococcus and Taeniinae in Arctic Fox (Vulpes lagopus) 
of Northern Alaska: Characterization of the nadl gene fragment1
4.1 ABSTRACT
The family Cyclophyllidean tapeworms are the most prevalent cestode parasites of 
terrestrial vertebrates. Human infections of Echinococcus, a genus within this group, can 
result in significant morbidity and mortality rates of up to 80% when untreated.
Although well studied in other regions of Alaska, most on notably St. Lawrence Island, 
the distribution and abundance of Echinococcus species on the North Slope (Arctic 
regions north of the Brooks Range Mountains) of Alaska are poorly known. Climate 
change, industrial encroachment, increasing human population size, and changing 
dynamics of canid host populations (arctic fox, red fox, domestic dogs, wolves) are 
likely to impact risk factors for parasitic infection in the Arctic. Therefore, 
understanding current ecology and monitoring prevalence will be necessary to 
understand the human health consequences of ongoing and projected changes in the 
Arctic. We propose that canid definitive hosts provide the best sentinel for monitoring 
alterations in Echinococcus ecology and potential icreases in infection pressure to 
humans. In addition, we characterized a fragment o f the mitochondrial nadl gene of
1 Prepared for submission in the style of EcoHealth: Kirk CM, Ballweber L, Follman E, 
O’Hara TM. 2010. Molecular Ecology of Echinococcus and Taeniinae in Arctic Fox 
( Vulpes lagopus) of Northern Alaska: Characterization of the nadl gene fragment.
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Echinococcus, which also amplified two species of Taenia, from North Slope definitive 
hosts (arctic fox and sled dogs). We unequivocally identified the species of 
Echinococcus in this region as Echinococcus multilocularis and simultaneously detected 
isolates of Taenia crassiceps and Taenia polyacantha. Maximum likelihood analysis 
revealed that the North Slope isolate of Echinococcus multilocularis was most closely 
related to strains from China, consistent with the detection of Asian strains of the 
parasite in other regions of Alaska. Phylogenetic analyses for isolates of Taenia 
crassiceps and Taenia polyacantha demonstrated that isolates from the North Slope of 
Alaska were more similar to isolates from other regions of the Arctic than to isolates 
from subarctic regions of the state.
Within the diverse assemblage of cyclophyllidean tapeworms is the family Taeniidae, 
which includes the closely related subfamilies Taeninae and Echinococcinae. Both occur 
as adults in the intestine of carnivorous and omnivorous mammals. Some of these 
organisms are of substantial medical (zoonotic) and veterinary significance, with respect 
to morbidity and mortality in humans and production losses to domestic food animals 
worldwide (Hoberg, 2002).
In Alaska, two species of Echinococcus occur: E. granulosus and E. multilocularis. 
Intermediate hosts for E. granulosus include moose (Alces alces), reindeer/caribou 
(Rangifer tarandus); and for E. multilocularis, include voles (Microtus) and lemmings 
(Lemmus and Dicrostonyx). For both species of Echinococcus canids (domestic or wild) 
serve as definitive hosts, however E. granulosus utilizes wolves (Canis lupus) (and 
possibly coyotes [Canis latrans]) whereas E. multilocularis utilizes arctic (Vulpes 
lagopus) and red foxes (Vulpes vulpes, Castrodale, 2003). These parasites are 
ecologically segregated due to predator-prey relationships of their hosts; however when 
the two species are sympatric, the final or intermediate host of either species may 
occasionally be exposed to infection by the appropriate host stage of the other (Rausch,
1995). Canids are infected from eating hydatid cysts in intermediate host viscera. The 
pathway to humans and intermediate hosts is the ingestion of eggs shed in the feces of 
infected canids. Domestic dogs become infected with E. granulosis from consuming the
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4.2 INTRODUCTION
viscera of hunter-killed cervids and with E. multilocularis from eating intermediate 
arvicoline rodent hosts (Castrodale, 2003).
Echinococcus granulosis is endemic throughout all of Alaska and Canada, whereas 
the range of E. multilocularis is roughly equivalent and limited to that of the arctic fox. 
The parasite is endemic in northern tundra regions, extending from western Alaska to 
Hudson Bay and to subarctic St. Lawrence Island and Nunavak Island. Echinococcus 
multilocularis is also found in some islands of the Canadian Arctic Archipelago, but has 
not been found on the northernmost islands of Canada (Eckert and Deplazes, 2004).
Human cases of cystic echinococcus (CE) caused by infection with E. granulosis have 
been reported throughout Alaska, except for the Aleutians. In contrast, human cases of 
alveolar echinococcus (AE) caused by E. multilocularis have only been reported on St. 
Lawrence Island and the North Slope (Castrodale, 2003). Since the 1950s, over 300 
cases of echinococcosis have been reported to the Alaska State Section of 
Epidemiology, mostly from St. Lawrence Island or other rural parts of the State 
(Castrodale, 2003).
Historically, rates of echinococcosis increased when Inupiat Eskimos transitioned from 
nomadic to a sedentary lifestyle, as missionaries and the military established 
infrastructure. The sanitary effect of moving was lost and people began living in close 
proximity to dogs (and dog feces), which they relied on for transportation. Sled dogs had
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access to infected caribou viscera discarded by hunters and/or infected microtine 
rodents. These conditions created hyperendemic foci, with the highest human infection 
rates ever recorded. On St. Lawrence Island, for example, the number of human AE 
cases reached 98/100,000 annually prior to the institution of education and control 
programs.
The most recent investigations of Echinococcus prevalence in Alaska were conducted on 
St. Lawrence Island between 1985 and 1990 to evaluate the effectiveness of 
Echinococcus control programs and near Barrow (western Alaska North Slope) during a 
snowy owl (Nyctea scandiaca) breeding ecology study in 2005 (Rausch et al., 1990;
Holt et al., 2005). Rausch et al. (1990) found prevalence rates in voles (N=528) of 5% 
(95% Cl: 3.4-7%2; an 83% reduction from pre-control measures) on St. Lawrence 
Island. Holt et al. (2005) found metacestode prevalence among brown lemmings 
(N=476) near Barrow, on Alaska’s North Slope, to be lower, at 0.9% (95% Cl:
UL=LL2). Historical prevalence of AE (human infection with E. multilocularis) in the 
North Slope region, where host populations experience dramatic fluctuations, was also 
comparatively lower (Rausch and Fay, 2002). Rausch suggested higher prevalence in 
microtine intermediate and canid definitive hosts on St. Lawrence Island was facilitated 
by the relative stability of wild host populations (e.g. higher density).
2 Calculated here as described in: Hughes-Hanks JM, Rickard LG, Panuska C, Saucier 
JR, O’Hara TM, Dehn L, Rolland RM. 2005. Prevalence of Cryptosporidium spp. and 
Giardia spp. in five marine mammal species. Journal of Parasitology 91 (5): 1225-1228.
160
Since the 1990’s, only eight cases of CE and no cases of AE have been reported to the 
Alaska State Section of Epidemiology (Castrodale, 2003). Nine suspected cases were 
reported to the Alaska State Section of Epidemiology between 2003 and 2010 (pers. 
comm., L. Castrodale 2010). A recent study prompted by the discovery of a cerebral 
cystic hydatid in a 6 year old girl in Saskatchewan, Canada demonstrated that at least 
11% of humans in the village had antibodies to E. granulosis and eggs were detected 
(via PCR) in the feces of 6% of local dogs. Because dog ownership, hunting, and 
trapping were not detected as risk factors for specific antibody presence, Himsworth et 
al. (2010) hypothesized that exposure resulted from indirect contact with canine feces in 
the environment.
Although Echinococcus species have been well characterized in other regions of Alaska 
especially St. Lawrence Island, there is limited information available describing the 
parasite in its definitive hosts on the North Slope. Rausch (1967) documented E. 
multilocularis in 8.7% (95% Cl: 5.2-13.4%2) of arctic fox (N=207) and 1 red fox (N=4) 
from the Arctic Coast (Colville Delta to Point Hope, including Brooks Range) based on 
parasite morphology alone. Furthermore, human cases of AE from the North Slope have 
not been evaluated beyond histopathology, and despite histopathological evidence of 
metacestodes of E. multilocularis in lemmings near Barrow (Holt et al., 2005), the 
parasite’s identity was not confirmed.
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Retreating sea ice, and other impacts of climate change, along with industrial 
encroachment and increasing human population size suggest that risk factors for 
parasitic infection may be changing on Alaska’s North Slope, which presents a public 
health concern for Arctic residents. However, the distribution and abundance of 
Echinococcus species in this region is poorly known. Here, we use molecular genetic 
techniques to describe occurrence of Echinococcus in its definitive North Slope hosts. 
We also describe occurrence of two Taeniinae species in these same hosts. Furthermore, 
we suggest that canid definitive hosts, and particularly arctic fox, provide the best 
sentinels for monitoring change in Echinococcus infection pressure to humans due to 
their feeding ecology, distribution, shorter prepatentcy, and the availability of 
noninvasive and reliable means of parasite detection, and association with human 
habitation. In addition, the combined use of this sentinel and technology allow for 
monitoring which can assess risk of exposure (based on prevalence as well as strain 
identification) rather than relying on detection of end stage disease in humans.
4.3 METHODS
4.3.1 Sample Collection
We examined Arctic fox (N=46), sled dog (N = 12) and red fox (N = 1) fecal samples 
obtained from animals living along the Alaska North Slope. Samples were obtained 
opportunistically and thus do not constitute a random sample. The majority of samples 
were obtained in association with human populations and this facilitated our goal of 
assessing infection pressure to humans as this organism is of significant public health
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concern. From a public health perspective, the determination of “true prevalence” was 
not the ultimate goal (and largely unfeasible). The evalation of presence versus absence 
of this parasite in animals in close associations with humans is of value in assessing 
health risk to humans.
Twenty-eight samples were collected by the North Slope Borough Veterinary Clinic and 
Department of Wildlife Management from foxes that were trapped for recreation and as 
part of the animal damage control (rabies) program for the Public Health Office.
Samples were harvested between October 21 and December 7, 1999 from animals in the 
Barrow landfill (N=12), Barrow gravel pit (N=2), and near the DEW (Defense Early 
Waming)-line facility near Barrow (N=9) (Figure 4.1). Two arctic foxes were trapped in 
Kaktovik, 2 in Point Lay and the location of one harvested red fox was unknown (Figure 
4.1). Samples were also derived from live arctic fox captured by University of Alaska 
Fairbanks personnel in June 2005 (N=8) and between June 30th and July 11th, 2007 
(N=l 1) in the Prudhoe Bay Unit. Domestic canine samples were obtained from sled 
dogs belonging to one team from Barrow on February 25, 2007. Live captured arctic fox 
were taken using Tomahawk live traps baited with canned tuna throughout the Prudhoe 
Bay Unit approximately between 148°60’ and 147°50’ longitude and from the coast to 
approximately 70°00 (Figure 4.1). Capture of arctic fox and sampling procedures for 
live sampled arctic fox and sled dogs were approved by an independent animal care and 
use committee (University of Alaska Fairbanks, Institutional Animal Care and Use 
Committee Assurances 04-41, 05-15, and 07-30).
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4.3.2 Sample Preparation and Molecular Analyses
All fecal (defecated) samples and fox colons were frozen at -80°C for at least two weeks 
prior to handling in order to reduce viability of Echinococcus spp. eggs. Approximately 
3 gm of each fecal sample was suspended in 4.5 ml of 0.01 M phosphate-buffered saline, 
pH 7.2, containing 0.01 M EDTA (PBS-EDTA), and the suspension was filtered using 
sterile cheesecloth. The filtrate was centrifuged at 800 x g for 10 minutes and 
supernatant discarded; the pellet was washed two more times in PBS-EDTA at 1200 x g. 
After the final wash, the pellet was re-suspended in 1 ml of PBS-EDTA and used for 
DNA extraction with the FastDNA kit (MP Biomedicals, Solon, Ohio, USA) as 
previously described (da Silva et al., 1999), except for the substitution of binding matrix 
A for binding matrix F.Final purification used a QIAquick PCR purification kit 
(QIAGEN, Valencia, CA, USA).
After reviewing the published literature on genotyping techniques for Echinococcus, we 
chose primer sets targeting a gene located in the mitochondrial genome, NADH 
dehydrogenase-1 (ND1-F: 5-AGA TTC GTA AGG GGC CTA ATA-3; ND1-R: 5-ACC 
ACT AAC TAA TTC ACT TTC-3), which amplifies a 488bp fragment of the gene 
(Bowles 1992). We selected primer sequences, which were conserved among all 
Echinococcus species and subtypes identified to date (Echinococcus multilocularis, 
Echinococcus granulosis [G1-G10], Echinococcus shiquicus), yet which would amplify 
products containing enough diversity in order to differentiate between species and 
subtypes. PCR amplification was performed in 50pl reactions containing 5pi DNA,
164
200pm of each dNTP, 2.5 mM MgCL, 0.2 pm of each primer and 1.5 U of AmpliTaq 
Gold. The PCR was performed with an initial denaturation step of 95 ” C for 5 minutes, 
followed by 40 cycles of 95 ° C for 30s, 48 ° C for 60s and 72 ° C for 60s. All samples in 
which an amplicon of the appropriate size was present were run in duplicate. Amplicons 
were purified using QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, USA) 
according to manufacturer’s instructions. Direct sequencing was performed in both the 
forward and reverse directions using the same primers used in the PCR with use of the 
BigDye™ Terminator Kit (Applied Biosystems, Foster City, CA, USA) and an automated 
sequencer (AB1 3130 Genetic Analyzer, Applied Biosystems) according to the 
manufacturer’s instructions. Primer sequences were removed prior to sequence analyses. 
The complete sequence assemblies were created using Lasergene® v7.0 (DNASTAR, 
Inc., Madison, WI, USA) using nucleotide data with quality higher than 20 (e.g. the base 
call is at least 99% accurate; Ewing and Green, 1998). Sequences resulting from a 
BLAST search of the National Center for Biotechnology Information (NCBI) database 
were imported and aligned with fox sequences using Clustal W in the Lasergene® v7.0 
software package. Appropriate likelihood models were determined using the Akaike 
Information Criterion implemented in ModelTest 3.7, PAUP* 4.0bl0 (Posada and 
Crandall, 1998; Posada and Buckley, 2004). PHYML (Guindon and Gascuel, 2003) was 
used to construct maximum likelihood (ML) trees for partial nadl gene sequences. Trees 
were generated for each of the three species of parasite found in order to assess their 
relatedness to isolates of the same species representative of a given region, as available 
in GenBank.
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The primers used in this study amplified Echinococcus and Taeniinae mitochondrial 
DNA from 95.7% and 100% of arctic fox samples and sled dog samples. To determine 
prevalence of Echinococcus, we examined the PCR products sequences. Echinococcus 
multilocularis were found only in arctic fox collected in 1999 in Barrow near the DEW- 
line, landfill or gravel pit. Taenia crassiceps was detected in animals sampled in all three 
years, at all locations, including both arctic fox and sled dogs in Barrow. Taenia 
polyacantha was detected in one arctic fox in 1999 (Table 4.1a). Only T. crassiceps was 
detected in sled dogs and although PCR products of expected size were generated from 
all 12 animals, sequences could not be resolved for 7 dogs sampled (Table 4.1b) due to 
the presence of multiple peaks. Isolates of a given species of parasite from individual 
arctic and red fox, as well as sled dogs, were identical.
Based on Clustal W and maximum likelihood analysis, the Alaska arctic fox isolate of 
Echinococcus was most closely related to an isolate of E. multilocularis from China (2 
nucleotide differences, Figure 4.2) and least related to the European E. multilocularis 
isolate (Figures 4.3). This finding is consistent with studies of Echinococcus in other 
Alaskan species using other genes. Interestingly, the only 2 positions where the Alaska 
and China isolates differed were identical in all isolates except the Alaska fox isolate 
(Figure 4.2).
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4.4 RESULTS
The T. crassiceps North Slope, Alaska arctic fox isolate contained one polymorphism 
(G/C) at position 254 (Figure 4.4). This was the only difference from identical isolates 
from a Svalbard arctic fox and Svalbard southern vole (Microtus levis), sequences with 
which it formed a clade (Figure 4.5). The North Slope isolate was more closely related 
to isolates from Svalbard than to an isolate from a meadow vole {Microtus 
pennsylvanicus) in Fairbanks (Interior Alaska, 5 nucleotide differences), based on 
maximum likelihood analysis (Figures 4.4 and 4.5). In general, there was consistency in 
which nucleotide sites were variable across isolates from various regions.
The T. polyacantha North Slope, Alaska arctic fox isolate demonstrated the greatest 
homology with a sequence isolated from an arctic fox sampled in Svalbard and from a 
brown lemming in Canada (Figure 4.6). However, it did not form a clade with any 
sequence (Figure 4.7) in the analysis. The Alaska isolate differed from both by only two 
nucleotides (Figure 4.6). The Svalbard and Canada sequences both had a T at position 
80, whereas the Alaska sequence contained a G. The Alaska arctic fox isolate differed 
from both the Svalbard isolate and Canada lemming isolate, each by an additional 
transition (different nucleotide for each isolate, Figure 4.4).
4.5 DISCUSSION
Our examination of the mitochondrial nadl gene fragment confirmed, for the first time, 
the identity of E. multilocularis in arctic fox, the definitive host for the sylvatic cycle of 
this organism, from Alaska’s North Slope. Previous examination of Echinococcus in this
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region tentatively identified the species as E. multilocularis, however the parasite’s 
identity at the molecular level was not investigated. Rausch identified E. multilocularis 
in arctic and red fox in this region based on morphology of organisms observed in arctic 
and red fox (Rausch, 1967). Furthermore, human cases of AE from the North Slope had 
not been evaluated beyond histopathology, and despite histopathological evidence of 
metacestodes of E. multilocularis (Flolt et al., 2005), the parasite’s identity was not 
confirmed at the genetic level or at the molecular level.
The primers used in this study to amplify Echinococcus mitochondrial DNA were not 
specific to Echinococcus, but also amplified other Taeniinae present in fecal samples. As 
a result, PCR products were obtained from 95.7% and 100% of arctic fox samples and 
sled dog samples, respectively, and 1 red fox sample. In order to determine the true 
prevalence of Echinococcus, therefore we needed to examine the sequences of the 
resulting PCR products. The most common Taeniidae observed was Taenia crassiceps 
(N=22), followed by E. multilocularis (N=7) and Taenia polyacantha (N=l). Both 
organisms have life cycles similar to that o f E. multilocularis and they are acquired by 
arctic fox through the consumption of arvicoline rodents that serve as intermediate hosts. 
There were seven amplification products sequenced from sled dogs that could not be 
unequivocally identified. Based on the electropherogram, it was apparent that multiple 
sequences were present, indicating the presence of at least 2 different species. Because 
these primers amplify multiple species of Taeniidae, cloning of amplification products 
would be necessary for the resolution of these sequences.
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4.5.1 Phylogenetics
The genus Taenia contains greater genetic diversity than Echinococcus. Among Taenia 
species, there is the greatest intraspecifc variability among T. polyacantha isolates (0­
9.2% based on nadl gene) and the least among T. crassiceps (0-1.6% nadl gene) 
(Lavikainen et al., 2008). The closer genetic relationship of the North Slope arctic fox 
isolates with southern voles from Svalbard than with isolates from meadow voles in 
Fairbanks, Alaska may reflect differences in ecoregion. Both Svalbard and the North 
Slope are in the Arctic zone, whereas Fairbanks, Alaska is Subarctic. The T. 
polyacantha Alaska isolate clustered among the arctic strains (Lavikainen et al., 2008).
Echinococcus multilocularis consists of three clades based on geographic origin:
Europe, Asia, and North America. Previous genetic (cob, nad2, coxl and elp exons) 
studies of E. multilocularis on isolates from St. Lawrence Island Alaska have found both 
North American and Asian strains present (Nakao et al., 2009). The authors of this 
phylogeographic analysis suggested the observed coexistence may have resulted from an 
evolutionary scenario in which distinct parasite populations derived from glacial refugia 
have been maintained by indigenous host mammals. Throughout periods of the 
Pleistocene, sea levels fell as a result of glaciation forming the Bering land bridge, 
which connected Asia and North America (Pielou, 1991).
We could not assess the relatedness of our isolate to those representing North America 
since these studies did not examine the nad 1 gene. However, based on the maximum
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likelihood analysis of analysis of strains for which genetic information was available, 
the Alaska strain is most closely related to a strain from China (Nakao et al., 2009). This 
study provides the first evidence of the Asian strain not only on St. Lawrence Island, but 
on the mainland of Alaska. This is not unexpected since fox are known to travel great 
distances, including between islands and mainland. Such travel has been implicated in 
the spread of rabies and distemper epizootics (Ritter, 1981; Bohm et al., 1989; Campbell 
et al., 2007) and thus could easily disperse the parasite.
Echinococcus multilocularis has apparently undergone range expansion in European 
over the last few decades, generating increasing awareness of this parasite as a public 
health issue. Strains previously thought to exist only in Asia were later documented in 
Eastern European nations including Poland and Estonia (Moks et al., 2005). These 
findings are supported in the phylogenetic analyses here, which demonstrates these 
Eastern European strains to be more closely related to the Chinese strain than the 
European isolate. Due to the lack of previous studies in this area however, it is uncertain 
if this observation is a actually a result of recent range expansion or if the parasite was 
already endemic to the area.
4.5.2 Concerns for Climate Change Impacts on Host Ecology
On the North Slope of Alaska the brown lemming, collared lemming (Dicrostonyx 
groenlandicus), tundra vole, and singing vole (Microtus miurus) are present 
(MacDonald and Cook, 2009) and therefore represent potential intermediate hosts for E.
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multilocularis. The arctic and red fox are definitive hosts in the sylvatic cycle of the 
parasite in this region. The lemming population undergoes high amplitude fluctuations 
every 3-4 years and can comprise up to 90% of the diet of arctic fox in peak years 
(Rausch and Fay, 2002). The arctic fox population in northern Alaska follows the cyclic 
abundance of lemmings and other rodents. Populations flourish when these prey are 
abundant and decline when prey populations decline, due to food availability. Arctic fox 
can use sea ice extensively for forage (e.g. seal carrion) presumably more so in years 
when winter foods are limited, for example in low lemming years. Pamperin et al.
(2008) followed individuals outfitted with location transmitters and suggested that diets 
for arctic fox using sea-ice were likely 100% marine while on the sea-ice given their 
consistent locations at distances that would preclude periodic trips to shore to feed on 
terrestrial resources. Rabies outbreaks occur in Alaska arctic fox populations during the 
winter months (Ritter, 1981) when rodent availability is lowest and access to birds (and 
eggs) as alternative prey is lacking, approximately every 3-5 years when rodent 
populations drop. It is hypothesized that traveling over long distances, congregation at 
food sources and scavenging on infected carcasses in combination with nutritional stress 
may facilitate such outbreaks. There is concern that diminishing sea ice may lead to 
increased presence of foxes and polar bears (Ursus maritimus), for example at human 
settlements (e.g. landfills and whale carcasses remains) and industrial sites where 
anthropogenic food sources are present. For density dependent diseases, the presence of 
anthropogenic food sources such as baiting and waste stations that concentrate animals 
in a given area can greatly enhance transmission rates (Wobeser, 2006). Although E.
171
multilocularis is less density dependent than for example canine distemper virus 
(morbillivirus), owing to the fact that it is maintained in multiple hosts and therefore not 
tied to a critical community size for one population, such sites of attraction could create 
transmission foci.
The North Slope is currently a region of apparent relative low endemicity for E. 
multilocularis, however this may change as alterations in climate cause range changes of 
suitable intermediate and definitive hosts, and with the encroachment of industry (areas 
of definitive host concentration). It is recognized that the Arctic is especially vulnerable 
to climate change because global warming is most pronounced at high latitudes. The 
arctic tundra is predicted to shrink with global warming as the boreal forest zone moves 
north (ACIA, 2004). Although this shift is not of immediate imminence, ecological 
processes and species inhabiting the tundra ecosystem are likely to be affected well 
before the tundra becomes forested (Fuglei and Ims, 2008). With warming, population 
cycles of lemmings and voles are likely to decrease in amplitude and become 
increasingly unstable as such cycles appear to depend on long, cold and stable winters 
(Yoccoz and Ims, 1999; Aars and Ims, 2002). This is because warmer, unstable winters 
with repeated freeze-thaw events can result in the formation of ice crust, reducing access 
to forage. However, in the short term arctic fox populations could benefit from the 
increased availability of carrion following population crashes in herbivores resulting 
from the same phenomenon. Such events have been documented in reindeer and musk 
oxen populations in different locations in the Arctic (Aanes et al., 2000; Forchhammer
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and Boertmann, 1993).
The recent northward expansion of the red fox, a dominant competitor and predator of 
arctic fox, is well documented (Tannerfeldt et al., 2002; Hersteinsson and MacDonald, 
1992). Observations suggest the northward expansion of red fox has resulted in direct 
mortality of arctic fox by the larger, more aggressive red fox (Pamperin et al., 2006).
The availability o f anthropogenic food sources at village landfills and around industrial 
sites can result in conspecific and interspecific aggregations of animals, potentially 
enhancing parasite transmission. Furthermore, data from collared animals revealed that 
arctic fox living near the Prudhoe Bay Unit (actively leased and utilized oil and gas field 
located on the North Slope) remained in the local area throughout winter (Pamperin, 
2008). In contrast, arctic fox living in the National Petroleum Reserve-Alaska (NPR-A), 
an undeveloped area, traveled greater distances and spent considerable time scavenging 
carrion on the sea-ice during the winter (Pamperin, 2008; Pamperin et al., 2008).
The reduction of the sea ice has implications for the ability of arctic fox to access marine 
resources. Species which depend upon the sea-ice as a platform for resting, breeding, 
and hunting such as walrus (Odobenus rosmarus), some seals and polar bear are 
anticipated to be significantly affected by the loss of sea ice (Burek et al., 2008; Wiig et 
al., 2008). Similarly, the ability of arctic fox to hunt ringed seal (Pusa hispida) pups and 
scavenge on the remains of polar bear kills is likely to be diminished. Such alterations in 
arctic fox feeding ecology have significant implications for the transmission dynamics
of the Taeniidae since they have a trophic dependent life cycle. As the diet o f the arctic 
fox changes, so will its parasite fauna.
4.5.3 Concern for Climate Change Impacts on Echinococcosis and Human Health
Public health officials are concerned that climate change may increase Echinococcus 
exposure of humans in the Arctic (Parkinson and Butler, 2005). We suggest that canid 
definitive hosts, and particularly arctic fox, present the best sentinels for monitoring 
change in parasite prevalence due to their feeding ecology, shorter prepatency (e.g. 
relative to humans) and the availability of noninvasive and reliable means of parasite 
detection. The arctic fox presents a particularly useful sentinel due to its ubiquity in 
areas of endemicity and because it is sometimes targeted in control programs to reduce 
the public health threat of rabies and in recreational use for furs. Thus, Echinococcus can 
be monitored opportunistically during the course of these efforts, in a similar manner as 
our work presented here.
Change in infection pressure of Echinococcus to humans and assessment of change in 
human infection rates will be difficult to detect due to the long duration between 
infection and onset of symptoms. Humans are believed to be infected at a young age, 
with preclinical periods of 20 to 30 years (Rausch et al., 1990). Growth of Echinococcus 
cysts is variable, with rates as slow as slow as 1 mm to 5 mm per year (Palowski et al., 
2001). An infected individual may remain asymptomatic for decades or permanently, 
depending upon whether cyst’s location induces pathologic changes in the infected
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organ and/or if the cyst ruptures. Furthermore, diagnostics including imaging 
techniques, mainly ultrasound and computed tomography examination for abdominal 
echinococcosis and X-ray for lung echinococcosis, and immunodiagnostic tests, are 
costly and sometimes inaccurate (Eckert et al., 2001). Species confirmation of causative 
agent via PCR is not routinely performed, further limiting assessment of infection 
patterns by epidemiologists. The ultrasound examination can be used under field 
conditions for population screening, but the others require a clinical setting. In rural 
Alaska, where most infections occur, diagnosis can be limited by access to such 
technologies and expert medical professionals. Perhaps most importantly, monitoring 
the end stage disease in humans does not adequately address potential and actual 
exposure public health concerns.
Once infected canids are identified in a defined area, measures to prevent infection in 
humans can be undertaken. Control measures such as the administration of praziquantel 
(a parasiticide) and changes in dog husbandry practices conbined with education are 
demonstrated means of reducing human infection with Echinococcus (Rausch et al., 
1990). The prophylactic administration of partasiticide is costly and inefficient due to 
the window of time in which canids can be re-infected (Eckert et al., 2001).
The prepatent period in canids is typically around 42 and 28 days for E. granulosis and 
E. multilocularis, respectively (Eckert et al., 2001). Thus, changes in parasite levels can 
be detected on a timescale that more closely follows alterations in the ecology of the
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disease as they occur in real time. Eggs are shed in the feces of canid definitive hosts 
therefore necropsy is not required for diagnosis. Detection of metacestodes in sylvatic 
intermediate hosts (rodents and cervids), however, does require necropsy. Furthermore, 
the development E. granulosis metacestodes in cervids is slower in these long-lived 
species. The prevalence in intermediate hosts is lower than in canid definitive hosts. As 
a result, sampling of many more animals is required in order to establish prevalence 
rates with narrow confidence intervals, and to detect change. The use of PCR can 
reliably distinguish between species and strains of Echinococcus and the application of 
phylogenetics allows for the evaluation of differences. This distinction has particular 
importance in public health since strains of Echinococcus spp. can be of varying 
virulence (Rausch et al., 1990; Moro and Schantz, 2006). Such measures cannot be 
accomplished using histopathology alone. Knowledge of strain types that are currently 
present will allow for observation of alterations in parasite ecology. The use of 
molecular technology for monitoring Echinococcus in canids offers the most rapid, 
economical and detailed epidemiological insights into changes in the ecology of the 
disease, when compared to following infection in humans or intermediate hosts.
4.6 CONCLUSION
We have unequivocally identified the species of Echinococcus present in arctic fox on 
the North Slope of Alaska as E. multilocularis. There is, however, little information 
available regarding the current ecology and transmission dynamics of E. multilocularis 
in the High Arctic. With anticipated changes in Arctic ecology due to climate change
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and increasing anthropogenic influences, prevalence of this zoonotic agent is likely to 
change with shifts in host ranges. Because Echinococcus infection poses a significant 
public health concern; understanding its ecology in the Arctic and monitoring its 
prevalence will be necessary to understand the human health consequences of ongoing 
and projected changes in the Arctic. We suggest that canids present the best sentinels for 
monitoring the impact of change on the ecology of Echinococcus. Such studies can be 
conducted opportunistically in cooperation with rabies and predator control programs, 
trapping and health assessments in targeted areas. Although we could not assess the 
relationship of the strain we isolated from arctic fox to North America strains (genetic 
information was unavailable in the database), the North Slope isolate was most similar 
to Asian isolates based on maximum likelihood analysis. This observation is consistent 
with the previous detection of Asian isolates in St. Lawrence Island, Alaska. Sequence 
analysis of isolates of T. crassiceps and T. polyacantha demonstrated the greatest 
homology with isolates derived from the same host ( V. lagopus).
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Figure 4.1 Map of the Alaska North Slope displaying fox and dog sampling area.
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AGGTTGGTTTTGCTGGTTTGTTGCAGAGATTTGCTGATTTGTTAAAGTTA 5 0 
AGGTTGGTTTTGCTGGTTTGTTGCAGAGATTTGCTGATTTGTTAAAGTTA 5 0
----------------------- GCTGGTTTGTTGCAGAGATTTGCTGATTTGTTAAAGTTA 3 9
— GTTS-CCTTGCTGGTTT-TTGCAGAGATTTGCTGATTTGTTAAAGTTA 4 6
-------------------------------------------------------------------- GCTGATTTGTTAAAGTTA 18
-------------------TTGCTGGTTN-YTGCAGAGATTTGCTGATTTGTTAAAGTTA 4 0
* * * * * * * * * * * * * * * * * *
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 100 
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 100 
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 8 9 
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 9 6 
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 6 8 
GTGATCAAGTTTAAGAATTTTTATTTTCAAAGTCGTAGGTATATTGGTTT 9 0 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
GTTGGGTGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 150 
GTTGGGTGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 150 
GTTGGGCGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 139 
GTTGGGTGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 146 
GTTGGGTGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 118 
GTTGGGTGTTTTTTTGTTAATAATTTTGGTTATTATATATTCTTTTATTT 140 
* * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 200 
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 200 
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 189 
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 196 
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 168 
ATGGTAGATATTATAGTGTTAGTTATAATAGTCTTTCAGTATTGTGGTTT 190 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGCTGGTTGGGG 250 
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGCTGGTTGGGG 250 
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGTTGGTTGGGG 239 
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGCTGGTTGGGG 246 
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGCTGGTTGGGG 218 
TTAGCTGTTGCTAGTATTTCTAGGTATTCTTTGTTGTGTGCTGGTTGGGG 240 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * *
Figure 4.2 Clustal W alignment for partial nadl gene sequence of E. multilocularis 
isolated from arctic foxes in 1999, northern Alaska.
190
E . m u l t i l o c u la r i s _ A k - V . la g o p u s *  
E . m u lt i lo c u la r is _ _ C h -H u m a n  
E . m u l t i l o c u la r i s _ G r - R o d e n t  
E . m u l t  i l o c u l a r  is _ P o -V .v u lp e s _ _ 7  
E . m u l t i l o c u la r i s _ E s - V . v u lp e s  
E . m u I t i lo c u la r is _ P o - V . v u lp e s _ 7
E , m u l t i l o c u la r i s _ A k - V . la g o p u s *  
E .m u lt i lo c u la r is _ C h - H u m a n  
E .m u l t i l o c u la r i s _ G r - R o d e n t  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7  
E . m u l t i l o c u la r i s _ E s - V . v u lp e s  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7
E . m u l t i l o c u la r i s _ A k - V . la g o p u s *  
E .m u lt i lo c u la r is _ C h - H u m a n  
E .m u l t i l o c u la r i s _ G r - R o d e n t  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7  
E . mu l t i l o c u la r i s _ _ E s - V .  v u lp e s  
E .m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7
E . m u l t i l o c u l a r i s _ A k - V . la g o p u s *  
E .m u l t i lo c u la r is _ C h - H u m a n  
E . m u l t i l o c u la r i s _ G r - R o d e n t  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7  
E . m u l t i l o c u la r i s _ E s - V . v u lp e s  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7
E . m u l t i l o c u la r i s _ A k - V . la g o p u s *  
E .m u lt i lo c u la r is _ _ C h -H u m a n  
E . m u l t i l o c u la r i s _ G r - R o d e n t  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7  
E . m u l t i l o c u la r i s _ E s - V . v u lp e s  
E . m u l t i l o c u la r i s _ P o - V . v u lp e s _ 7
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 300 
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 300 
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 289 
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 296 
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 268 
TAGTTACAATAAATATTCGTTTTTAAGTTCTGTTCGATGTGCTTTTGGGT 290 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 350 
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 350 
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 339 
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 346 
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 318 
CTGTTAGGTTTGAAGCTTGTTTTATGTGTGTGGTAATTTTTTGTTCTTTG 340
★ ★ ★ i t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TGTTACTGTAGGTATAATTTGATTGATTTTTATTATAGTTGTTGATGAGG 400 
TGTTACTGTAGGTATAATTTGATTGATTTTTATTATAGTTGTTGATGAAG 400 
TGTTACTGTAGGTATAATTTGGTTGATTTTTATTATAGTTGTTGATGAAG 389 
TGTTACTGTAGGTATAATTTGATTGATTTTTATTATAGTTGTTGATGAAG 396 
TGTTACTGTAGGTATAATTTGATTGATTTTTATTATAGTTGTTGATGAAG 368 
TGTTACTGTAGGTATAATTTGATTGATTTTTATTATAGTTGTTGATGAAG 390 
* * * * ★ * ★ * * * * * * ★ ★ ★ * * ★ ★ *  t ★★* * ★★★* * * ★* * * ★* * * ■ * * * * * * ★*  > * 
TTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 450 
CTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 450 
CTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 439 
CTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 446 
CTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 418 
CTTGTTGTTGTTTCCATTGATTTATGGATTGTTTTTGGTGTGTGTGCTAT 440
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i t
GTGAGACTAATCGTATACCATTTGATTATGGGGAGTCT---------------488
GTGAGACTAATCGTATACCATTTGATTATGGGGAGTCT---------------488
GTGAGACTAATCGTACTCCATTTGATTATGGG----------------------------471
GTGAGACTAATCGTATACCATTTGATTATGGGGAGTCT---------------484
GTGAGACT------------------------------------------------------------------------------- 426
GTGAGACTAATCGTATACCATTTGATTATGGGGAGTCTGAAAGT 484 
* * * * * * * *
Figure 4.2 (Continued)
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T . c r a s s ic e p s _ R u - M . f o r t i s
T . c r a s s ic e p s _ S v - V . la g o p u s  
T . c r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s *
T . c r a s s ic e p s _ R u - M .g r e g a l is  
T . c r a s s ic e p s _ A k - M .p e n n s y lv a n ic  
T . c r a s s ic e p s _ R u - M . f o r t i s
AGGTGGGTATTATTGGGTTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 5 0 
AGGTGGGTATTATTGGGTTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 50 
AGGTGGGTATTATTGGGTTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 50 
AGGTGGGTATTATTGGGTTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 50 
AGGTGGGTATTATTGGGTTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 5 0 
AGGTGGGTATTATTGGATTATTTCAGAGTTTTTCTGATTTACTAAAGTTA 50 
* * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
GTGGTTAAGTTTAAGAATTATAAATTTTGTGTACGTAGAAATTATAGTTT 100 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
ATTAGGAGCTTTTCTTTTAGTTTTTTTAGTTATTTGTTATTCGTTTTTGT 150 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
ATGGTGGTTATTATAGATTTAAATTTAAAAGTTTTTCTATGTTGTGAGTG 200 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TTAGTTTTATCTAGTCTTTGTAGTTATTCTATTTTATGTGTGGGTTGAGG 250 
TTAGTTTTATCTAGTCTTTGTAGTTATTCTATTTTATGTGTGGGTTGAGG 250 
TTAGTTTTATCTAGTCTTTGTAGTTATTCTATTTTATGTGTGGGTTGAGG 250 
TTGGTTTTATCTAGTCTTTGTAGTTATTCTGTTTTATGTGTGGGTTGAGG 250 
TTAGTTTTATCTAGTCTTTGTAGTTATTCTATTTTATGTGTGGGTTGAGG 250 
TTAGTTTTATCTAGTCTTTGTAGTTATTCTATTTTATGTGTGGGTTGAGG 250 
* *  * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * *
Figure 4.4 Clustal W alignment for partial nadl gene sequence of T crassiceps isolated 
from arctic foxes and sled dogs in 1999, 2005, and 2007, northern Alaska
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T .e r a s s ic e p s _ S v - V . la g o p u s  
T . c r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s  *
T . c r a s s ic e p s _ R u - M .g r e g a l is  
T .c ra s s ic e p s _ A k - M .p e n n s y lv a m c  
T . e r a s s ic e p s _ R u - M . fo r t is
T .e r a s s ic e p s _ S v - V . la g o p u s  
T .e r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s *  
T . c r a s s ic e p s _ R u - M .g r e g a l is  
T . c ra s s ic e p s _ A k - M .p e n n s y lv a n ic  
T . c r a s s ic e p s _ R u - M . f o r t is
T .e r a s s ic e p s _ S v - V . la g o p u s  
T . e r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s *
T .e r a s s ic e p s _ R u - M .g r e g a l is  
T .c r a s s ic e p s _ A k - M .p e n n s y lv a m c  
T . c r a s s ic e p s _ R u - M . f o r t is
T . c r a s s ic e p s _ S v - V . la g o p u s  
T . c r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s  * 
T . c r a s s ic e p s _ R u - M .g r e g a l is  
T . c r a s s ic e p s _ A k - M .p e n n s y lv a n ic  
T . c r a s s ic e p s _ R u - M . f o r t is
T . c r a s s ic e p s _ S v - V . la g o p u s  
T . c r a s s ic e p s _ S v - M . le v is  
T . c r a s s ic e p s _ A k - V . la g o p u s *
T . c r a s s ic e p s _ R u - M .g r e g a l is  
T .c ra s s ic e p s _ A k - M .p e n n s y lv a m c  
T . c r a s s ic e p s _ R u - M . f o r t is
TAGGTATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
TAGGTATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
TAGSTATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
TAGATATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
TAGATATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
TAGATATAGTAAATATTCTTTTTTAAGTTCTGTTCGTTGTGCTTTTAGTT 300 
* *  *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTATTTTCTGCGTTA 350 
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTATTTTCTGCGTTA 350 
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTATTTTCTGCGTTA 350 
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTGTTTTCTGCGTTA 350 
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTTTTTTCTGCGTTA 350 
CGATTAGGTTTGAAGCTTGTTTTATGTGTATTGTTGTTTTTTCTGCGTTA 350 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * *
TGTTTTAGTAGTTATAGTTTGGTAGATGTGTATTTTAGGGATTGATCATT 400  
Tg t t TTAGTAGTTATAGTTTGGTAGATGTGTATTTTAGGGATTGATCATT 400  
TGTTTTAGTAGTTATAGTTTGGTAGATGTGTATTTTAGGGATTGATCATT 400  
TGTTTTAGTAGTTATAGTTTGGTAGATGTGTATTTTAGGGATTGATCATT 400  
TGTTTTAGTAGTTATAGTTTGGTGGATGTGTATTATAGGGATTGATCATT 400  
TGTTTTAGTAGTTATAGTTTGGTGGATGTGTATTATAGGGATTGATCATT 400  
* * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * *  * * * * * * * * * * * * * * *
GATTTTGTTGTTTCCGTTAATTATAATTGTGTATTTAGTATGTATTTTGT 450  
GATTTTGTTGTTTCCGTTAATTATAATTGTGTATTTAGTATGTATTTTGT 450 
GATTTTGTTGTTTCCGTTAATTATAATTGTGTATTTAGTATGTATTTTGT 450 
GATTTTGTTGTTTCCGTTAATTATAATTGTGTATTTAGTATGTATTTTGT 450 
GATTTTGTTGTTTCCGTTAATTATAATTGTGTACTTAGTATGTATTTTGT 450 
Ga t t TTGTTGTTTCCGTTAATTATAATCGTGTACTTAGTATGTATTTTGT 450  
* * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * * * *
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
GTGAAACGAAACGTAGTCCATTTGATTATGGGGAGGCT 488 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Figure 4.4 (Continued)
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T.crassiceps Ak-M .pennsylvanicus 
318
-------------------------------T.crassiceps Ru-M .fortis
1 0.002 [
T.crassiceps R u-M .gregalis
582
895
T.crassiceps A k-V  .lagopus*
T.crassiceps Sv-M .levis
725
T.crassiceps Sv-V .lagopus
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T . p o ly c a n th a _ D e -M . g la r o e lu s  AGGTTGGTATAATGGGTTTATTTCAAAGTTTTTCTGATTTGTTGAAGTTA
T . p o ly c a n th a _ S c -M . g la r o e lu s  AGGTTGGTATAATGGGTTTATTTCAAAGTTTTTCTGATTTGTTGAAGTTA
T . p o ly c a n th a _ F i - V . la g o p u s  AGGTTGGTATAATGGGTTTATTTCAAAGTTTTTCTGATTTGTTGAAGTTA
T . p o ly c a n th a _ T u -M . g u e n th e r i  AGGTTGGTATAATGGGTTTATTTCAAAGTTTTTCTGATTTGTTGAAGTTA
T . p o ly c a n th a _ A k - V . la g o p u s *  AGGTTGGTATAATGGGTTTGTTTCAAAGTTTTTCTGATTTGTTGAAGTTG
T . p o ly c a n th a _ S v - V . la g o p u s  AGGTTGGTATAATGGGTTTGTTTCAAAGTTTTTCTGATTTGTTGAAGTTG
T . p o ly c a n th a _ C a - L . t r im u c r o n a tu  AGGTTGGTATAATGGGTTTGTTTCAAAGTTTTTCTGATTTGTTGAAGTTG
T .p o ly c a n th a _ G r - D ._ g r o e n la n d ic  AGGTTGGTATAATGGGTTTGTTTCAAAGTTTTTCTGATTTGTTGAAGTTG
* * * * * * * * * * * * * * * * * * * ^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * #
T .p o ly c a n th a _ D e -M .  g la r o e lu s  ATAGTTAAGAGTAAGGAATATTATTTTAGTAGTCGTAGTTGGGTAGGTTT
T . p o ly c  a n th a _ S c -M . g la r o e lu s  ATAGTTAAGAGTAAGGAATATTATTTTAGTAGTCGTAGTTGGGTAGGTTT
T . p o ly c a n t h a _ F i - V . la g o p u s  ATAGTTAAGAGTAAGGAATATTATTTTAGTAGTCGTAGTTGGGTAGGTTT
T . p o ly c a n th a _ T u -M . g u e n th e r i  ATAGTTAAGAGTAAGGAATATTATTTTAGTAGTCGTAGTTGGGTAAGTTT
T .p o ly c a n th a _ A k - V . la g o p u s *  ATAATTAAGAGTAAGAGTTTTTATTTTAGGAGTCGTAGATGAGTGGGTTT
T . p o ly c a n th a _ S v -V .  la g o p u s  ATAATTAAGAGTAAGAGTTTTTATTTTAGTAGTCGTAGATGAGTGGGTTT
T . p o ly c a n th a _ C a - L . t r  im u c r o n a tu  ATAATTAAGAGTAAGAGTTTTTATTTTAGTAGTCGTAGATGAGTGGGTTT
T . p o ly c a n th a _ G r - D ._ g r o e n la n d ic  ATAATTAAGGGTAAGAATTTTTATTTTAGGAGTCGTAGATGAGTGGGTTT
* * * ^ * * * * * #* * * * * ## * * * * * * * * * * * *  * * * * * * * * 2 * * ^ * * ^ ^ * * * *
T .p o ly c a n th a _ D e - M .g la r o e lu s  GTTTGGGGTTTTTTTATTGGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ S c -M . g la r o e lu s  GTTTGGGGTTTTTTTATTGGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ F i- V . la g o p u s  GTTTGGGGTTTTTTTATTGGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ T u - M .g u e n th e r i  GTTTGGGGTTTTTTTATTGGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T .p o ly c a n th a _ A k - V . la g o p u s *  ATTTGGAGTTTTTTTATTAGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ S v - V . la g o p u s  ATTTGGAGTTTTTTTATTAGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ C a - L . t r im u c r o n a t u  ATTTGGAGTTTTTTTATTAGTTTGTTTGGTTTTGTTTTATTCATTTATAT
T . p o ly c a n th a _ G r - D ._ g r o e n la n d ic  ATTCGGAGTTTTTTTATTAGTTTGTTTGGTTTTGTTTTATTCATTTATAT
★ * * ★ * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
T . p o ly c a n th a _ D e -M . g la r o e lu s  ATGGTGGATATTATAGGTCTAGTTTTAATTCTCTTTCTTTATTGTGATTT
T .p o ly c a n th a _ S c -M .  g la r o e lu s  ATGGTGGATATTATAGGTCTAGTTTTAATTCTCTTTCTTTATTGTGATTT
T . p o ly c a n th a _ F i - V .  la g o p u s  ATGGTGGATATTATAGGTCTAGTTTTAATTCTCTTTCTTTATTGTGATTT
T . p o ly c a n th a _ T u -M . g u e n th e r i  ATGGTGGATATTATAGGTCTAGTTTTAATTCTCTTTCTTTATTGTGGTTT
T . p o ly c a n th a _ A k - V .  la g o p u s *  ATGGTGGGTATTATAGGTCTAGATTTAATTCTCTTTCTTTATTATGGTTT
T . p o ly c a n th a _ S v -V .  la g o p u s  ATGGTGGGTATTATAGGTCTAGATTTAATTCTCTTTCTTTATTATGGTTT
T . p o ly c a n th a _ C a - L . t r im u c r o n a t u  ATGGTGGGTATTATAGGTCTAGATTTAATTCTCTTTCTTTATTATGGTTT
T . p o ly c a n th a _ G r - D ._ g r o e n la n d ic  ATGGTGGGTATTATAGGTCTAGATTTAATTCTCTTTCTTTATTATGGTTT******* . ************** ; ******************** # * * . * * *
T . p o ly c a n th a _ D e -M . g la r o e lu s  TTAGTGGTTTCAAGTTTTTGTAGGTATGCGATAATGTCTGCTGGTTGAGG
T .p o ly c a n th a _ S c -M .  g la r o e lu s  TTAGTGGTTTCAAGTTTTTGTAGGTATGCGATAATGTCTGCTGGTTGAGG
T . p o ly c  a n th a _ F i - V . la g o p u s  TTAGTGGTTTCAAGTTTTTGTAGGTATGCGATAATGTCTGCTGGTTGAGG
T . p o ly c a n th a J T u -M . g u e n th e r i  TTAGTGGTTTCAAGTTTTTGTAGGTATGCGATAATGTCTGCTGGTTGAGG
T .p o ly c a n th a _ A k - V . la g o p u s *  TTAGTTATTTCTAGTTTTTGTAGGTATGCCATAATGTCTGCTGGTTGAGG
T . p o ly c a n th a _ S v - V . la g o p u s  TTAGTTATTTCTAGTTTTTGTAGGTATGCCATAATGTCTGCTGGTTGGGG
T . p o ly c a n th a _ C a - L . t r im u c r o n a t u  TTAGTTATTTCTAGTTTTTGTAGGTATGCCATAATGTCTGCTGGTTGAGG
T . p o ly c a n th a _ G r -D  . _ g r o e n la n d ic  TTAGTCATTTCTAGTTTTTGTAGGTACGCCATAATGTCTGCTGGTTGAGG
* * * * *  ^ * * * * j * * * * * * * * * * * * * *  * *  * * * * * * * * * * * * * * * * * #* *
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Figure 4.6 Clustal W alignment for partial nadl gene sequence of T. polyacantha 
isolated from an arctic fox in 1999, northern Alaska.
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T .p o ly c a n th a _ D e - M .g la r o e lu s  
T . p o ly c a n th a _ S c -M . g la r o e lu s  
T . p o ly c a n th a _ F i- V . la g o p u s  
T . p o ly c a n th a _ T u -M . g u e n th e r i  
T . p o ly c a n th a _ A k - V . la g o p u s  *
T . p o ly c a n th a _ S v - V . la g o p u s
T . p o ly c a n th a _ C a - L . t r im u c r o n a t u
T .p o ly c a n th a _ G r - D ._ g r o e n la n d ic
T .p o ly c a n th a _ D e - M .g la r o e lu s  
T .p o ly c a n th a _ S c - M .g la r o e lu s  
T . p o ly c a n t h a _ F i - V . la g o p u s  
T . p o ly c a n th a _ _ T u -M . g u e n th e r i  
T . p o ly c a n th a _ A k - V . la g o p u s *  
T . p o ly c a n th a _ S v - v . la g o p u s  
T . p o ly c a n th a _ C a - L . t r im u c r o n a tu  
T . p o ly c a n th a _ G r - D . _ g r o e n la n d ic
T .p o ly c a n th a _ D e - M .g la r o e lu s  
T . p o ly c a n th a _ S c -M . g la r o e lu s  
T . p o ly c a n th a _ F i - V . la g o p u s  
T . p o ly c a n th a _ T u -M . g u e n th e r i  
T . p o ly c a n th a _ A k - V . la g o p u s *
T . p o ly c a n th a _ S v - V . la g o p u s
T . p o ly c a n th a _ C a - L . t r im u c r o n a tu
T .p o ly c a n th a _ G r - D ._ g r o e n la n d ic
T .p o ly c a n th a _ D e - M .g la r o e lu s  
T .p o ly c a n th a _ S c - M .g la r o e lu s  
T . p o ly c a n th a _ F i - V . la g o p u s  
T . p o ly c a n th a _ T u -M . g u e n th e r i  
T . p o ly c a n th a _ A k - V . la g o p u s  * 
T .p o ly c a n th a _ S v - V . la g o p u s  
T . p o ly c a n th a _ C a - L . t r im u c r o n a tu  
T . p o ly c a n th a _ G r - D . _ g r o e n la n d ic
T .p o ly c a n th a _ D e - M .g la r o e lu s  
T .p o ly c a n th a _ S c - M .g la r o e lu s  
T .p o ly c a n th a _ F i - V . la g o p u s  
T . p o ly c a n th a _ T u -M . g u e n th e r i  
T . p o ly c a n th a _ A k - V . la g o p u s  * 
T .p o ly c a n th a _ S v - v . la g o p u s  
T . p o ly c a n th a _ C a - L . t r im u c r o n a tu  
T . p o ly c a n th a _ G r - D . _ g r o e n la n d ic
TAGTTATAGTAATTATTCATTCTTGAGTTCAATACGTTGTGCGTTTGGTT 300 
TAGTTATAGTAATTATTCATTCTTGAGTTCAATACGTTGTGCGTTTGGTT 300 
TAGTTATAGTAATTATTCATTCTTGAGTTCAATACGTTGTGCGTTTGGTT 300 
TAGTTATAGTAATTATTCATTCTTGAGTTCAATACGTTGTGCGTTTGGTT 300 
TAGTTATAGCAATTATTCATTTTTGAGTTCGATACGTTGTGCATTTGGTT 300 
TAGTTATAGCAATTATTCATTTTTGAGTTCGATACGTTGTGCATTTGGTT 300 
TAGTTATAGAAATTATTCATTTTTGAGTTCGATACGTTGTGCATTTGGTT 300 
TAGTTATAGTAATTATTCATTTTTGAGTTCGATACGTTGTGCGTTTGGTT 300 
* * * * * * * * *  * * * * * * * * * * *  * * * * * * * * #* * * * * * * * * * * ^ * * * * * * *
CTATAAGATTTGAGGCATGTTTTATGTGTATTGTTATATTTTCTGTGTTA 350 
CTATAAGATTTGAGGCATGTTTTATGTGTATTGTTATATTTTCTGTGTTA 350 
CTATAAGATTTGAGGCATGTTTTATGTGTATTGTTATATTTTCTGTGTTA 350 
CTATAAGATTTGAGGCATGTTTTATGTGTATTGTTATATTTTCTGTGTTA 350 
CTATAAGATTTGAGGCATGTTTTATGTGCATAGTGATTTTTTCTGTGTTG 350 
CTATAAGATTTGAGGCATGTTTTATGTGCATAGTGATTTTTTCTGTGTTG 350 
CTATAAGATTTGAGGCATGTTTTATGTGCATAGTGATTTTTTCTGTGTTG 350 
CTATAAGATTTGAGGCATGTTTTATGTGTATAGTGATTTTTTCTGTGTTG 350 
* * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * • * *  * * ; * * * * * * * * * * * #
TGTTGTGGTAGGTATAGTTTGTTGGATTTTTTTTATTTAGATTATTTTTC 400 
TGTTGTGGTAGGTATAGTTTGTTGGATTTTTTTTATTTAGATTATTTTTC 400 
TGTTGTGGTAGGTATAGTTTGTTGGATTTTTTTTATTTAGATTATTTTTC 400 
TGTTGTGGTAGGTATAGTTTGTTGGATTTTTTTTATTTAGATTATTTTTC 400 
TGTTATGGTAGTTATAGTTTGTTAGATTATTTTTATTTAGATTATTTTTC 400 
TGTTATGGTAGTTATAGTTTGTTAGATTATTTTTATTTAGATTATTTTTC 400 
TGTTATGGTAGTTATAGTTTGTTAGATTATTTTTATTTAGATTATTTTTC 400 
TGTTATGGTAGTTATAGTTTGTTAGATTATTTTTATTTAGATTATTTTTC 400 
* * * * #* * * * * *  * * * * * * * * * * * #* * * * »  * * * * * * * * * * * * * * * * * * * * *
TTGTATTATATACCCATGTGTATTTATATTGTATTTGATTTGTATATTAT 450 
TTGTATTATATACCCATGTGTATTTATATTGTATTTGATTTGTATATTAT 450 
TTGTATTATATACCCATGTGTATTTATATTGTATTTGATTTGTATATTAT 450 
TTGTATTATATACCCATGTGTATTTATATTGTATTTGATTTGTATATTAT 450 
TTGTATCATATACCCATGTATCTTTGTATTGTATCTTGTTTGTATATTAT 450 
TTGTATCATATACCCATGTATCTTTGTATTGTATCTTGTTTGTATATTAT 450 
TTGTATCATATACCCATGTATCTTTGTATTGTATCTTGTTTGTATATTAT 450 
TTGTATTATATATCCATGTATCTTTATATTGTATCTTGTTTGTATATTAT 450 
* * * * * *  * * * * *  * * * * * * #* ^ * * * #* * * * * * * *  *  ^ * * * * * * * * * * * *
GTGAGACTAATCGTATTCCATTTGATTATAGTGAGGCT 488 
GTGAGACTAATCGTATTCCATTTGATTATAGTGAGGCT 488 
GTGAGACTAATCGTATTCCATTTGATTATAGTGAGGCT 488
GTGAGACTAATCGTATTCCATTTGATTATA-------------------480
GTGAGACTAATCGTACCCCATTTGATTATAGAGAATCT 488 
GTGAGACTAATCGTACCCCATTTGATTATAGAGAATCT 488 
GTGAGACTAATCGTACCCCATTTGATTATAGAGAATCT 488 
GCGAGACTAATCGTACCCCGTTTGATTATAGAGAGTCT 488 
*  * * * * * * * * * * * * *  * * # * * * * * * * * * *
Figure 4.6 (Continued)
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— T polycantha Ca-L trimucronatus
— T polycantha Sv-V lagopus
T polycantha Ak-V lagopus*
T polycantha Gr-D groenlandicus
— T polycantha Tu-M guentheri
T polycantha Fi-V vulpes
T polycantha De-M glaroelus
T polycantha Sc-M glaroelus
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Table 4.1 Prevalence of Taeniidae in arctic fox and sled dogs for three sampling years in northern Alaska, 
(a)
Taeniidae Prevalence in Arctic Fox
Year (N)
Total (46) 1999 (26*) 2005 (8*) 2007 (12*)
Species Prevalence 95% Cl Prevalence 95% Cl Prevalence 95% Cl Prevalence 95% Cl
E. multilocularis 15.20% 6.3-28.9% 26.90% 11.6-47.8% 0% 0-36.9% 0% 0-26.5%
T. crassiceps 47.80% 32.9-63.1% 42.30% 23.4-63.1% 50% 15.7-84.3% 8.30% 0.2-38.5
T. polyacantha 2.20% 0.1-11.5% 2.20% 0.1-11.5% 0% 0-36.9% 0% 0-26.5%
(b)
Taeniidae Prevalence in Sled dogs
2007 (12*)
Species Prevalence 95% Cl
E. multilocularis 0% 0-26.5%
T. crassiceps 58.30% 27.8-84.8%
Mixed/Equivocal 41.70% 15.2-72.3%
‘ Samples collected from the cecum o f  necropsied animals. 
* Samples were defecated from live animals (fecals).
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Investigators anticipate that the health of Arctic marine ecosystems will be disrupted by 
climate change and the associated loss of sea ice (ACIA, 2004; Fuglei and Ims, 2008; 
Regehr et al., 2009; Stirling et al., 1999). The status of polar bears and arctic fox as arctic 
sentinels facilitates their use to assess climate change effects on ecosystem health. By 
monitoring the health status and exposure to infectious agents of these sentinels, we can 
gain insight into the impact of ongoing changes in the Arctic. To this end, this thesis 
strives to coalesce the relevant biological variables and ecological context in the analysis 
and interpretation o f these data.
Currently, limited data exist on the health status of U.S. polar bear populations.
We provide a benchmark for hematological parameters of southern Beaufort Sea polar 
bears, thus facilitating assessment of this biomarker over time. We also establish 
seroprevalence and risk factors for “indicator” pathogens in this species. Associations we 
develop between serological evidence of exposure to infectious agents and hematological 
parameters described substantiate the value of using this biomarker to monitor polar bear 
health. These measures provide a “tool set” for evaluating Arctic ecosystem health.
Lowered counts of some leukocyte types in female polar bears with dependent young 
suggest this cohort may be less resilient than other sex and age groups to new challenges 
that may accompany ongoing ecosystem changes. Lowered resilience of reproducing
CONCLUSION
females may compound the already observed declines in reproductive performance of 
females related to declining sea-ice availability (Stirling et al., 1999; Regehr et al., 2009). 
This cohort is directly responsible for recruitment and thus is also important for status 
and trends assessment. Therefore, this cohort should be targeted in future polar bear 
health monitoring, research programs, and conservation monitoring that assesses arctic 
ecosystem health.
A warming Arctic may alter microbial and parasite transmission pathways as well as 
susceptibility of apex predators, including humans, to disease. However, we lack basic 
information on the current ecology of most infectious agents in northern Alaska. Because 
morbilliviruses and T. gondii pass between terrestrial and aquatic environments, they are 
of concern for marine organisms in a warming world. Changes in morbillivirus and T. 
gondii prevalence that may occur with climate change could pose an increased threat to 
the health of local people living along the coast and wildlife.
We examined a fragment of the P gene in morbillivirus isolated from arctic fox during 
and outbreak of rabies and during 2007. The morbillivirus appears canine (terrestrial) at 
the genetic level however; it cannot be distinguished from marine strains using diagnostic 
serology assays. Although we were unable to examine viral sequences from polar bears, 
serology suggests morbillivirus circulating among polar bears is distinct from that which 
infected sympatric arctic foxes in 2007. Without viral RNA sequences from polar bears, 
seals, or other sympatric species of arctic fox, we cannot determine which cross species
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transmissions of the virus are significant in northern Alaska. The results of this study 
underscore the limitations of using serology alone to examine morbillivirus 
epizootiology. Phylogenetic analyses however, do suggest that the strain isolated from 
arctic fox is distinct from European, Asian, Eurasian, and North American field strains 
and most closely related to “arctic isolates” of CDV. Future studies should target 
isolation of morbilliviral nucleic acid from other carnivores across the Arctic and also 
sequence the less conserved H and fusion (F) genes of the strain isolated from North 
Slope arctic fox, in order to elucidate the phylogeny of this virus in the Arctic. Isolation 
of species and region specific pathogens is very important for development of appropriate 
research and diagnostic tools. Thus we provide a practical means to fulfill this need in the 
context of the “One Health” perspective.
The hematology and serology data we present for Alaskan polar bears emphasize the 
potential importance of synergisms among various potential stressors (morbillivirus, 
organochlorines, climate change, increased human presence etc.) that may undermine the 
resistence (immune system) of polar bears to changes in their habitats. We have set the 
stage to use these hematologic measures as a biomarker to assess polar bear responses to 
changing infectious agents, nutritional status, and toxicant exposure that may result from 
global warming. The seroprevalence patterns we establish for two “indicator” infectious 
agents (morbillivirus and T. gondii) and associations we demonstrate between 
seroprevalence and hematological biomarkers illustrate how monitoring polar bear health 
can provide an index of changing pathogen occurrence throughout the Arctic. Similarly,
we propose canids to be the best sentinels for monitoring the impact of climate change on 
the ecology of Echinococcus.
Despite its public health significance as a zoonosis, there is limited information available 
regarding the current ecology and transmission dynamics of E. multilocularis in the 
northern Alaska. With anticipated changes in Arctic ecology due to climate change and 
increasing anthropogenic influences, prevalence of this zoonotic agent is likely to change 
with host range shifts. Understanding its ecology and monitoring its prevalence will be 
necessary to understand the human health consequences of ongoing and projected 
changes in the Arctic. We identified the species of Echinococcus present in arctic fox on 
the Alaska North Slope as E. multilocularis. Similar to our investigation of CDV, such 
studies can be conducted opportunistically as samples become available from rabies and 
predator control programs, trapping and health assessments of Arctic canids. Although 
we could not assess the relationship of the strain we isolated from arctic fox to North 
America strains (genetic information was unavailable in the database), the North Slope 
arctic fox isolate was most similar to Asian isolates based on maximum likelihood 
analysis. This observation is consistent with the previous detection of Asian isolates in St. 
Lawrence Island, Alaska. Sequence analysis of isolates of T. crassiceps and T. 
polyacantha demonstrated the greatest homology with isolates derived from the same 
host (V. lagopus).
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Ongoing and anticipated changes in the Arctic have generated concern for both the health
of human and of wildlife populations and communities. The health of ecosystems is 
reflected in the health of animals inhabiting those ecosystems and the identification of 
Arctic sentinels is critical at this time, and possibly overdue. Many data gaps remain 
regarding the status of Arctic fauna, which hinder our ability to assess the impacts of 
climate change on ecosystem health in the Arctic. Baseline health information on 
monitored species is needed in order to address change over time and to better interpret 
data collected on movement (e.g., satellite collars), body condition (morphometries), 
abundance and trends (mark-recapture), and feeding ecology. Furthermore, there is a 
need to improve knowledge of pathogens currently present, as well at their transmission 
dynamics and to establish mechanisms to detect emergence of pathogens of concern.
With the use of biomarkers, we may detect changes at the physiological level before they 
manifest at the population level, thus facilitating proactive measures with a greater 
chance of success (noting a significant change in abundance or recruitment is “after the 
fact”). We suggest that a “One Health” approach provides the best tools for addressing 
these knowledge gaps and provide examples of how this may be accomplished in the 
Arctic. Understanding Arctic ecosystem health will require the collaborative efforts of 
experts in diverse fields as well as input from local, traditional ecological knowledge over 
the proper spatial and temporal scales.
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